0,1,2,3
ABBV,3 DAYS AGO,AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/abbvie-to-present-at-the-10th-annual-svb-leerink-global-healthcare-conference-2021-02
ABC,"FEB 4, 2021",AmerisourceBergen Reports Fiscal 2021 First Quarter Results,https://www.nasdaq.com/press-release/amerisourcebergen-reports-fiscal-2021-first-quarter-results-2021-02-04
ABCL,5 DAYS AGO,"AbCellera Appoints Ester Falconer, Ph.D., as Chief Technology Officer",https://www.nasdaq.com/press-release/abcellera-appoints-ester-falconer-ph.d.-as-chief-technology-officer-2021-02-11
ABCM,"JAN 28, 2021",Abcam Plc Appointment of Non-Executive Directors,https://www.nasdaq.com/press-release/abcam-plc-appointment-of-non-executive-directors-2021-01-28
ABEO,4 DAYS AGO,New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene Therapy,https://www.nasdaq.com/press-release/new-positive-phase-1-2-interim-data-presented-at-worldsymposiumtm-shows
ABIO,"DEC 15, 2020",ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19,https://www.nasdaq.com/press-release/arca-biopharma-announces-first-patients-enrolled-in-aspen-covid-19-phase-2b-clinical
ABMD,"JAN 29, 2021",Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist,https://www.nasdaq.com/press-release/large-clinical-study-presented-at-sts-2021-finds-79-survival-rate-with-impella-5.5
ABT,"JAN 27, 2021",Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021,https://www.nasdaq.com/press-release/abbott-reports-fourth-quarter-2020-results-issues-strong-double-digit-growth-forecast
ABUS,"JAN 25, 2021",Arbutus Announces 2021 Corporate Objectives and Provides Financial Update,https://www.nasdaq.com/press-release/arbutus-announces-2021-corporate-objectives-and-provides-financial-update-2021-01-25
ACAD,6 DAYS AGO,"Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021",https://www.nasdaq.com/press-release/acadia-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2020-financial
ACER,5 DAYS AGO,Acer Therapeutics Announces Topline Results from its Bioequivalence Trial of ACER-001 Compared to BUPHENYL® Under Fed Conditions,https://www.nasdaq.com/press-release/acer-therapeutics-announces-topline-results-from-its-bioequivalence-trial-of-acer-001
ACET,14 HOURS AGO,"Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares",https://www.nasdaq.com/press-release/adicet-bio-inc.-announces-closing-of-%24152-million-public-offering-and-concurrent
ACHC,6 DAYS AGO,ACADIA HEALTHCARE ANNOUNCES DATE FOR FOURTH QUARTER AND YEAR-END 2020 EARNINGS RELEASE,https://www.nasdaq.com/press-release/acadia-healthcare-announces-date-for-fourth-quarter-and-year-end-2020-earnings
ACHV,5 DAYS AGO,"Achieve Life Sciences to Present at the MicroCap Rodeo Winter Wonderland Conference on February 16, 2021",https://www.nasdaq.com/press-release/achieve-life-sciences-to-present-at-the-microcap-rodeo-winter-wonderland-conference
ACIU,5 DAYS AGO,AC Immune’s Alzheimer’s Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study,https://www.nasdaq.com/press-release/ac-immunes-alzheimers-vaccine-generates-potent-anti-ptau-antibody-response-in-a-phase
ACOR,5 DAYS AGO,Acorda Therapeutics Announces Completion of Sale of Manufacturing Operations to Catalent,https://www.nasdaq.com/press-release/acorda-therapeutics-announces-completion-of-sale-of-manufacturing-operations-to
ACRS,6 DAYS AGO,Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/aclaris-therapeutics-to-participate-in-the-10th-annual-svb-leerink-global-healthcare
ACRX,"JAN 20, 2021",AcelRx Announces Pricing of $27.5 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/acelrx-announces-pricing-of-%2427.5-million-public-offering-of-common-stock-2021-01-20
ACST,"FEB 9, 2021",Acasti Pharma Announces Results for Third Quarter of Fiscal 2021,https://www.nasdaq.com/press-release/acasti-pharma-announces-results-for-third-quarter-of-fiscal-2021-2021-02-09
ADAP,5 DAYS AGO,"Adaptimmune to Report Fourth Quarter/ Full Year 2020 Financial Results and Business Updates on Thursday, February 25, 2021",https://www.nasdaq.com/press-release/adaptimmune-to-report-fourth-quarter-full-year-2020-financial-results-and-business
ADCT,"FEB 5, 2021",ADC Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Day,https://www.nasdaq.com/press-release/adc-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021-oncology-day-2021
ADIL,"JAN 26, 2021",Adial Pharmaceuticals Closes Acquisition of Purnovate,https://www.nasdaq.com/press-release/adial-pharmaceuticals-closes-acquisition-of-purnovate-2021-01-26
ADILW,"MAR 26, 2019","Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer",https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-appointment-bankole-johnson-md-chief-medical-officer
ADMA,"FEB 1, 2021","ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN",https://www.nasdaq.com/press-release/adma-biologics-receives-fda-approval-for-adma-biocenters-plasma-collection-facility
ADMP,"FEB 2, 2021",Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock,https://www.nasdaq.com/press-release/adamis-pharmaceuticals-announces-closing-of-public-offering-of-common-stock-2021-02
ADMS,6 DAYS AGO,"Adamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021",https://www.nasdaq.com/press-release/adamas-to-announce-fourth-quarter-and-year-end-2020-financial-results-and-host
ADPT,"FEB 2, 2021","Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021",https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-fourth-quarter-and-full-year-2020-financial
ADTX,"JAN 29, 2021","Immunologist and Clinical Transplant Expert, Dolly B. Tyan, PhD, Joins Aditxt as Senior VP of Clinical Development - Transplantation",https://www.nasdaq.com/press-release/immunologist-and-clinical-transplant-expert-dolly-b.-tyan-phd-joins-aditxt-as-senior
ADUS,5 DAYS AGO,Addus Homecare Announces Fourth-Quarter and Year-End 2020 Earnings Release and Conference Call,https://www.nasdaq.com/press-release/addus-homecare-announces-fourth-quarter-and-year-end-2020-earnings-release-and
ADVM,6 DAYS AGO,"Adverum to Present Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD at the Angiogenesis, Exudation, and Degeneration 2021 Virtual Meeting",https://www.nasdaq.com/press-release/adverum-to-present-data-from-the-optic-phase-1-trial-with-advm-022-intravitreal-gene
ADXN,20 HOURS AGO,Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use Disorder,https://www.nasdaq.com/press-release/addex-gabab-positive-allosteric-modulator-demonstrates-promise-in-alcohol-use
ADXS,"JAN 25, 2021",Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update,https://www.nasdaq.com/press-release/advaxis-reports-fiscal-year-2020-financial-results-and-provides-a-business-update
AEMD,6 DAYS AGO,Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/aethlon-medical-announces-third-quarter-financial-results-and-provides-corporate-0
AERI,"JAN 11, 2021",Aerie Pharmaceuticals Receives European Commission Approval for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%,https://www.nasdaq.com/press-release/aerie-pharmaceuticals-receives-european-commission-approval-for-roclandar-netarsudil
AEZS,2 HOURS AGO,Aeterna Zentaris Announces $10.0 Million Bought Deal Offering of Common Shares,https://www.nasdaq.com/press-release/aeterna-zentaris-announces-%2410.0-million-bought-deal-offering-of-common-shares-2021
AFIB,"FEB 9, 2021","Acutus Medical, Inc. Appoints New Chief Financial Officer and New Board Member",https://www.nasdaq.com/press-release/acutus-medical-inc.-appoints-new-chief-financial-officer-and-new-board-member-2021-02
AFMD,"FEB 3, 2021",Affimed Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors,https://www.nasdaq.com/press-release/affimed-announces-collaboration-with-roche-to-study-afm24-in-combination-with-pd-l1
AGE,"DEC 22, 2020","AgeX Therapeutics, Inc. Announces That Its Annual Meeting of Stockholders Will Be Conducted Online Only",https://www.nasdaq.com/press-release/agex-therapeutics-inc.-announces-that-its-annual-meeting-of-stockholders-will-be
AGEN,"FEB 9, 2021",Andy Hurley Named Agenus Chief Commercial Officer,https://www.nasdaq.com/press-release/andy-hurley-named-agenus-chief-commercial-officer-2021-02-09
AGIO,5 DAYS AGO,"Agios to Webcast Conference Call of Fourth Quarter and Year End 2020 Financial Results on February 25, 2021",https://www.nasdaq.com/press-release/agios-to-webcast-conference-call-of-fourth-quarter-and-year-end-2020-financial
AGLE,"FEB 3, 2021",Aeglea BioTherapeutics Announces Transition of Chief Financial Officer,https://www.nasdaq.com/press-release/aeglea-biotherapeutics-announces-transition-of-chief-financial-officer-2021-02-03
AGRX,"JAN 4, 2021",Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference,https://www.nasdaq.com/press-release/agile-therapeutics-to-participate-in-fireside-chat-at-the-h.c.-wainwright-bioconnect
AGTC,9 HOURS AGO,"AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021",https://www.nasdaq.com/press-release/agtc-to-present-at-the-ois-gene-therapy-innovation-showcase-on-february-18-2021-2021
AHCO,4 DAYS AGO,AdaptHealth Corp. Schedules Fourth Quarter and Full Year 2020 Financial Results and Conference Call,https://www.nasdaq.com/press-release/adapthealth-corp.-schedules-fourth-quarter-and-full-year-2020-financial-results-and
AHPI,,,
AIH,"FEB 9, 2021",Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China,https://www.nasdaq.com/press-release/chinese-aesthetic-treatment-industry-white-paper-2020-jointly-released-by-aih-and
AIKI,3 HOURS AGO,AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock,https://www.nasdaq.com/press-release/aikido-pharma-inc.-announces-%2410-million-bought-deal-offering-of-common-stock-2021-02
AIM,12 HOURS AGO,AIM ImmunoTech Announces Ethics Committee Approval to Commence Phase 1 Clinical Study of Ampligen as an Intranasal Therapy,https://www.nasdaq.com/press-release/aim-immunotech-announces-ethics-committee-approval-to-commence-phase-1-clinical-study
AKBA,"FEB 8, 2021",Akebia Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results and Discuss Recent Business Highlights,https://www.nasdaq.com/press-release/akebia-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-and
AKER,"DEC 2, 2020",Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent,https://www.nasdaq.com/press-release/akers-proposed-merger-partner-mymd-pharmaceuticals-announces-issuance-of-key-patent
AKRO,"JAN 4, 2021",Akero Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/akero-therapeutics-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference
AKTX,"FEB 1, 2021",Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease,https://www.nasdaq.com/press-release/akari-therapeutics-adds-histamine-inhibitor-votucalis-to-pipeline-to-treat
AKU,"NOV 2, 2020",Akumin Inc. Announces Completion of Offering of Senior Secured Notes,https://www.nasdaq.com/press-release/akumin-inc.-announces-completion-of-offering-of-senior-secured-notes-2020-11-02
AKUS,"JAN 11, 2021",Akouos and Blueprint Genetics Announce the Resonate Program to Improve Access to Genetic Testing for Individuals with Auditory Neuropathy,https://www.nasdaq.com/press-release/akouos-and-blueprint-genetics-announce-the-resonate-program-to-improve-access-to
ALBO,5 DAYS AGO,Albireo Presents Odevixibat Commercialization Road to $1 Billion,https://www.nasdaq.com/press-release/albireo-presents-odevixibat-commercialization-road-to-%241-billion-2021-02-11
ALC,"JAN 20, 2021",Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S.,https://www.nasdaq.com/press-release/alcon-launches-precision1-for-astigmatism-contact-lenses-in-the-u.s.-2021-01-20
ALDX,"FEB 4, 2021",Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design,https://www.nasdaq.com/press-release/aldeyra-therapeutics-announces-phase-3-tranquility-dry-eye-disease-trial-design-2021
ALEC,"JAN 25, 2021",Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL002 in Individuals with Early Alzheimer’s Disease,https://www.nasdaq.com/press-release/alector-announces-first-participant-dosed-in-phase-2-study-evaluating-al002-in
ALGN,"FEB 3, 2021",Align Technology Announces the iTero Element Plus Series Next Generation of Scanners and Imaging Systems,https://www.nasdaq.com/press-release/align-technology-announces-the-itero-element-plus-series-next-generation-of-scanners
ALGS,"FEB 3, 2021",Aligos Therapeutics Presents Data for its Chronic Hepatitis B Drug Candidates at the 30th Annual Conference of the Asian Pacific Association for the Study of the Liver,https://www.nasdaq.com/press-release/aligos-therapeutics-presents-data-for-its-chronic-hepatitis-b-drug-candidates-at-the
ALIM,1 DAY AGO,Alimera Sciences to Present at the Microcap Rodeo Winter Wonderland Conference,https://www.nasdaq.com/press-release/alimera-sciences-to-present-at-the-microcap-rodeo-winter-wonderland-conference-2021
ALKS,5 DAYS AGO,"Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2020 and Provides Financial Expectations for 2021",https://www.nasdaq.com/press-release/alkermes-plc-reports-financial-results-for-the-fourth-quarter-and-year-ended-dec.-0
ALLK,"DEC 22, 2020",Allakos Appoints Natalie Holles to its Board of Directors,https://www.nasdaq.com/press-release/allakos-appoints-natalie-holles-to-its-board-of-directors-2020-12-22
ALLO,6 DAYS AGO,Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies,https://www.nasdaq.com/press-release/notch-therapeutics-closes-%2485-million-series-a-financing-to-develop-pipeline-of
ALNA,"FEB 2, 2021","Allena Pharmaceuticals Appoints Richard D. Katz, M.D. as Chief Financial Officer",https://www.nasdaq.com/press-release/allena-pharmaceuticals-appoints-richard-d.-katz-m.d.-as-chief-financial-officer-2021
ALNY,5 DAYS AGO,Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity,https://www.nasdaq.com/press-release/alnylam-pharmaceuticals-reports-fourth-quarter-and-full-year-2020-financial-results
ALPN,"JAN 6, 2021",Alpine Immune Sciences Announces Executive Leadership Addition and Promotion,https://www.nasdaq.com/press-release/alpine-immune-sciences-announces-executive-leadership-addition-and-promotion-2021-01
ALRN,"JAN 11, 2021","Aileron Therapeutics Announces Completion of $35.9 Million Registered Direct Offering with Participation by New Fundamental Healthcare Investors Acorn Bioventures, BVF Partners, L.P. and Maven Investment Partners",https://www.nasdaq.com/press-release/aileron-therapeutics-announces-completion-of-%2435.9-million-registered-direct-offering
ALT,"DEC 30, 2020","Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B",https://www.nasdaq.com/press-release/altimmune-begins-multinational-phase-2-clinical-trial-of-heptcelltm-a-novel
ALVR,5 DAYS AGO,AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience,https://www.nasdaq.com/press-release/allovir-research-presented-at-the-2021-transplantation-cellular-therapy-meeting
ALXN,"FEB 4, 2021",Alexion Reports Fourth Quarter and Full Year 2020 Results,https://www.nasdaq.com/press-release/alexion-reports-fourth-quarter-and-full-year-2020-results-2021-02-04
ALXO,"JAN 11, 2021",ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2021,https://www.nasdaq.com/press-release/alx-oncology-provides-corporate-update-and-highlights-key-milestones-in-2021-2021-01
AMED,"FEB 9, 2021",Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date,https://www.nasdaq.com/press-release/amedisys-announces-fourth-quarter-and-year-end-earnings-release-and-conference-call-0
AMGN,5 HOURS AGO,FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer,https://www.nasdaq.com/press-release/fda-grants-sotorasib-priority-review-designation-for-the-treatment-of-patients-with
AMPE,12 HOURS AGO,"Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference",https://www.nasdaq.com/press-release/ampio-pharmaceuticals-inc.-to-present-at-upcoming-investor-conference-2021-02-16
AMPH,"DEC 29, 2020","Amphastar Announces Approval for Glucagon for Injection Kit, 1mg",https://www.nasdaq.com/press-release/amphastar-announces-approval-for-glucagon-for-injection-kit-1mg-2020-12-29
AMRN,"FEB 9, 2021",Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong,https://www.nasdaq.com/press-release/amarin-provides-update-on-vascepar-icosapent-ethyl-regulatory-review-processes-in
AMRX,"FEB 4, 2021","Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26, 2021",https://www.nasdaq.com/press-release/amneal-to-report-fourth-quarter-full-year-2020-results-on-february-26-2021-2021-02-04
AMS,"NOV 12, 2020",American Shared Hospital Services Reports Third Quarter 2020 Financial Results,https://www.nasdaq.com/press-release/american-shared-hospital-services-reports-third-quarter-2020-financial-results-2020
AMTI,"JAN 19, 2021",Applied Molecular Transport Appoints Douglas Rich as Chief Technical Officer,https://www.nasdaq.com/press-release/applied-molecular-transport-appoints-douglas-rich-as-chief-technical-officer-2021-01
AMYT,"FEB 4, 2021",Amryt and Medison Pharma Sign Multi-Regional Distribution Agreements in Canada and Israel,https://www.nasdaq.com/press-release/amryt-and-medison-pharma-sign-multi-regional-distribution-agreements-in-canada-and
ANAB,"JAN 7, 2021",AnaptysBio to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/anaptysbio-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference-2021-01-07
ANCN,"DEC 15, 2020",Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement,https://www.nasdaq.com/press-release/anchiano-therapeutics-and-chemomab-announce-entry-into-definitive-merger-agreement
ANGN,"FEB 9, 2021","Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares",https://www.nasdaq.com/press-release/angion-biomedica-corp.-announces-closing-of-%24117-million-initial-public-offering-and
ANGO,"FEB 1, 2021","AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs",https://www.nasdaq.com/press-release/angiodynamics-appoints-richard-c.-rosenzweig-senior-vice-president-general-counsel
ANIK,"FEB 9, 2021","Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021",https://www.nasdaq.com/press-release/anika-to-issue-fourth-quarter-and-year-end-2020-financial-results-on-thursday-march-4
ANIP,4 HOURS AGO,"ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021",https://www.nasdaq.com/press-release/ani-pharmaceuticals-to-discuss-fourth-quarter-and-full-year-2020-financial-results-on
ANIX,12 HOURS AGO,Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates,https://www.nasdaq.com/press-release/anixa-biosciences-begins-animal-testing-of-covid-19-therapeutic-candidates-2021-02-16
ANNX,"FEB 8, 2021","Annexon Welcomes William H. Carson, M.D. to the Board of Directors",https://www.nasdaq.com/press-release/annexon-welcomes-william-h.-carson-m.d.-to-the-board-of-directors-2021-02-08
ANPC,"FEB 8, 2021",China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility),https://www.nasdaq.com/press-release/chinas-nmpa-approved-starting-of-registration-testing-of-anpac-bio-class-iii-medical
ANTM,"FEB 8, 2021","Anthem to Host Virtual Investor Day Conference on March 3, 2021",https://www.nasdaq.com/press-release/anthem-to-host-virtual-investor-day-conference-on-march-3-2021-2021-02-08
ANVS,14 HOURS AGO,Annovis Bio to Present at the BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/annovis-bio-to-present-at-the-bio-ceo-investor-digital-conference-2021-02-16
APEN,"FEB 8, 2021",Apollo Endosurgery Announces CEO Transition,https://www.nasdaq.com/press-release/apollo-endosurgery-announces-ceo-transition-2021-02-08
APLS,"FEB 5, 2021",Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/apellis-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-18
APLT,5 DAYS AGO,"Applied Therapeutics, Inc. Announces Pricing of Public Offering of 3,000,000 Shares of Common Stock",https://www.nasdaq.com/press-release/applied-therapeutics-inc.-announces-pricing-of-public-offering-of-3000000-shares-of
APM,"JAN 20, 2021","Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)",https://www.nasdaq.com/press-release/aptorum-group-receives-clearance-from-health-canada-to-initiate-a-phase-1-clinical
APOP,"NOV 20, 2020",Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelerate Progress in 2021,https://www.nasdaq.com/press-release/cellect-biotechnology-reports-third-quarter-financial-and-operating-results-recent
APOPW,,,
APRE,"JAN 8, 2021","Aprea Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021",https://www.nasdaq.com/press-release/aprea-therapeutics-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference-on
APT,"NOV 5, 2020","Alpha Pro Tech, Ltd. Announces Financial Results for the Third Quarter of 2020",https://www.nasdaq.com/press-release/alpha-pro-tech-ltd.-announces-financial-results-for-the-third-quarter-of-2020-2020-11
APTO,"DEC 6, 2020",Aptose Presents Highlights from ASH and Corporate Update Event,https://www.nasdaq.com/press-release/aptose-presents-highlights-from-ash-and-corporate-update-event-2020-12-06
APTX,5 DAYS AGO,Aptinyx to Participate at 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/aptinyx-to-participate-at-10th-annual-svb-leerink-global-healthcare-conference-2021
APVO,"FEB 9, 2021",Aptevo Confirms Receipt of Nominations and Proposal Notice,https://www.nasdaq.com/press-release/aptevo-confirms-receipt-of-nominations-and-proposal-notice-2021-02-09
APYX,"FEB 1, 2021","Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 31, 2021",https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-fourth-quarter-and-fiscal-year-2020-financial
AQST,"FEB 9, 2021","Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors",https://www.nasdaq.com/press-release/aquestive-therapeutics-strengthens-board-of-directors-with-appointments-of-julie-krop
ARAV,13 HOURS AGO,"Aravive Announces $21.0 Million Registered Direct Offering with Eshelman Ventures, LLC Priced At-The-Market",https://www.nasdaq.com/press-release/aravive-announces-%2421.0-million-registered-direct-offering-with-eshelman-ventures-llc
ARAY,"FEB 5, 2021","Accuray to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference",https://www.nasdaq.com/press-release/accuray-to-participate-in-btigs-virtual-medtech-digital-health-life-science-and
ARCT,5 DAYS AGO,Arcturus Therapeutics to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/arcturus-therapeutics-to-present-at-upcoming-investor-conferences-2021-02-11
ARDS,"NOV 24, 2020","Aridis Pharmaceuticals to Host Fireside Chat with Analysts to Discuss 2021 Outlook for its Lead Programs and Novel mAb Discovery Platform on December 4th, 2020",https://www.nasdaq.com/press-release/aridis-pharmaceuticals-to-host-fireside-chat-with-analysts-to-discuss-2021-outlook
ARDX,"NOV 23, 2020",Ardelyx to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference,https://www.nasdaq.com/press-release/ardelyx-to-present-at-the-piper-sandler-32nd-annual-virtual-healthcare-conference
ARGX,"FEB 5, 2021",argenx announces closing of global offering,https://www.nasdaq.com/press-release/argenx-announces-closing-of-global-offering-2021-02-05
ARMP,"JAN 27, 2021",Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs,https://www.nasdaq.com/press-release/armata-pharmaceuticals-announces-%2420-million-investment-to-support-advancement-of-the
ARNA,5 HOURS AGO,Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23,https://www.nasdaq.com/press-release/arena-pharmaceuticals-to-release-fourth-quarter-full-year-2020-financial-results-and
ARPO,"JAN 5, 2021",Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial,https://www.nasdaq.com/press-release/aerpio-announces-strategic-review-after-topline-results-from-razuprotafib-glaucoma
ARQT,,,
ARTL,12 HOURS AGO,"Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer",https://www.nasdaq.com/press-release/artelo-biosciences-announces-appointment-of-andrew-yates-ph.d.-as-senior-vice
ARTLW,,,
ARVN,"FEB 8, 2021",Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day,https://www.nasdaq.com/press-release/arvinas-to-present-at-the-guggenheim-healthcare-talks%3A-2021-oncology-day-2021-02-08
ARWR,"FEB 4, 2021",Arrowhead Pharmaceuticals Reports Fiscal 2021 First Quarter Results,https://www.nasdaq.com/press-release/arrowhead-pharmaceuticals-reports-fiscal-2021-first-quarter-results-2021-02-04
ASLN,"JAN 26, 2021",New Research Published in Toxicology in Vitro Provides Insight Into the Hepatotoxicity of DHODH Inhibitors Suggesting ASLAN003 Has the Potential to Be Best-In-Class,https://www.nasdaq.com/press-release/new-research-published-in-toxicology-in-vitro-provides-insight-into-the
ASMB,"FEB 5, 2021",Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021
ASND,"JAN 10, 2021",Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/ascendis-pharma-a-s-provides-vision-3x3-update-at-39th-annual-j.p.-morgan-healthcare
ASRT,4 DAYS AGO,"Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $34.3 Million",https://www.nasdaq.com/press-release/assertio-holdings-inc.-announces-closing-of-registered-direct-offering-of-%2434.3
ATEC,12 HOURS AGO,ATEC to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/atec-to-participate-in-upcoming-investor-conferences-2021-02-16
ATHA,6 DAYS AGO,Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/athira-pharma-announces-exercise-of-underwriters-option-to-purchase-additional-shares
ATHE,"FEB 9, 2021",Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials,https://www.nasdaq.com/press-release/alterity-therapeutics-announces-funding-from-michael-j.-fox-foundation-for-ath434
ATHX,13 HOURS AGO,Athersys Announces Cooperation Agreement With HEALIOS K.K.,https://www.nasdaq.com/press-release/athersys-announces-cooperation-agreement-with-healios-k.k.-2021-02-16
ATNF,"JAN 11, 2021",180 Life Sciences Corp. to Present at the Biotech Showcase(TM) Digital 2021 Conference,https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-present-at-the-biotech-showcasetm-digital-2021-conference
ATNFW,,,
ATNM,5 DAYS AGO,Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting Iomab-B and Pivotal Phase 3 SIERRA Trial at 2021 Transplantation & Cellular Therapy Annual Meeting,https://www.nasdaq.com/press-release/actinium-showcases-targeted-conditioning-program-with-2-oral-presentations
ATNX,5 DAYS AGO,Almirall announces New England Journal of Medicine publication of Phase III data demonstrating efficacy and safety of Klisyri® (tirbanibulin),https://www.nasdaq.com/press-release/almirall-announces-new-england-journal-of-medicine-publication-of-phase-iii-data
ATOS,6 DAYS AGO,Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Accomplishments and Strategy for 2021,https://www.nasdaq.com/press-release/atossa-therapeutics-president-and-ceo-dr.-steven-c.-quay-issues-annual-letter-to-0
ATRA,"FEB 8, 2021",Atara Biotherapeutics Presents Key Data for Advancing the Development of Tab-cel® and ATA188 at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience,https://www.nasdaq.com/press-release/atara-biotherapeutics-presents-key-data-for-advancing-the-development-of-tab-celr-and
ATRC,6 DAYS AGO,AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/atricure-to-participate-at-the-svb-leerink-10th-annual-global-healthcare-conference
ATRI,"NOV 13, 2020",Atrion Corporation Declares Quarterly Cash Dividend,https://www.nasdaq.com/press-release/atrion-corporation-declares-quarterly-cash-dividend-2020-11-13
ATRS,"JAN 11, 2021",Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million,https://www.nasdaq.com/press-release/antares-pharma-announces-full-year-2021-revenue-guidance-of-%24175-200-million-2021-01
ATXI,"DEC 18, 2020",Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network,https://www.nasdaq.com/press-release/avenue-therapeutics-announces-publication-of-real-world-data-on-nonmedical-use-of
AUPH,"JAN 22, 2021",FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis,https://www.nasdaq.com/press-release/fda-approves-aurinia-pharmaceuticals-lupkynistm-voclosporin-for-adult-patients-with
AUTL,4 DAYS AGO,Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs,https://www.nasdaq.com/press-release/autolus-announces-closing-of-public-offering-and-full-exercise-of-option-to-purchase
AVDL,6 DAYS AGO,Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/avadel-pharmaceuticals-to-participate-in-a-fireside-chat-at-the-10th-annual-svb
AVEO,5 DAYS AGO,AVEO Oncology Announces Presentation of Key Subgroup and Quality of Life Analyses from the Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma,https://www.nasdaq.com/press-release/aveo-oncology-announces-presentation-of-key-subgroup-and-quality-of-life-analyses
AVGR,"FEB 3, 2021","Aegis Capital Corp. acted as Sole Bookrunner on a $14.4 Million Bought Deal Offering for Avinger, Inc. (NASDAQ: AVGR)",https://www.nasdaq.com/press-release/aegis-capital-corp.-acted-as-sole-bookrunner-on-a-%2414.4-million-bought-deal-offering
AVIR,"FEB 8, 2021",Atea Pharmaceuticals Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2,https://www.nasdaq.com/press-release/atea-pharmaceuticals-announces-publication-of-preclinical-data-highlighting-potent
AVNS,5 DAYS AGO,"Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full-Year 2020 Financial Results",https://www.nasdaq.com/press-release/avanos-medical-inc.-to-webcast-conference-call-discussing-fourth-quarter-and-full-0
AVRO,"FEB 8, 2021",AVROBIO Announces 100% Kidney Substrate Reduction at 12 Months Post-Gene Therapy in First Patient Dosed with plato® Gene Therapy Platform in Fabry Disease Phase 2 Trial,https://www.nasdaq.com/press-release/avrobio-announces-100-kidney-substrate-reduction-at-12-months-post-gene-therapy-in
AVXL,5 DAYS AGO,Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook,https://www.nasdaq.com/press-release/anavex-life-sciences-reports-fiscal-2021-first-quarter-financial-results-and-business
AWH,4 DAYS AGO,"Aspira Women’s Health, Inc. to Participate in BTIG’s Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference",https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-participate-in-btigs-virtual-medtech-digital-health-life
AXGN,"FEB 4, 2021","Axogen, Inc. to Participate at Upcoming February Investor Conferences",https://www.nasdaq.com/press-release/axogen-inc.-to-participate-at-upcoming-february-investor-conferences-2021-02-04
AXLA,"JAN 11, 2021","Axcella Announces IND Clearance for AXA1665, Program Updates and 2021 Milestones",https://www.nasdaq.com/press-release/axcella-announces-ind-clearance-for-axa1665-program-updates-and-2021-milestones-2021
AXNX,15 HOURS AGO,Axonics® Receives FDA Approval for Third-Generation Implantable Neurostimulator,https://www.nasdaq.com/press-release/axonicsr-receives-fda-approval-for-third-generation-implantable-neurostimulator-2021
AXSM,14 HOURS AGO,"Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021",https://www.nasdaq.com/press-release/axsome-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results-on
AYLA,"JAN 28, 2021",Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with Notch-Activated Triple Negative Breast Cancer,https://www.nasdaq.com/press-release/ayala-pharmaceuticals-announces-first-patient-dosed-in-phase-2-tenacity-clinical
AYTU,5 DAYS AGO,"Aytu BioScience Announces Record Fiscal Q2 2021 Net Revenue of $15.1 Million, an Increase of 377% Year-Over-Year",https://www.nasdaq.com/press-release/aytu-bioscience-announces-record-fiscal-q2-2021-net-revenue-of-%2415.1-million-an
AZN,12 HOURS AGO,/C O R R E C T I O N -- AliveCor/,https://www.nasdaq.com/press-release/c-o-r-r-e-c-t-i-o-n-alivecor-2021-02-16
AZRX,14 HOURS AGO,AzurRx BioPharma to Present at The Microcap Rodeo Winter Wonderland Conference,https://www.nasdaq.com/press-release/azurrx-biopharma-to-present-at-the-microcap-rodeo-winter-wonderland-conference-2021
AZYO,1 DAY AGO,"Aziyo Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021",https://www.nasdaq.com/press-release/aziyo-biologics-to-report-fourth-quarter-and-full-year-2020-financial-results-on
BASI,5 DAYS AGO,"Bioanalytical Systems, Inc., doing business as Inotiv, Appoints Greg Beattie as Chief Operating Officer",https://www.nasdaq.com/press-release/bioanalytical-systems-inc.-doing-business-as-inotiv-appoints-greg-beattie-as-chief
BAX,4 HOURS AGO,Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director,https://www.nasdaq.com/press-release/baxter-appoints-dr.-david-wilkes-to-its-board-and-albert-stroucken-as-lead
BBI,"JAN 19, 2021","Brickell Biotech Announces Publication of Japan Pivotal Phase 3 Study Results for Sofpironium Bromide Gel, 5% (ECCLOCK®) in the Journal of Dermatology",https://www.nasdaq.com/press-release/brickell-biotech-announces-publication-of-japan-pivotal-phase-3-study-results-for
BBIO,4 DAYS AGO,"BridgeBio Pharma, Inc. Announces Pricing of Secondary Offering of Common Stock",https://www.nasdaq.com/press-release/bridgebio-pharma-inc.-announces-pricing-of-secondary-offering-of-common-stock-2021-02
BCAB,"DEC 18, 2020",BioAtla Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/bioatla-announces-closing-of-initial-public-offering-and-full-exercise-of-the
BCDA,"FEB 2, 2021",BioCardia Update on Cell Therapy Product Development and 2021 Milestones,https://www.nasdaq.com/press-release/biocardia-update-on-cell-therapy-product-development-and-2021-milestones-2021-02-02
BCDAW,,,
BCEL,"NOV 12, 2020",Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments,https://www.nasdaq.com/press-release/atreca-reports-third-quarter-2020-financial-results-and-recent-corporate-developments
BCLI,"FEB 9, 2021",BrainStorm Announces Feedback from FDA Type-C Meeting on Future NurOwn® Manufacturing Plan,https://www.nasdaq.com/press-release/brainstorm-announces-feedback-from-fda-type-c-meeting-on-future-nurownr-manufacturing
BCRX,5 DAYS AGO,BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25,https://www.nasdaq.com/press-release/biocryst-to-report-fourth-quarter-and-full-year-2020-financial-results-on-february-25
BCYC,"JAN 26, 2021",Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data of Tumor-Targeted Immune Cell Agonists (TICAs™) in the Journal for ImmunoTherapy of Cancer,https://www.nasdaq.com/press-release/bicycle-therapeutics-announces-publication-of-article-highlighting-preclinical-data
BDSI,5 DAYS AGO,BioDelivery Sciences CFO Terry Coelho Promoted to Executive Vice President,https://www.nasdaq.com/press-release/biodelivery-sciences-cfo-terry-coelho-promoted-to-executive-vice-president-2021-02-11
BDSX,15 HOURS AGO,Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools,https://www.nasdaq.com/press-release/biodesix-partners-with-chicago-public-schools-for-covid-19-testing-to-safely-reopen
BDTX,5 DAYS AGO,Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series,https://www.nasdaq.com/press-release/black-diamond-therapeutics-to-present-at-the-bmo-biopharma-spotlight-series-2021-02
BDX,4 DAYS AGO,BD to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/bd-to-present-at-upcoming-investor-conferences-2021-02-12
BDXB,"DEC 2, 2020",BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years,https://www.nasdaq.com/press-release/bd-to-invest-%241.2-billion-in-pre-fillable-syringe-manufacturing-capacity-over-next-0
BEAM,,,
BEAT,"FEB 2, 2021",Investors Bancorp Set to Join S&P SmallCap 600,https://www.nasdaq.com/press-release/investors-bancorp-set-to-join-sp-smallcap-600-2021-02-02
BFRA,"FEB 2, 2021","Biofrontera AG: Ludwig Lutter appointed new Chief Financial Officer effective March 1, 2021",https://www.nasdaq.com/press-release/biofrontera-ag%3A-ludwig-lutter-appointed-new-chief-financial-officer-effective-march-1
BGNE,"JAN 27, 2021",BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma,https://www.nasdaq.com/press-release/beigene-announces-positive-topline-results-for-global-phase-3-trial-of-tislelizumab
BHC,14 HOURS AGO,Bausch Health Announces Participation In Upcoming Investor Conferences,https://www.nasdaq.com/press-release/bausch-health-announces-participation-in-upcoming-investor-conferences-2021-02-16
BHVN,"FEB 8, 2021",Biohaven Provides Update On ESG Practices,https://www.nasdaq.com/press-release/biohaven-provides-update-on-esg-practices-2021-02-08
BIIB,5 DAYS AGO,Biogen Announces the Expiration Date Results of Its Cash Tender Offer,https://www.nasdaq.com/press-release/biogen-announces-the-expiration-date-results-of-its-cash-tender-offer-2021-02-11
BIOC,12 HOURS AGO,Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients,https://www.nasdaq.com/press-release/study-shows-biocepts-target-selectortm-detects-mutations-in-quantity-not-sufficient
BIOL,6 DAYS AGO,"BIOLASE, Inc. Announces Closing Of $14.4 Million Bought Offering",https://www.nasdaq.com/press-release/biolase-inc.-announces-closing-of-%2414.4-million-bought-offering-2021-02-10
BIVI,"OCT 30, 2020",BioVie Interview to Air on Bloomberg International on the RedChip Money Report,https://www.nasdaq.com/press-release/biovie-interview-to-air-on-bloomberg-international-on-the-redchip-money-report-2020
BKD,"JAN 11, 2021",Brookdale Reports December 2020 Occupancy,https://www.nasdaq.com/press-release/brookdale-reports-december-2020-occupancy-2021-01-11
BLCM,"FEB 8, 2021",Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin,https://www.nasdaq.com/press-release/ponce-therapeutics-inc.-commences-first-r-d-program-in-anti-aging-products-for-skin
BLFS,12 HOURS AGO,BioLife Solutions Promotes Marcus Schulz to Chief Revenue Officer,https://www.nasdaq.com/press-release/biolife-solutions-promotes-marcus-schulz-to-chief-revenue-officer-2021-02-16
BLPH,"JAN 4, 2021",Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference,https://www.nasdaq.com/press-release/bellerophon-to-present-at-the-h.c.-wainwright-virtual-bioconnect-2021-conference-2021
BLRX,"JAN 22, 2021",BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter,https://www.nasdaq.com/press-release/biolinerx-announces-closing-of-%2434.5-million-bought-deal-offering-and-full-exercise
BLU,"JAN 14, 2021",BELLUS Health to Present at the Eleventh International Virtual Cough Symposium,https://www.nasdaq.com/press-release/bellus-health-to-present-at-the-eleventh-international-virtual-cough-symposium-2021
BLUE,13 HOURS AGO,bluebird bio Announces Temporary Suspension on Phase 1/2 and Phase 3 Studies of LentiGlobin Gene Therapy for Sickle Cell Disease (bb1111),https://www.nasdaq.com/press-release/bluebird-bio-announces-temporary-suspension-on-phase-1-2-and-phase-3-studies-of
BMRA,"JAN 15, 2021",Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update,https://www.nasdaq.com/press-release/biomerica-reports-fiscal-2021-second-quarter-financial-results-and-provides-business
BMRN,"JAN 28, 2021",BioMarin Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index,https://www.nasdaq.com/press-release/biomarin-earns-top-marks-in-human-rights-campaigns-2021-corporate-equality-index-2021
BMY,"FEB 8, 2021",Adjuvant Treatment with Opdivo (nivolumab) Demonstrates Statistically Significant and Clinically Meaningful Improvement in Disease-Free Survival in Patients with Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial,https://www.nasdaq.com/press-release/adjuvant-treatment-with-opdivo-nivolumab-demonstrates-statistically-significant-and
BNR,"FEB 8, 2021","Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021",https://www.nasdaq.com/press-release/burning-rock-announces-preliminary-fourth-quarter-and-full-year-2020-results-and
BNTC,"DEC 7, 2020",Benitec Biopharma Announces 2020 Annual Stockholder Meeting,https://www.nasdaq.com/press-release/benitec-biopharma-announces-2020-annual-stockholder-meeting-2020-12-07
BNTX,4 DAYS AGO,Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine,https://www.nasdaq.com/press-release/pfizer-and-biontech-to-supply-the-united-states-with-100-million-additional-doses-of
BOLT,"FEB 9, 2021",Bolt Biotherapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/bolt-biotherapeutics-announces-closing-of-initial-public-offering-and-full-exercise
BPMC,6 DAYS AGO,"Blueprint Medicines to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021",https://www.nasdaq.com/press-release/blueprint-medicines-to-report-fourth-quarter-and-full-year-2020-financial-results-on
BPTH,14 HOURS AGO,"Bio-Path Holdings, Inc. Announces Pricing of $13.0 Million Public Offering of Common Stock",https://www.nasdaq.com/press-release/bio-path-holdings-inc.-announces-pricing-of-%2413.0-million-public-offering-of-common
BSGM,12 HOURS AGO,BioSig Appoints Brenda Castrodad to Lead Human Resources,https://www.nasdaq.com/press-release/biosig-appoints-brenda-castrodad-to-lead-human-resources-2021-02-16
BSX,4 DAYS AGO,Boston Scientific Announces February and March 2021 Conference Schedule,https://www.nasdaq.com/press-release/boston-scientific-announces-february-and-march-2021-conference-schedule-2021-02-12
BTAI,4 DAYS AGO,BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a Potential Treatment for Agitation and Opioid Withdrawal Symptoms,https://www.nasdaq.com/press-release/bioxcel-therapeutics-to-host-virtual-key-opinion-leader-event-to-highlight-bxcl501-as
BVXV,6 DAYS AGO,BiondVax Announces Exercise in Full of Underwriter's Over-Allotment Option in Follow-on Offering,https://www.nasdaq.com/press-release/biondvax-announces-exercise-in-full-of-underwriters-over-allotment-option-in-follow
BWAY,14 HOURS AGO,BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales,https://www.nasdaq.com/press-release/brainsway-enhances-commercial-leadership-team-with-the-addition-of-fran-hackett-as
BXRX,13 HOURS AGO,Baudax Bio Reports 2020 Annual Financial Results,https://www.nasdaq.com/press-release/baudax-bio-reports-2020-annual-financial-results-2021-02-16
BYSI,"DEC 29, 2020","BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021",https://www.nasdaq.com/press-release/beyondspring-to-present-at-the-j.p.-morgan-healthcare-conference-on-january-14-2021
CABA,"JAN 7, 2021",Cabaletta Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/cabaletta-bio-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference-2021-01
CAH,"FEB 5, 2021",Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021,https://www.nasdaq.com/press-release/cardinal-health-reports-second-quarter-results-for-fiscal-year-2021-2021-02-05
CALA,"JAN 11, 2021",INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium,https://www.nasdaq.com/press-release/incb001158-biliary-tract-cancer-data-to-be-presented-at-2021-virtual-asco
CALT,"FEB 4, 2021",First Patient Dosed in NefIgArd Open Label Extension Study,https://www.nasdaq.com/press-release/first-patient-dosed-in-nefigard-open-label-extension-study-2021-02-04
CANF,"JAN 4, 2021",Can-Fite to Present at Biotech Showcase Digital 2021,https://www.nasdaq.com/press-release/can-fite-to-present-at-biotech-showcase-digital-2021-2021-01-04
CAPR,"FEB 1, 2021",Capricor Therapeutics Announces Development of Serology Test to Confirm Activity of SARS-CoV-2 Vaccines,https://www.nasdaq.com/press-release/capricor-therapeutics-announces-development-of-serology-test-to-confirm-activity-of
CARA,"JAN 11, 2021",Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Pruritus in Patients with Notalgia Paresthetica,https://www.nasdaq.com/press-release/cara-initiates-phase-2-trial-of-oral-korsuvatm-for-the-treatment-of-pruritus-in
CASI,14 HOURS AGO,CASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 Revenues And Provides Business Updates,https://www.nasdaq.com/press-release/casi-pharmaceuticals-announces-preliminary-fourth-quarter-and-full-year-2020-revenues
CATB,"JAN 29, 2021",Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.,https://www.nasdaq.com/press-release/catabasis-pharmaceuticals-announces-acquisition-of-quellis-biosciences-inc.-2021-01
CBAY,6 DAYS AGO,CymaBay Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/cymabay-therapeutics-to-present-at-the-svb-leerink-10th-annual-global-healthcare
CBIO,5 DAYS AGO,Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock,https://www.nasdaq.com/press-release/catalyst-biosciences-announces-partial-exercise-and-closing-of-over-allotment-option
CBLI,"DEC 22, 2020","Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During ""J.P. Morgan Week 2021""",https://www.nasdaq.com/press-release/cytocom-to-participate-in-biotech-showcase-and-h.c.-wainwright-bioconnect-2021-during
CBMG,"FEB 8, 2021","Cellular Biomedicine Group, Inc. Stockholders Approve Merger",https://www.nasdaq.com/press-release/cellular-biomedicine-group-inc.-stockholders-approve-merger-2021-02-08
CBPO,"JAN 25, 2021",China Biologic Announces Extraordinary General Meeting of Shareholders,https://www.nasdaq.com/press-release/china-biologic-announces-extraordinary-general-meeting-of-shareholders-2021-01-25
CCCC,5 DAYS AGO,C4 Therapeutics to Participate in BMO BioPharma Spotlight Series,https://www.nasdaq.com/press-release/c4-therapeutics-to-participate-in-bmo-biopharma-spotlight-series-2021-02-11
CCM,"DEC 28, 2020",Concord Medical Announces Divestment of Singapore Concord International Hospital,https://www.nasdaq.com/press-release/concord-medical-announces-divestment-of-singapore-concord-international-hospital-2020
CCXI,"JAN 6, 2021",ChemoCentryx to Participate in Two Upcoming Investor Conferences,https://www.nasdaq.com/press-release/chemocentryx-to-participate-in-two-upcoming-investor-conferences-2021-01-06
CDAK,4 DAYS AGO,Codiak Announces Pricing of $57.8 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/codiak-announces-pricing-of-%2457.8-million-public-offering-of-common-stock-2021-02-11
CDMO,"FEB 3, 2021",Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing,https://www.nasdaq.com/press-release/humanigen-and-avid-bioservices-enter-into-cgmp-manufacturing-agreement-for-covid-19
CDMOP,"FEB 3, 2021",Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing,https://www.nasdaq.com/press-release/humanigen-and-avid-bioservices-enter-into-cgmp-manufacturing-agreement-for-covid-19
CDNA,4 DAYS AGO,CareDx to Report Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/caredx-to-report-fourth-quarter-and-full-year-2020-financial-results-2021-02-12
CDTX,5 DAYS AGO,Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium,https://www.nasdaq.com/press-release/cidara-therapeutics-to-present-new-data-for-rezafungin-and-influenza-avcs-at-the-21st
CELC,4 HOURS AGO,Celcuity Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights,https://www.nasdaq.com/press-release/celcuity-reports-fourth-quarter-and-full-year-2020-financial-results-and-recent
CEMI,"JAN 14, 2021",Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems,https://www.nasdaq.com/press-release/chembio-diagnostics-announces-ce-mark-for-dpp-sars-cov-2-antigen-and-igm-igg-test
CERC,"FEB 2, 2021",Cerecor Announces Fast Track Designation for CERC-803 for the Treatment of Leukocyte Adhesion Deficiency Type II,https://www.nasdaq.com/press-release/cerecor-announces-fast-track-designation-for-cerc-803-for-the-treatment-of-leukocyte
CERE,"JAN 28, 2021",Cerevel Therapeutics Hosts Inaugural Virtual R&D Event to Review Darigabat (CVL-865) and Provide Overview of Key Preclinical Programs,https://www.nasdaq.com/press-release/cerevel-therapeutics-hosts-inaugural-virtual-rd-event-to-review-darigabat-cvl-865-and
CEREW,,,
CERS,5 DAYS AGO,"Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021",https://www.nasdaq.com/press-release/cerus-corporation-to-release-fourth-quarter-and-full-year-2020-financial-results-on
CFMS,4 DAYS AGO,"Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock",https://www.nasdaq.com/press-release/conformis-inc.-announces-pricing-of-%2485-million-underwritten-offering-of-common-stock
CFRX,5 DAYS AGO,ContraFect Announces Appointment of Dr. Jane F. Barlow to Board of Directors,https://www.nasdaq.com/press-release/contrafect-announces-appointment-of-dr.-jane-f.-barlow-to-board-of-directors-2021-02
CGEM,"JAN 12, 2021",Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/cullinan-management-announces-closing-of-initial-public-offering-and-full-exercise-of
CGEN,14 HOURS AGO,"Compugen to Release Fourth Quarter and Full Year 2020 Results on Thursday, February 25, 2021",https://www.nasdaq.com/press-release/compugen-to-release-fourth-quarter-and-full-year-2020-results-on-thursday-february-25
CGIX,4 HOURS AGO,Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules,https://www.nasdaq.com/press-release/cancer-genetics-announces-closing-of-%2417.5-million-common-stock-offering-priced-at
CHE,"FEB 3, 2021","Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24",https://www.nasdaq.com/press-release/chemed-to-report-fourth-quarter-2020-earnings-february-23-related-conference-call-to
CHEK,"JAN 27, 2021",Check-Cap Issues Letter to Shareholders,https://www.nasdaq.com/press-release/check-cap-issues-letter-to-shareholders-2021-01-27
CHEKZ,,,
CHFS,13 HOURS AGO,"CHF Solutions, Inc. To Announce Fourth Quarter 2020 Financial Results on March 2, 2021",https://www.nasdaq.com/press-release/chf-solutions-inc.-to-announce-fourth-quarter-2020-financial-results-on-march-2-2021
CHMA,"JAN 19, 2021",Chiasma Announces Hiring of John Doyle as Chief Financial Officer,https://www.nasdaq.com/press-release/chiasma-announces-hiring-of-john-doyle-as-chief-financial-officer-2021-01-19
CHRS,13 HOURS AGO,Coherus Announces CFO Transition Plans,https://www.nasdaq.com/press-release/coherus-announces-cfo-transition-plans-2021-02-16
CI,5 DAYS AGO,Positivity Around Vaccine Roll-Out and Future Availability Leads to Improved Perceptions on Whole Health,https://www.nasdaq.com/press-release/positivity-around-vaccine-roll-out-and-future-availability-leads-to-improved
CJJD,4 DAYS AGO,China Jo-Jo Drugstores Reports Third Quarter Fiscal 2021 Financial Results,https://www.nasdaq.com/press-release/china-jo-jo-drugstores-reports-third-quarter-fiscal-2021-financial-results-2021-02-12
CKPT,"JAN 6, 2021",Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences,https://www.nasdaq.com/press-release/checkpoint-therapeutics-to-participate-in-three-january-2021-virtual-investor
CLBS,4 DAYS AGO,"Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules",https://www.nasdaq.com/press-release/caladrius-biosciences-inc.-announces-%2465-million-registered-direct-offerings-priced
CLDX,"JAN 4, 2021","Celldex Appoints Freddy A. Jimenez, Esq. as Senior Vice President and General Counsel",https://www.nasdaq.com/press-release/celldex-appoints-freddy-a.-jimenez-esq.-as-senior-vice-president-and-general-counsel
CLLS,20 HOURS AGO,Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells,https://www.nasdaq.com/press-release/cytovia-therapeutics-and-cellectis-partner-to-develop-talenr-gene-edited-ipsc-derived
CLNN,14 HOURS AGO,Clene Nanomedicine Initiates Phase 2 Study of CNM-ZnAg for Patients with COVID-19,https://www.nasdaq.com/press-release/clene-nanomedicine-initiates-phase-2-study-of-cnm-znag-for-patients-with-covid-19
CLNNW,,,
CLOV,"FEB 9, 2021","Clover Health Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against Clover Health Investments, Corp. (NASDAQ: CLOV, CLOVW); Lead Plaintiff Deadline is April 6, 2021",https://www.nasdaq.com/press-release/clover-health-stock%3A-berger-montague-investigates-alleged-securities-fraud-claims
CLOVW,,,
CLPT,5 DAYS AGO,"ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems",https://www.nasdaq.com/press-release/clearpoint-neuro-inc.-announces-multi-product-joint-development-option-agreement-with
CLRB,6 DAYS AGO,Cellectar to Present at BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/cellectar-to-present-at-bio-ceo-investor-digital-conference-2021-02-10
CLRBZ,,,
CLSD,14 HOURS AGO,"Clearside Biomedical Announces CLS-AX (axitinib injectable suspension) Presentation Delivered at Angiogenesis, Exudation, and Degeneration 2021 Program",https://www.nasdaq.com/press-release/clearside-biomedical-announces-cls-ax-axitinib-injectable-suspension-presentation
CLSN,4 DAYS AGO,Celsion Corporation Announces Formation of Vaccine Advisory Board,https://www.nasdaq.com/press-release/celsion-corporation-announces-formation-of-vaccine-advisory-board-2021-02-12
CLVR,6 DAYS AGO,Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations,https://www.nasdaq.com/press-release/blueberries-medical-appoints-former-clever-leaves-global-head-of-b2b-as-president-of
CLVRW,,,
CLVS,5 DAYS AGO,Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting,https://www.nasdaq.com/press-release/clovis-oncology-presents-data-in-advanced-prostate-cancer-at-asco-2021-genitourinary
CMD,"JAN 12, 2021",STERIS Announces Definitive Agreement to Acquire Cantel Medical,https://www.nasdaq.com/press-release/steris-announces-definitive-agreement-to-acquire-cantel-medical-2021-01-12
CMPI,"JAN 4, 2021",Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team,https://www.nasdaq.com/press-release/checkmate-pharmaceuticals-announces-key-additions-to-executive-management-team-2021
CMPS,"FEB 9, 2021",COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists,https://www.nasdaq.com/press-release/compass-pathways-expands-its-discovery-center-through-new-collaborations-with-world
CMRX,"JAN 25, 2021",Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/chimerix-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of
CNC,6 DAYS AGO,Centene Corporation Prices Offering of Senior Notes,https://www.nasdaq.com/press-release/centene-corporation-prices-offering-of-senior-notes-2021-02-10
CNCE,"FEB 1, 2021",Concert Pharmaceuticals Announces Results from CTP-692 Phase 2 Trial in Patients with Schizophrenia,https://www.nasdaq.com/press-release/concert-pharmaceuticals-announces-results-from-ctp-692-phase-2-trial-in-patients-with
CNMD,5 HOURS AGO,CONMED Corporation to Participate in a Virtual Fireside Chat at the SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/conmed-corporation-to-participate-in-a-virtual-fireside-chat-at-the-svb-leerink
CNSP,"JAN 13, 2021",InvestorBrandNetwork Announces C3 Chat Show Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco,https://www.nasdaq.com/press-release/investorbrandnetwork-announces-c3-chat-show-podcast-with-cns-pharmaceuticals-inc.
CNST,"JAN 7, 2021",Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer,https://www.nasdaq.com/press-release/constellation-pharmaceuticals-appoints-brendan-delaney-as-chief-commercial-officer
CNTG,"DEC 18, 2020",CENTOGENE Announces Voting Results of Extraordinary General Meeting,https://www.nasdaq.com/press-release/centogene-announces-voting-results-of-extraordinary-general-meeting-2020-12-18
CO,5 DAYS AGO,Global Cord Blood Corporation Announces Termination of Discussion Regarding Cordlife Merger Proposal,https://www.nasdaq.com/press-release/global-cord-blood-corporation-announces-termination-of-discussion-regarding-cordlife
COCP,"JAN 21, 2021",Cocrystal Pharma Presentation at the reimagine Health Research Symposium Features Overview of Platform Technology and Four Antiviral Case Studies,https://www.nasdaq.com/press-release/cocrystal-pharma-presentation-at-the-reimagine-health-research-symposium-features
CODX,12 HOURS AGO,"Co-Diagnostics, Inc. to Present on Direct Saliva Testing Technology at Molecular Med Tri-Con",https://www.nasdaq.com/press-release/co-diagnostics-inc.-to-present-on-direct-saliva-testing-technology-at-molecular-med
COGT,5 DAYS AGO,Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021,https://www.nasdaq.com/press-release/cogent-biosciences-to-present-at-lifesci-partners-virtual-precision-oncology-day-2021
COLL,5 DAYS AGO,Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate Update,https://www.nasdaq.com/press-release/collegium-to-host-conference-call-to-discuss-fourth-quarter-2020-financial-results
COO,"FEB 4, 2021",CooperCompanies Announces Release Date for First Quarter 2021,https://www.nasdaq.com/press-release/coopercompanies-announces-release-date-for-first-quarter-2021-2021-02-04
CORT,"FEB 8, 2021","Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update",https://www.nasdaq.com/press-release/corcept-therapeutics-announces-fourth-quarter-full-year-2020-preliminary-selected
CPHI,"NOV 13, 2020","China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results",https://www.nasdaq.com/press-release/china-pharma-holdings-inc.-reports-third-quarter-2020-financial-results-2020-11-13
CPIX,"NOV 17, 2020","Introducing RediTrex®, A New Methotrexate Delivery System",https://www.nasdaq.com/press-release/introducing-reditrexr-a-new-methotrexate-delivery-system-2020-11-17
CPRX,"JAN 6, 2021",Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update,https://www.nasdaq.com/press-release/catalyst-pharmaceuticals-announces-strategic-plan-for-product-portfolio-expansion-for
CRBP,"JAN 20, 2021",Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases,https://www.nasdaq.com/press-release/corbus-pharmaceuticals-announces-presentations-at-the-new-york-academy-of-sciences
CRDF,9 HOURS AGO,Cardiff Oncology to Present at the LifeSci Partners Precision Oncology Day,https://www.nasdaq.com/press-release/cardiff-oncology-to-present-at-the-lifesci-partners-precision-oncology-day-2021-02-16
CRHM,"FEB 9, 2021","CRH Medical Corporation Announces Acquisition of Oak Tree Anesthesia Associates, LLC",https://www.nasdaq.com/press-release/crh-medical-corporation-announces-acquisition-of-oak-tree-anesthesia-associates-llc
CRIS,"FEB 9, 2021",Curis Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies,https://www.nasdaq.com/press-release/curis-doses-first-patient-in-phase-1-study-of-ca-4948-in-combination-with-ibrutinib
CRL,"JAN 28, 2021","Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening",https://www.nasdaq.com/press-release/charles-river-announces-strategic-partnership-with-cypre-expanding-3d-in-vitro
CRMD,"JAN 21, 2021",CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange,https://www.nasdaq.com/press-release/cormedix-inc.-to-begin-trading-on-the-nasdaq-stock-exchange-2021-01-21
CRNX,"FEB 4, 2021",Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study,https://www.nasdaq.com/press-release/crinetics-pharmaceuticals-lead-acth-antagonist-for-congenital-adrenal-hyperplasia-and
CRSP,5 HOURS AGO,CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/crispr-therapeutics-provides-business-update-and-reports-fourth-quarter-and-full-1
CRTX,1 DAY AGO,Cortexyme Provides Regulatory Update on Development Program for Atuzaginstat in Alzheimer’s Disease,https://www.nasdaq.com/press-release/cortexyme-provides-regulatory-update-on-development-program-for-atuzaginstat-in
CRVS,4 DAYS AGO,Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock,https://www.nasdaq.com/press-release/corvus-pharmaceuticals-announces-pricing-of-public-offering-of-common-stock-2021-02
CRY,5 DAYS AGO,CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/cryolife-reports-fourth-quarter-and-full-year-2020-financial-results-2021-02-11
CSBR,"JAN 19, 2021",Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics,https://www.nasdaq.com/press-release/champions-oncology-announces-partnership-with-code-ocean-to-expand-the-functionality
CSII,5 DAYS AGO,"Cardiovascular Systems, Inc. to Participate at Four Upcoming Investor Conferences",https://www.nasdaq.com/press-release/cardiovascular-systems-inc.-to-participate-at-four-upcoming-investor-conferences-2021
CSTL,"FEB 8, 2021",Castle Biosciences to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/castle-biosciences-to-present-at-upcoming-investor-conferences-2021-02-08
CSU,"JAN 28, 2021",Capital Senior Living Launches New Memory Care Program “Magnolia Trails”,https://www.nasdaq.com/press-release/capital-senior-living-launches-new-memory-care-program-magnolia-trails-2021-01-28
CTIC,5 DAYS AGO,CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-02-11
CTLT,6 DAYS AGO,Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029,https://www.nasdaq.com/press-release/catalent-announces-upsizing-and-pricing-of-private-offering-of-senior-unsecured-0
CTMX,"FEB 4, 2021",CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology Day,https://www.nasdaq.com/press-release/cytomx-therapeutics-to-present-at-guggenheim-healthcare-talks-2021-oncology-day-2021
CTSO,14 HOURS AGO,CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/cytosorbents-to-present-at-the-10th-annual-svb-leerink-global-healthcare-conference
CTXR,11 HOURS AGO,Citius Pharmaceuticals Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021,https://www.nasdaq.com/press-release/citius-pharmaceuticals-issues-shareholder-letter-with-corporate-update-on-recent
CTXRW,,,
CUE,"FEB 8, 2021",Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer,https://www.nasdaq.com/press-release/cue-biopharma-initiates-patient-dosing-in-phase-1-study-of-cue-101-in-combination
CUTR,"FEB 2, 2021","Cutera, Inc. to Announce Fourth Quarter and Full-Year 2020 Results on February 17, 2021",https://www.nasdaq.com/press-release/cutera-inc.-to-announce-fourth-quarter-and-full-year-2020-results-on-february-17-2021
CVAC,4 DAYS AGO,"CureVac Initiates Rolling Submission With European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV",https://www.nasdaq.com/press-release/curevac-initiates-rolling-submission-with-european-medicines-agency-for-covid-19
CVET,"JAN 28, 2021","Covetrus Takes Gold at Learning Technologies Awards Company honored for work with UK Charity, Dogs Trust",https://www.nasdaq.com/press-release/covetrus-takes-gold-at-learning-technologies-awards-company-honored-for-work-with-uk
CVM,12 HOURS AGO,CEL-SCI Corporation Reports First Quarter Fiscal 2021 Financial Results,https://www.nasdaq.com/press-release/cel-sci-corporation-reports-first-quarter-fiscal-2021-financial-results-2021-02-16
CVS,12 HOURS AGO,CVS Health Reports Fourth Quarter And Full-Year 2020 Results And Provides 2021 Full Year Guidance,https://www.nasdaq.com/press-release/cvs-health-reports-fourth-quarter-and-full-year-2020-results-and-provides-2021-full
CWBR,"FEB 9, 2021",CohBar to Present at the BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/cohbar-to-present-at-the-bio-ceo-investor-digital-conference-2021-02-09
CYAD,"FEB 2, 2021",Celyad Oncology Announces February 2021 Conference Schedule,https://www.nasdaq.com/press-release/celyad-oncology-announces-february-2021-conference-schedule-2021-02-02-0
CYCC,6 DAYS AGO,Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/cyclacel-pharmaceuticals-announces-presentation-at-2021-bio-ceo-investor-digital
CYCCP,6 DAYS AGO,Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/cyclacel-pharmaceuticals-announces-presentation-at-2021-bio-ceo-investor-digital
CYCN,"JAN 25, 2021",Cyclerion Therapeutics Announces Clinical and Scientific Advisory Boards,https://www.nasdaq.com/press-release/cyclerion-therapeutics-announces-clinical-and-scientific-advisory-boards-2021-01-25
CYH,"FEB 3, 2021",COMMUNITY HEALTH SYSTEMS TO BROADCAST FOURTH QUARTER AND YEAR-END 2020 CONFERENCE CALL LIVE ON THE INTERNET,https://www.nasdaq.com/press-release/community-health-systems-to-broadcast-fourth-quarter-and-year-end-2020-conference
CYRX,"FEB 8, 2021",Blackstone Converts $51 million of Cryoport Series C Preferred Stock Into Common Stock,https://www.nasdaq.com/press-release/blackstone-converts-%2451-million-of-cryoport-series-c-preferred-stock-into-common
CYTK,5 DAYS AGO,"Cytokinetics to Announce Fourth Quarter Results on February 25, 2021",https://www.nasdaq.com/press-release/cytokinetics-to-announce-fourth-quarter-results-on-february-25-2021-2021-02-11
DARE,13 HOURS AGO,"Daré Bioscience to Participate at the Women’s Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021",https://www.nasdaq.com/press-release/dare-bioscience-to-participate-at-the-womens-health-innovation-series%3A-contraception
DBVT,5 DAYS AGO,"Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2021",https://www.nasdaq.com/press-release/monthly-information-regarding-the-total-number-of-voting-rights-and-total-number-26
DCPH,"FEB 9, 2021","Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results",https://www.nasdaq.com/press-release/deciphera-pharmaceuticals-inc.-announces-fourth-quarter-and-full-year-2020-financial
DCTH,5 DAYS AGO,Delcath Systems to Participate at Upcoming Virtual Investor Conferences,https://www.nasdaq.com/press-release/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2021-02-11
DFFN,13 HOURS AGO,Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients,https://www.nasdaq.com/press-release/diffusion-pharmaceuticals-completes-phase-1b-study-of-tsc-in-hospitalized-covid-19
DFHT,"DEC 18, 2020",Deerfield Healthcare Technology Acquisitions Corp. Announces Proposed Business Combination to Form CareMax,https://www.nasdaq.com/press-release/deerfield-healthcare-technology-acquisitions-corp.-announces-proposed-business
DFHTU,,,
DFHTW,,,
DGX,8 HOURS AGO,"Quest Diagnostics To Speak At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",https://www.nasdaq.com/press-release/quest-diagnostics-to-speak-at-citis-2021-healthcare-services-medtech-tools-hcit
DMAC,"JAN 11, 2021",DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference,https://www.nasdaq.com/press-release/diamedica-therapeutics-to-present-at-the-h.c.-wainwright-bioconnect-conference-2021
DMTK,6 DAYS AGO,DermTech Enters Into Agreement with Blue Cross Blue Shield of Texas,https://www.nasdaq.com/press-release/dermtech-enters-into-agreement-with-blue-cross-blue-shield-of-texas-2021-02-10
DNLI,4 DAYS AGO,Denali Therapeutics Reports Positive Three-Month Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with Hunter Syndrome (MPS II),https://www.nasdaq.com/press-release/denali-therapeutics-reports-positive-three-month-data-from-phase-1-2-study-with-etv
DRIO,"JAN 27, 2021",DarioHealth Announces Acquisition of Leading Digital Musculoskeletal Company Upright Technologies and $70 Million Financing,https://www.nasdaq.com/press-release/dariohealth-announces-acquisition-of-leading-digital-musculoskeletal-company-upright
DRIOW,,,
DRNA,5 DAYS AGO,Dicerna Initiates PHYOX™4 Trial of Nedosiran for Primary Hyperoxaluria Type 3,https://www.nasdaq.com/press-release/dicerna-initiates-phyoxtm4-trial-of-nedosiran-for-primary-hyperoxaluria-type-3-2021
DRRX,"FEB 4, 2021",DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/durect-corporation-announces-pricing-of-%2442.5-million-public-offering-of-common-stock
DTIL,"FEB 4, 2021",Precision BioSciences to Present at Guggenheim Healthcare Talks 2021 Oncology Day,https://www.nasdaq.com/press-release/precision-biosciences-to-present-at-guggenheim-healthcare-talks-2021-oncology-day
DVA,5 DAYS AGO,DaVita Inc. 4th Quarter 2020 Results,https://www.nasdaq.com/press-release/davita-inc.-4th-quarter-2020-results-2021-02-11
DVAX,5 HOURS AGO,Dynavax to Present at the Cowen 41st Annual Health Care Conference,https://www.nasdaq.com/press-release/dynavax-to-present-at-the-cowen-41st-annual-health-care-conference-2021-02-16
DXCM,5 DAYS AGO,Dexcom Launches Inaugural Venture Capital Fund,https://www.nasdaq.com/press-release/dexcom-launches-inaugural-venture-capital-fund-2021-02-11
DXR,"FEB 5, 2021",DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-OF-CARE BLOOD VOLUME ANALYZER,https://www.nasdaq.com/press-release/daxor-corporation-awarded-grant-from-the-center-for-advancing-point-of-care
DYAI,1 DAY AGO,Dyadic to Present at Upcoming Events,https://www.nasdaq.com/press-release/dyadic-to-present-at-upcoming-events-2021-02-15
DYN,"FEB 8, 2021","Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs",https://www.nasdaq.com/press-release/dyne-therapeutics-appoints-ashish-dugar-ph.d.-mba-senior-vice-president-global-head
DYNT,5 DAYS AGO,Dynatronics Reports Second Quarter Results,https://www.nasdaq.com/press-release/dynatronics-reports-second-quarter-results-2021-02-11
EAR,5 DAYS AGO,Eargo to Present at 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/eargo-to-present-at-10th-annual-svb-leerink-global-healthcare-conference-2021-02-11
EARS,"JAN 29, 2021",Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis,https://www.nasdaq.com/press-release/auris-medical-announces-initiation-of-clinical-investigation-of-am-301-in-allergic
EBS,"FEB 4, 2021","Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18, 2021",https://www.nasdaq.com/press-release/emergent-biosolutions-to-release-fourth-quarter-and-full-year-2020-financial-results
ECOR,13 HOURS AGO,electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Adolescent Migraine,https://www.nasdaq.com/press-release/electrocore-announces-510k-clearance-of-gammacoretm-non-invasive-vagus-nerve
EDAP,"JAN 20, 2021","EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year",https://www.nasdaq.com/press-release/edap-announces-record-preliminary-unaudited-fourth-quarter-2020-revenue-of-eur-15.3
EDIT,"FEB 8, 2021",Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer,https://www.nasdaq.com/press-release/editas-medicine-announces-appointment-of-james-c.-mullen-as-chief-executive-officer
EDSA,14 HOURS AGO,Edesa Biotech Reports Fiscal First Quarter 2021 Results,https://www.nasdaq.com/press-release/edesa-biotech-reports-fiscal-first-quarter-2021-results-2021-02-16
EGRX,"FEB 2, 2021","Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin Trial",https://www.nasdaq.com/press-release/eagle-pharmaceuticals-receives-additional-fda-questions-regarding-vasopressin-court
EHC,"FEB 8, 2021","Encompass Health Corp. and Ascension St. John announce plans to build a 40-bed rehabilitation hospital in Owasso, Oklahoma",https://www.nasdaq.com/press-release/encompass-health-corp.-and-ascension-st.-john-announce-plans-to-build-a-40-bed
EIGR,"FEB 8, 2021",Eiger Announces ILIAD Study Results of Peginterferon Lambda in COVID-19 Published in Lancet Respiratory Medicine 2021,https://www.nasdaq.com/press-release/eiger-announces-iliad-study-results-of-peginterferon-lambda-in-covid-19-published-in
ELAN,4 DAYS AGO,Elanco to Participate in the BofA Securities Animal Health Virtual Summit,https://www.nasdaq.com/press-release/elanco-to-participate-in-the-bofa-securities-animal-health-virtual-summit-2021-02-12
ELAT,,,
ELDN,"JAN 19, 2021",Eledon Pharmaceuticals to Participate in the Virtual Noble Capital Markets' Seventeenth Annual Investor / Equity Conference,https://www.nasdaq.com/press-release/eledon-pharmaceuticals-to-participate-in-the-virtual-noble-capital-markets
ELMD,"FEB 9, 2021","Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results",https://www.nasdaq.com/press-release/electromed-inc.-announces-fiscal-2021-second-quarter-financial-results-2021-02-09
ELOX,"FEB 9, 2021",Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Cystic Fibrosis,https://www.nasdaq.com/press-release/eloxx-announces-publication-of-scientific-manuscript-on-elx-02-in-the-journal-of-2
ENDP,"JAN 26, 2021",Endo to Announce Fourth-Quarter and Full-Year 2020 Financial Results,https://www.nasdaq.com/press-release/endo-to-announce-fourth-quarter-and-full-year-2020-financial-results-2021-01-26
ENLV,13 HOURS AGO,"Enlivex Announces Issuance of New U.S. Patent Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn’s Disease, Ulcerative Colitis and GvHD Using Allocetra Immunotherapy",https://www.nasdaq.com/press-release/enlivex-announces-issuance-of-new-u.s.-patent-covering-methods-of-treating-gout
ENOB,"SEP 10, 2020",Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference,https://www.nasdaq.com/press-release/enochian-biosciences-to-present-to-investors-at-22nd-annual-h.c.-wainwright-global
ENSG,"FEB 3, 2021",The Ensign Group Reports Fourth Quarter and Fiscal Year 2020 Results,https://www.nasdaq.com/press-release/the-ensign-group-reports-fourth-quarter-and-fiscal-year-2020-results-2021-02-03
ENTA,"FEB 8, 2021","Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET",https://www.nasdaq.com/press-release/enanta-pharmaceuticals-reports-financial-results-for-its-fiscal-first-quarter-ended
ENTX,"FEB 8, 2021",Entera Bio Initiates New Research Program For Oral GLP-2,https://www.nasdaq.com/press-release/entera-bio-initiates-new-research-program-for-oral-glp-2-2021-02-08
ENTXW,,,
ENZ,"FEB 3, 2021",Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin,https://www.nasdaq.com/press-release/enzo-announces-issuance-of-u.s.-patent-for-polyclonal-antibodies-against-osteoporosis
EOLS,"DEC 16, 2020",Evolus Provides Update on United States International Trade Commission (ITC) Case,https://www.nasdaq.com/press-release/evolus-provides-update-on-united-states-international-trade-commission-itc-case-2020
EPIX,5 HOURS AGO,ESSA Pharma Announces Proposed Public Offering of Common Shares,https://www.nasdaq.com/press-release/essa-pharma-announces-proposed-public-offering-of-common-shares-2021-02-16
EPZM,15 HOURS AGO,Epizyme Announces Date of Fourth Quarter and Full Year 2020 Financial Results and Participation in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/epizyme-announces-date-of-fourth-quarter-and-full-year-2020-financial-results-and
EQ,4 DAYS AGO,Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience,https://www.nasdaq.com/press-release/equillium-presents-positive-interim-clinical-data-of-itolizumab-in-first-line
ERYP,6 DAYS AGO,ERYTECH tiendra une présentation à l’occasion du BIO CEO & Investor Conference 2021,https://www.nasdaq.com/press-release/erytech-tiendra-une-presentation-a-loccasion-du-bio-ceo-investor-conference-2021-2021
ESPR,"FEB 9, 2021","Esperion to Report Fourth Quarter and Full Year 2020 Financial Results February 23, 2021",https://www.nasdaq.com/press-release/esperion-to-report-fourth-quarter-and-full-year-2020-financial-results-february-23
ESTA,13 HOURS AGO,Establishment Labs Announces Participation in the Cowen 41st Annual Healthcare Conference,https://www.nasdaq.com/press-release/establishment-labs-announces-participation-in-the-cowen-41st-annual-healthcare
ETNB,"JAN 5, 2021",89bio Provides Business Outlook for 2021,https://www.nasdaq.com/press-release/89bio-provides-business-outlook-for-2021-2021-01-05
ETON,5 HOURS AGO,Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/eton-pharmaceuticals-to-participate-in-10th-annual-svb-leerink-global-healthcare
ETTX,"JAN 26, 2021",Entasis Therapeutics Announces Sulbactam-Durlobactam Expanded Access Program for Patients in the U.S.,https://www.nasdaq.com/press-release/entasis-therapeutics-announces-sulbactam-durlobactam-expanded-access-program-for
EVFM,12 HOURS AGO,"Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for Women",https://www.nasdaq.com/press-release/evofem-biosciences-launches-u.s.-direct-to-consumer-campaign-to-accelerate-awareness
EVLO,14 HOURS AGO,"Evelo Biosciences Appoints John A. Hohneker, M.D. to Board of Directors",https://www.nasdaq.com/press-release/evelo-biosciences-appoints-john-a.-hohneker-m.d.-to-board-of-directors-2021-02-16
EVOK,"JAN 20, 2021",Evoke Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/evoke-pharma-announces-closing-of-public-offering-of-common-stock-and-full-exercise
EW,"JAN 31, 2021",Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years,https://www.nasdaq.com/press-release/edwards-resilia-tissue-aortic-valve-demonstrates-favorable-safety-and-efficacy-at
EXAS,5 HOURS AGO,"Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen",https://www.nasdaq.com/press-release/exact-sciences-to-acquire-ashion-analytics-and-enter-research-collaboration-with-city
EXEL,3 DAYS AGO,Exelixis Highlights Positive Results for CABOMETYX® (cabozantinib) in Patients with Metastatic Papillary Renal Cell Carcinoma in SWOG S1500/PAPMET Study at ASCO GU,https://www.nasdaq.com/press-release/exelixis-highlights-positive-results-for-cabometyxr-cabozantinib-in-patients-with
EYE,"FEB 4, 2021",National Vision Appoints Jose Armario to Board of Directors,https://www.nasdaq.com/press-release/national-vision-appoints-jose-armario-to-board-of-directors-2021-02-04
EYEG,"FEB 1, 2021",EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation,https://www.nasdaq.com/press-release/eyegate-pharmaceuticals-announces-management-transition-in-support-of-strategic
EYEN,13 HOURS AGO,Eyenovia to Host Key Opinion Leader Webinar on Presbyopia,https://www.nasdaq.com/press-release/eyenovia-to-host-key-opinion-leader-webinar-on-presbyopia-2021-02-16
EYES,"SEP 22, 2020",Second Sight Medical Products Inc. Announces Resumption of Its Early Feasibility Study of the Orion® Cortical Visual Prosthesis at UCLA,https://www.nasdaq.com/press-release/second-sight-medical-products-inc.-announces-resumption-of-its-early-feasibility
EYESW,,,
FATE,"JAN 8, 2021","Fate Therapeutics Announces Completion of Public Offering of Common Stock and Pre-Funded Warrants, and Full Exercise of Underwriters’ Option to Purchase Additional Shares",https://www.nasdaq.com/press-release/fate-therapeutics-announces-completion-of-public-offering-of-common-stock-and-pre
FBIO,"FEB 2, 2021",Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”),https://www.nasdaq.com/press-release/mustang-bio-provides-updates-on-its-lentiviral-gene-therapies-for-the-treatment-of-x
FBIOP,,,
FBRX,4 DAYS AGO,"Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules",https://www.nasdaq.com/press-release/forte-biosciences-inc.-reports-inducement-grants-under-nasdaq-listing-rules-2021-02
FDMT,"DEC 15, 2020",4D Molecular Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/4d-molecular-therapeutics-announces-closing-of-initial-public-offering-and-full
FENC,"NOV 16, 2020",Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update,https://www.nasdaq.com/press-release/fennec-pharmaceuticals-announces-third-quarter-2020-financial-results-and-provides
FGEN,4 DAYS AGO,FibroGen to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/fibrogen-to-present-at-upcoming-investor-conferences-2021-02-12
FHTX,,,
FIXX,"FEB 8, 2021",Homology Medicines Announces First Presentation of Data with HMI-203 In Vivo Gene Therapy Development Candidate for Hunter Syndrome,https://www.nasdaq.com/press-release/homology-medicines-announces-first-presentation-of-data-with-hmi-203-in-vivo-gene
FLGT,11 HOURS AGO,BioIQ Partners with Fulgent Genetics to Bring COVID-19 Variant Detection to COVID-19 Testing Programs,https://www.nasdaq.com/press-release/bioiq-partners-with-fulgent-genetics-to-bring-covid-19-variant-detection-to-covid-19
FLXN,"FEB 1, 2021","National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®",https://www.nasdaq.com/press-release/national-basketball-retired-players-association-sheryl-swoopes-and-flexion
FMS,"SEP 16, 2020",Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day,https://www.nasdaq.com/press-release/essential-role-of-ultrapure-dialysis-fluid-highlighted-on-world-patient-safety-day
FMTX,"JAN 20, 2021",Forma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating FT-7051 for the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC),https://www.nasdaq.com/press-release/forma-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating
FOLD,5 DAYS AGO,Amicus’ AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase 3 PROPEL Study,https://www.nasdaq.com/press-release/amicus-at-gaa-shows-clinically-meaningful-significant-improvements-in-both
FONR,13 HOURS AGO,Fonar Announces 2nd Quarter and Six Months Financial Results for Fiscal 2021,https://www.nasdaq.com/press-release/fonar-announces-2nd-quarter-and-six-months-financial-results-for-fiscal-2021-2021-02
FPRX,"FEB 5, 2021",Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day,https://www.nasdaq.com/press-release/five-prime-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021%3A-oncology
FREQ,"FEB 8, 2021","Frequency Therapeutics Appoints Kevin Franck, Ph.D., as Senior Vice President, Strategic Marketing and New Product Planning",https://www.nasdaq.com/press-release/frequency-therapeutics-appoints-kevin-franck-ph.d.-as-senior-vice-president-strategic
FRLN,14 HOURS AGO,Freeline Announces Expansion of Executive Leadership,https://www.nasdaq.com/press-release/freeline-announces-expansion-of-executive-leadership-2021-02-16
FSTX,"JAN 20, 2021","F-star Granted Composition of Matter Patent for FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1",https://www.nasdaq.com/press-release/f-star-granted-composition-of-matter-patent-for-fs118-a-bispecific-antibody-0
FULC,"JAN 22, 2021",Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/fulcrum-therapeutics-announces-closing-of-public-offering-of-common-stock-and-full
FUSN,5 DAYS AGO,"Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to Board of Directors",https://www.nasdaq.com/press-release/fusion-pharmaceuticals-appoints-philina-lee-ph.d.-to-board-of-directors-2021-02-11
FVE,"JAN 28, 2021","Five Star Senior Living Inc. Fourth Quarter 2020 Conference Call Scheduled for Thursday, February 25th",https://www.nasdaq.com/press-release/five-star-senior-living-inc.-fourth-quarter-2020-conference-call-scheduled-for
FWP,"JAN 12, 2021","Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions",https://www.nasdaq.com/press-release/forward-pharma-announces-rescheduling-of-the-ep2801355-appeal-hearing-to-september-6
GALT,"DEC 11, 2020","Galectin Therapeutics, Inc. to Present at the 4th Annual Digital NASH Summit on December 17, 2020",https://www.nasdaq.com/press-release/galectin-therapeutics-inc.-to-present-at-the-4th-annual-digital-nash-summit-on
GBIO,"JAN 11, 2021",Generation Bio Announces Closing of Public Offering,https://www.nasdaq.com/press-release/generation-bio-announces-closing-of-public-offering-2021-01-11
GBS,13 HOURS AGO,GBS Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/gbs-inc.-reports-fourth-quarter-and-full-year-2020-financial-results-and-provides
GBT,"FEB 5, 2021",GBT Announces New Employment Inducement Grants,https://www.nasdaq.com/press-release/gbt-announces-new-employment-inducement-grants-2021-02-05
GEN           ,"FEB 2, 2021",Genesis HealthCare Announces Resident and Staff COVID-19 Vaccine Acceptance Rates,https://www.nasdaq.com/press-release/genesis-healthcare-announces-resident-and-staff-covid-19-vaccine-acceptance-rates
GENE,"JAN 25, 2021",Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering,https://www.nasdaq.com/press-release/genetic-technologies-announces-closing-of-%246.56-million-registered-direct-offering
GERN,"JAN 21, 2021",Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/geron-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-01-21
GH,13 HOURS AGO,Guardant Health Launches Guardant Reveal™ Liquid Biopsy Test for Residual Disease and Recurrence Monitoring in Patients with Early-Stage Colorectal Cancer,https://www.nasdaq.com/press-release/guardant-health-launches-guardant-revealtm-liquid-biopsy-test-for-residual-disease
GHSI,"JAN 28, 2021",Malaysia’s Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences,https://www.nasdaq.com/press-release/malaysias-ho-wah-genting-berhad-advises-guardion-health-sciences-that-it-has-received
GILD,9 HOURS AGO,Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach,https://www.nasdaq.com/press-release/gilead-sciences-and-wake-forest-university-school-of-divinity-partner-to-address-hiv
GKOS,"FEB 4, 2021",Glaukos Corporation to Release Fourth Quarter and Full Year 2020 Financial Results after Market Close on February 25,https://www.nasdaq.com/press-release/glaukos-corporation-to-release-fourth-quarter-and-full-year-2020-financial-results
GLMD,12 HOURS AGO,Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares,https://www.nasdaq.com/press-release/galmed-pharmaceuticals-announces-pricing-of-%2410-million-public-offering-of-ordinary
GLPG,6 DAYS AGO,Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF,https://www.nasdaq.com/press-release/galapagos-and-gilead-discontinue-isabela-phase-3-trials-in-ipf-2021-02-10
GLSI,"JAN 29, 2021",Greenwich LifeSciences Announces Exercise and Closing of Underwriter’s Over-Allotment Option,https://www.nasdaq.com/press-release/greenwich-lifesciences-announces-exercise-and-closing-of-underwriters-over-allotment
GLTO,"FEB 9, 2021",Galecto to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/galecto-to-present-at-upcoming-investor-conferences-2021-02-09
GLYC,"JAN 7, 2021",APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia,https://www.nasdaq.com/press-release/apl-106-uproleselan-granted-breakthrough-therapy-designation-in-china-for-the
GMAB,6 DAYS AGO,Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer,https://www.nasdaq.com/press-release/genmab-and-seagen-submit-tisotumab-vedotin-biologics-license-application-to-the-u.s.
GMDA,14 HOURS AGO,Gamida Cell Announces $75 Million Financing with Highbridge Capital Management,https://www.nasdaq.com/press-release/gamida-cell-announces-%2475-million-financing-with-highbridge-capital-management-2021
GMED,"JAN 28, 2021",Globus Medical Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call,https://www.nasdaq.com/press-release/globus-medical-schedules-fourth-quarter-and-full-year-2020-earnings-release-and
GMTX,6 DAYS AGO,Gemini Therapeutics Completes Enrollment in Phase 2a Trial of GEM103 in Dry Age-Related Macular Degeneration (AMD) in Patients with High-Risk Genetic Variants,https://www.nasdaq.com/press-release/gemini-therapeutics-completes-enrollment-in-phase-2a-trial-of-gem103-in-dry-age
GNCA,5 DAYS AGO,Genocea Provides Fourth Quarter 2020 Corporate Update,https://www.nasdaq.com/press-release/genocea-provides-fourth-quarter-2020-corporate-update-2021-02-11
GNFT,6 DAYS AGO,GENFIT annonce son calendrier financier pour 2021,https://www.nasdaq.com/press-release/genfit-annonce-son-calendrier-financier-pour-2021-2021-02-10
GNMK,3 HOURS AGO,GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference,https://www.nasdaq.com/press-release/genmark-diagnostics-to-participate-in-the-cowen-41st-annual-health-care-conference
GNPX,"FEB 9, 2021","Genprex, Inc. Announces $25 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules, Without Warrants",https://www.nasdaq.com/press-release/genprex-inc.-announces-%2425-million-registered-direct-offering-priced-at-the-market
GOSS,"FEB 4, 2021","Gossamer Bio to Host Webcast Focused on its Inflammatory Bowel Disease Program, GB004, on February 18, 2021",https://www.nasdaq.com/press-release/gossamer-bio-to-host-webcast-focused-on-its-inflammatory-bowel-disease-program-gb004
GOVX,5 DAYS AGO,GeoVax Announces Closing of $10.3 Million Bought Deal Offering,https://www.nasdaq.com/press-release/geovax-announces-closing-of-%2410.3-million-bought-deal-offering-2021-02-11
GOVXW,,,
GRAY,"FEB 1, 2021","Graybug Vision Appoints Bettina Maunz as Chief People Officer, Expanding the Company’s Executive Team",https://www.nasdaq.com/press-release/graybug-vision-appoints-bettina-maunz-as-chief-people-officer-expanding-the-companys
GRCL,"JAN 19, 2021","Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F, a FasTCAR-Enabled CAR-T Therapy for the Treatment of Relapsed or Refractory Adult B-ALL",https://www.nasdaq.com/press-release/gracell-biotechnologies-receives-ind-approval-from-china-nmpa-for-gc019f-a-fastcar
GRFS,"JAN 28, 2021",Alkahest Announces Peer-Reviewed Publication Demonstrating Safety and Tolerability of GRF6019 in Patients with Mild-to-Moderate Alzheimer’s Disease,https://www.nasdaq.com/press-release/alkahest-announces-peer-reviewed-publication-demonstrating-safety-and-tolerability-of
GRNV,"FEB 9, 2021",GreenVision Acquisition Corp. Announces Contribution to Trust Account to Extend Time Period to Complete a Business Combination,https://www.nasdaq.com/press-release/greenvision-acquisition-corp.-announces-contribution-to-trust-account-to-extend-time
GRNVR,,,
GRNVU,"DEC 4, 2019","GreenVision Acquisition Corp. Announces the Separate Trading of its Shares of Common Stock, Rights and Warrants Commencing December 9, 2019",https://www.nasdaq.com/press-release/greenvision-acquisition-corp.-announces-the-separate-trading-of-its-shares-of-common
GRNVW,,,
GRTS,"FEB 1, 2021",Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure,https://www.nasdaq.com/press-release/gilead-sciences-and-gritstone-announce-collaboration-utilizing-gritstones-vaccine
GRTX,"NOV 20, 2020",Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference,https://www.nasdaq.com/press-release/galera-therapeutics-to-participate-in-the-piper-sandler-32nd-annual-virtual
GSK,11 HOURS AGO,TUMS Expands Portfolio to Meet Consumer Demands for Naturally-Sourced Products,https://www.nasdaq.com/press-release/tums-expands-portfolio-to-meet-consumer-demands-for-naturally-sourced-products-2021
GTH,"FEB 9, 2021",Genetron Health’s Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China,https://www.nasdaq.com/press-release/genetron-healths-early-liver-cancer-screening-research-results-included-in-first
GTHX,4 DAYS AGO,FDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression,https://www.nasdaq.com/press-release/fda-approves-g1-therapeutics-coselatm-trilaciclib%3A-the-first-and-only-myeloprotection
GWPH,14 HOURS AGO,GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress,https://www.nasdaq.com/press-release/gw-pharmaceuticals-plc-reports-fourth-quarter-and-year-end-2020-financial-results-and
GXGX,"JAN 8, 2021",Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy,https://www.nasdaq.com/press-release/celularity-and-gx-acquisition-corp.-announce-merger-agreement-to-create-a-publicly
GXGXU,"JAN 8, 2021",Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy,https://www.nasdaq.com/press-release/celularity-and-gx-acquisition-corp.-announce-merger-agreement-to-create-a-publicly
GXGXW,,,
HAE,"FEB 2, 2021",Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website,https://www.nasdaq.com/press-release/haemonetics-3rd-quarter-fiscal-year-2021-earnings-release-available-on-investor
HALO,6 DAYS AGO,Halozyme To Host Fourth Quarter And Full Year 2020 Financial Results Webcast And Conference Call,https://www.nasdaq.com/press-release/halozyme-to-host-fourth-quarter-and-full-year-2020-financial-results-webcast-and
HARP,"JAN 13, 2021",Harpoon Therapeutics Granted Orphan Drug Designation from FDA for HPN217 for Treatment of Multiple Myeloma,https://www.nasdaq.com/press-release/harpoon-therapeutics-granted-orphan-drug-designation-from-fda-for-hpn217-for
HCA,"FEB 2, 2021",HCA Healthcare Reports Fourth Quarter 2020 Results and Provides 2021 Guidance,https://www.nasdaq.com/press-release/hca-healthcare-reports-fourth-quarter-2020-results-and-provides-2021-guidance-2021-02
HCM,"FEB 3, 2021",Chi-Med to Announce 2020 Final Results,https://www.nasdaq.com/press-release/chi-med-to-announce-2020-final-results-2021-02-03
HCSG,6 DAYS AGO,"Healthcare Services Group, Inc. Reports Q4 2020 Results",https://www.nasdaq.com/press-release/healthcare-services-group-inc.-reports-q4-2020-results-2021-02-10
HEC,"JAN 13, 2021","Talkspace to Merge with Hudson Executive Investment Corp., Forming the Only Publicly Traded Pure Play Virtual Behavioral Health Company",https://www.nasdaq.com/press-release/talkspace-to-merge-with-hudson-executive-investment-corp.-forming-the-only-publicly
HECCU,"JAN 13, 2021","Talkspace to Merge with Hudson Executive Investment Corp., Forming the Only Publicly Traded Pure Play Virtual Behavioral Health Company",https://www.nasdaq.com/press-release/talkspace-to-merge-with-hudson-executive-investment-corp.-forming-the-only-publicly
HECCW,,,
HEPA,14 HOURS AGO,Hepion Pharmaceuticals Announces Pricing of Public Offering,https://www.nasdaq.com/press-release/hepion-pharmaceuticals-announces-pricing-of-public-offering-2021-02-16
HGEN,5 DAYS AGO,Humanigen to Present and Participate at Multiple Upcoming Investor and Industry Conferences,https://www.nasdaq.com/press-release/humanigen-to-present-and-participate-at-multiple-upcoming-investor-and-industry
HIMS,6 DAYS AGO,"Hims & Hers Health, Inc. to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call",https://www.nasdaq.com/press-release/hims-hers-health-inc.-to-announce-fourth-quarter-and-full-year-2020-financial-results
HJLI,5 DAYS AGO,Hancock Jaffe Completes $41 Million Public Offering,https://www.nasdaq.com/press-release/hancock-jaffe-completes-%2441-million-public-offering-2021-02-11
HJLIW,,,
HLF,12 HOURS AGO,Herbalife Nutrition and The Herbalife Nutrition Foundation Donate More Than $3 Million to Help Eradicate Hunger Around the Globe,https://www.nasdaq.com/press-release/herbalife-nutrition-and-the-herbalife-nutrition-foundation-donate-more-than-%243
HNGR,5 DAYS AGO,Forbes Names Hanger One of America’s Best Employers,https://www.nasdaq.com/press-release/forbes-names-hanger-one-of-americas-best-employers-2021-02-11
HOLX,5 DAYS AGO,AMETEK Announces Appointment of Karleen Oberton to Board of Directors,https://www.nasdaq.com/press-release/ametek-announces-appointment-of-karleen-oberton-to-board-of-directors-2021-02-11
HOOK,14 HOURS AGO,HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/hookipa-pharma-to-participate-in-upcoming-svb-leerink-global-healthcare-conference
HOTH,6 DAYS AGO,"Hoth Therapeutics Scientific Advisory Board Member, Michael Peters, Ph.D., Publishes Whitepaper Regarding COVID-19 SARS-CoV-2 in bioRxiv",https://www.nasdaq.com/press-release/hoth-therapeutics-scientific-advisory-board-member-michael-peters-ph.d.-publishes
HRC,"FEB 5, 2021",Hillrom's Fiscal First Quarter Financial Results Exceed Guidance,https://www.nasdaq.com/press-release/hillroms-fiscal-first-quarter-financial-results-exceed-guidance-2021-02-05
HRMY,"DEC 17, 2020",Harmony Biosciences To Be Added To Russell 2000® And Russell 3000® Indexes,https://www.nasdaq.com/press-release/harmony-biosciences-to-be-added-to-russell-2000r-and-russell-3000r-indexes-2020-12-17
HROW,"FEB 9, 2021","Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate",https://www.nasdaq.com/press-release/melt-pharmaceuticals-completes-phase-1-study-for-sublingual-non-opioid-pain-and
HRTX,"JAN 21, 2021",Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery,https://www.nasdaq.com/press-release/heron-therapeutics-announces-publication-of-results-from-epoch-1-follow-on-study-of
HSDT,"FEB 2, 2021","Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021",https://www.nasdaq.com/press-release/helius-medical-technologies-to-release-fourth-quarter-and-fiscal-year-2020-financial
HSIC,12 HOURS AGO,Henry Schein One Appoints New Chief Executive Officer,https://www.nasdaq.com/press-release/henry-schein-one-appoints-new-chief-executive-officer-2021-02-16
HSKA,13 HOURS AGO,Heska to Present at Upcoming Conferences in February and March 2021,https://www.nasdaq.com/press-release/heska-to-present-at-upcoming-conferences-in-february-and-march-2021-2021-02-16
HSTO,12 HOURS AGO,Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men,https://www.nasdaq.com/press-release/histogen-announces-week-26-hst-001-study-results-for-the-treatment-of-androgenic
HTBX,4 DAYS AGO,Heat Biologics to Present at 2021 BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/heat-biologics-to-present-at-2021-bio-ceo-investor-digital-conference-2021-02-12
HUGE,3 DAYS AGO,"Cofttek, China's Largest Manufacturer of PEA, Draws Attention of Investors",https://www.nasdaq.com/press-release/cofttek-chinas-largest-manufacturer-of-pea-draws-attention-of-investors-2021-02-13
HUM,5 DAYS AGO,Humana and IBM Watson Health Collaborate to Simplify and Enhance the Member Experience for Humana Employer Group Customers,https://www.nasdaq.com/press-release/humana-and-ibm-watson-health-collaborate-to-simplify-and-enhance-the-member
HZNP,"FEB 3, 2021","Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2020 Financial Results and Host Webcast on Feb. 24, 2021",https://www.nasdaq.com/press-release/horizon-therapeutics-plc-to-release-fourth-quarter-and-full-year-2020-financial
IART,"JAN 20, 2021","Integra LifeSciences Completes the Acquisition of ACell, Inc.",https://www.nasdaq.com/press-release/integra-lifesciences-completes-the-acquisition-of-acell-inc.-2021-01-20
IBIO,5 HOURS AGO,iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/ibio-reports-fiscal-second-quarter-2021-financial-results-and-provides-corporate
ICAD,5 HOURS AGO,"iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/icad-to-participate-in-the-btig-virtual-medtech-digital-health-life-science
ICCC,8 HOURS AGO,"ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020",https://www.nasdaq.com/press-release/immucell-to-announce-unaudited-financial-results-for-the-year-ended-december-31-2020
ICLR,14 HOURS AGO,Cytocom Updates Investigational New Drug Application for Phase 2 Clinical Trial of CYTO-205 for the Treatment of COVID-19,https://www.nasdaq.com/press-release/cytocom-updates-investigational-new-drug-application-for-phase-2-clinical-trial-of
ICPT,5 DAYS AGO,"Intercept to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021",https://www.nasdaq.com/press-release/intercept-to-announce-fourth-quarter-and-full-year-2020-financial-results-on-february
ICUI,"FEB 4, 2021","ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2020 Earnings Conference Call",https://www.nasdaq.com/press-release/icu-medical-inc.-announces-time-of-fourth-quarter-and-fiscal-year-2020-earnings
IDRA,"JAN 11, 2021",Idera Pharmaceuticals to Present at Upcoming Conferences,https://www.nasdaq.com/press-release/idera-pharmaceuticals-to-present-at-upcoming-conferences-2021-01-11
IDXG,"FEB 4, 2021",Interpace Biosciences Announces CFO Leadership Transition,https://www.nasdaq.com/press-release/interpace-biosciences-announces-cfo-leadership-transition-2021-02-04
IDXX,5 HOURS AGO,IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences,https://www.nasdaq.com/press-release/idexx-laboratories-to-present-at-two-upcoming-institutional-investor-conferences-2021
IDYA,"FEB 8, 2021","IDEAYA Announces IDE397 IND Clearance by U.S. FDA to Initiate Phase 1 and Appointment of Matthew Maurer, M.D., as Vice President, Head of Clinical Oncology and Medical Affairs",https://www.nasdaq.com/press-release/ideaya-announces-ide397-ind-clearance-by-u.s.-fda-to-initiate-phase-1-and-appointment
IGMS,"FEB 5, 2021",IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day,https://www.nasdaq.com/press-release/igm-biosciences-to-present-at-the-guggenheim-healthcare-talks-2021-idea-forum
IKT,,,
IMAB,6 DAYS AGO,I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors,https://www.nasdaq.com/press-release/i-mab-announces-china-nmpa-clearance-for-phase-1-study-of-tj210-mor210-in-patients
IMAC,"FEB 4, 2021",IMAC Holdings Continues Florida Expansion with Acquisition of Tampa Clinic,https://www.nasdaq.com/press-release/imac-holdings-continues-florida-expansion-with-acquisition-of-tampa-clinic-2021-02-04
IMACW,,,
IMCR,14 HOURS AGO,Immunocore announces key appointments to management and Board,https://www.nasdaq.com/press-release/immunocore-announces-key-appointments-to-management-and-board-2021-02-16
IMGN,4 DAYS AGO,ImmunoGen Reports Recent Progress and 2020 Financial Results,https://www.nasdaq.com/press-release/immunogen-reports-recent-progress-and-2020-financial-results-2021-02-12
IMMP,"JAN 27, 2021",Immutep Announces Advancement Of Phase II Trial For Eftilagimod Alpha In Covid-19 Patients To Randomised Portion Of The Study,https://www.nasdaq.com/press-release/immutep-announces-advancement-of-phase-ii-trial-for-eftilagimod-alpha-in-covid-19
IMNM,"FEB 3, 2021",Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome’s COVID-19 Antibody Based Treatment,https://www.nasdaq.com/press-release/abzena-selected-by-immunome-to-develop-and-manufacture-antibody-cocktail-for
IMRA,"JAN 20, 2021","Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer",https://www.nasdaq.com/press-release/imara-announces-the-appointment-of-kenneth-attie-m.d.-as-chief-medical-officer-2021
IMRN,"JAN 11, 2021",Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021 Virtual Conference,https://www.nasdaq.com/press-release/immuron-to-participate-in-h.c.-wainwright-co.-bioconnect-2021-virtual-conference-2021
IMRNW,,,
IMTX,"DEC 2, 2020",Immatics Announces Third Quarter 2020 Financial Results and Business Update,https://www.nasdaq.com/press-release/immatics-announces-third-quarter-2020-financial-results-and-business-update-2020-12
IMTXW,"JUL 2, 2020",Immatics Announces Completion of Business Combination and Listing on NASDAQ,https://www.nasdaq.com/press-release/immatics-announces-completion-of-business-combination-and-listing-on-nasdaq-2020-07-0
IMUX,5 DAYS AGO,"Immunic, Inc. to Participate in the SVB Leerink 10th Annual Global Healthcare Conference on February 25",https://www.nasdaq.com/press-release/immunic-inc.-to-participate-in-the-svb-leerink-10th-annual-global-healthcare
IMV,"JAN 4, 2021",IMV to Participate in Two Upcoming Investor Events,https://www.nasdaq.com/press-release/imv-to-participate-in-two-upcoming-investor-events-2021-01-04
IMVT,13 HOURS AGO,"Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020",https://www.nasdaq.com/press-release/immunovant-reports-financial-results-for-the-quarter-and-nine-months-ended-december
INBX,"FEB 1, 2021",Inhibrx Announces Participation in Upcoming Investor Conference,https://www.nasdaq.com/press-release/inhibrx-announces-participation-in-upcoming-investor-conference-2021-02-01
INCY,5 DAYS AGO,Incyte to Present at Upcoming Investor Conference,https://www.nasdaq.com/press-release/incyte-to-present-at-upcoming-investor-conference-2021-02-11
INFI,4 DAYS AGO,Infinity Announces Pricing of $80 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/infinity-announces-pricing-of-%2480-million-public-offering-of-common-stock-2021-02-12
INFU,5 DAYS AGO,InfuSystem Announces New $75 Million Revolving Credit Facility,https://www.nasdaq.com/press-release/infusystem-announces-new-%2475-million-revolving-credit-facility-2021-02-11
INGN,12 HOURS AGO,Inogen Strengthens Board of Directors with Addition of Kristen Miranda,https://www.nasdaq.com/press-release/inogen-strengthens-board-of-directors-with-addition-of-kristen-miranda-2021-02-16
INM,13 HOURS AGO,InMed Announces Closing of US$4.5 Million Private Placement,https://www.nasdaq.com/press-release/inmed-announces-closing-of-us%244.5-million-private-placement-2021-02-16
INMB,"JAN 21, 2021","INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial",https://www.nasdaq.com/press-release/inmune-bio-inc.-announces-xpro1595-found-to-decrease-neuroinflammation-and
INMD,6 DAYS AGO,InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth,https://www.nasdaq.com/press-release/inmode-reports-record-fourth-quarter-and-full-year-2020-financial-results-quarterly
INO,13 HOURS AGO,"INOVIO to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021",https://www.nasdaq.com/press-release/inovio-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-1-2021
INSM,13 HOURS AGO,Insmed to Host Conference Call to Discuss Topline Data from Treprostinil Palmitil Inhalation Powder Phase 1 Study,https://www.nasdaq.com/press-release/insmed-to-host-conference-call-to-discuss-topline-data-from-treprostinil-palmitil
INSP,5 DAYS AGO,"Inspire Medical Systems, Inc. to Present at the 10th Annual SVB Leerink Global Healthcare Conference",https://www.nasdaq.com/press-release/inspire-medical-systems-inc.-to-present-at-the-10th-annual-svb-leerink-global
INVA,"FEB 3, 2021",Innoviva Reports Fourth Quarter 2020 Financial Results,https://www.nasdaq.com/press-release/innoviva-reports-fourth-quarter-2020-financial-results-2021-02-03
INVO,"JAN 27, 2021",INVO Bioscience Advances Commercialization into the European Fertility Market with Initial Orders of INVOcell (IVC) in Spain,https://www.nasdaq.com/press-release/invo-bioscience-advances-commercialization-into-the-european-fertility-market-with
INZY,"FEB 4, 2021","Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President and Chief Medical Officer",https://www.nasdaq.com/press-release/inozyme-pharma-appoints-deborah-wenkert-m.d.-as-senior-vice-president-and-chief
IONS,5 DAYS AGO,Ionis to hold 2020 financial results webcast,https://www.nasdaq.com/press-release/ionis-to-hold-2020-financial-results-webcast-2021-02-11
IOVA,"JAN 19, 2021",Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences,https://www.nasdaq.com/press-release/iovance-biotherapeutics-to-present-at-upcoming-healthcare-conferences-2021-01-19
IPA,6 DAYS AGO,IPA Announces Closing of Over-Allotment Option Associated with the Recently Completed Bought Deal Offering of Common Shares,https://www.nasdaq.com/press-release/ipa-announces-closing-of-over-allotment-option-associated-with-the-recently-completed
IPHA,"FEB 9, 2021",Innate Pharma Advances Lacutamab Clinical Development Program,https://www.nasdaq.com/press-release/innate-pharma-advances-lacutamab-clinical-development-program-2021-02-09
IQV,18 HOURS AGO,IQVIA Announces Offering of Senior Notes,https://www.nasdaq.com/press-release/iqvia-announces-offering-of-senior-notes-2021-02-16
IRIX,"JAN 11, 2021",IRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2020,https://www.nasdaq.com/press-release/iridex-announces-preliminary-operational-and-financial-results-for-fourth-quarter-0
IRMD,"FEB 4, 2021",IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results,https://www.nasdaq.com/press-release/iradimed-corporation-announces-fourth-quarter-2020-financial-results-2021-02-04
IRTC,4 DAYS AGO,"IRTC Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against iRhythm Technologies, Inc. (NASDAQ: IRTC); Lead Plaintiff Deadline is April 2, 2021",https://www.nasdaq.com/press-release/irtc-stock%3A-berger-montague-investigates-alleged-securities-fraud-claims-against
IRWD,"FEB 8, 2021",Ironwood Pharmaceuticals Announces CEO Transition,https://www.nasdaq.com/press-release/ironwood-pharmaceuticals-announces-ceo-transition-2021-02-08
ISEE,"JAN 5, 2021",IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/iveric-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-01-05
ISR,13 HOURS AGO,Isoray Announces the Appointment of Lisa Lauer As Vice President Business Development,https://www.nasdaq.com/press-release/isoray-announces-the-appointment-of-lisa-lauer-as-vice-president-business-development
ISRG,"JAN 21, 2021",Intuitive Announces Fourth Quarter Earnings,https://www.nasdaq.com/press-release/intuitive-announces-fourth-quarter-earnings-2021-01-21
ITCI,"JAN 21, 2021","CAPLYTA® (lumateperone) Open-Label Safety Switching Study in Patients with Schizophrenia Published in the Journal, Schizophrenia Research",https://www.nasdaq.com/press-release/caplytar-lumateperone-open-label-safety-switching-study-in-patients-with
ITMR,5 HOURS AGO,"Itamar Medical to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Tuesday, March 2, 2021",https://www.nasdaq.com/press-release/itamar-medical-to-report-fourth-quarter-and-full-year-2020-financial-results-and-host
ITOS,"JAN 5, 2021",iTeos to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/iteos-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference-2021-01-05
ITRM,6 DAYS AGO,Iterum Therapeutics plc Announces Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares,https://www.nasdaq.com/press-release/iterum-therapeutics-plc-announces-exercise-of-underwriters-option-to-purchase
IVA,,,
IVC,6 DAYS AGO,"Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2020",https://www.nasdaq.com/press-release/invacare-corporation-announces-financial-results-for-the-fourth-quarter-and-full-0
JAGX,"FEB 9, 2021",Noted Natural Products Industry Veteran Dr. Nigel Gericke Joins Scientific Strategy Team for Jaguar Health’s Recently Launched Mental Health Entheogen Therapeutics Initiative,https://www.nasdaq.com/press-release/noted-natural-products-industry-veteran-dr.-nigel-gericke-joins-scientific-strategy
JAZZ,13 HOURS AGO,"Jazz Pharmaceuticals Completes Submission of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia",https://www.nasdaq.com/press-release/jazz-pharmaceuticals-completes-submission-of-supplemental-new-drug-application-for
JNCE,4 DAYS AGO,"Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors",https://www.nasdaq.com/press-release/jounce-therapeutics-appoints-luisa-salter-cid-ph.d.-to-its-board-of-directors-2021-02
JNJ,"FEB 9, 2021",Johnson & Johnson Vision Celebrates 20 Years of Helping Cataract Patients with the See More Campaign and Global Patient Story Search,https://www.nasdaq.com/press-release/johnson-johnson-vision-celebrates-20-years-of-helping-cataract-patients-with-the-see
JWS,"NOV 12, 2020","Cano Health, a Leading Value-Based Care Delivery Platform for Seniors, to Become Publicly Traded via Merger with Jaws Acquisition Corp.",https://www.nasdaq.com/press-release/cano-health-a-leading-value-based-care-delivery-platform-for-seniors-to-become
KALA,14 HOURS AGO,Kala Pharmaceuticals Announces EYSUVIS™ Now Covered by Express Scripts,https://www.nasdaq.com/press-release/kala-pharmaceuticals-announces-eysuvistm-now-covered-by-express-scripts-2021-02-16
KALV,5 HOURS AGO,KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/kalvista-pharmaceuticals-announces-the-closing-of-its-upsized-public-offering-of
KDMN,5 HOURS AGO,Kadmon Announces Closing of $240 Million Convertible Senior Notes Offering Including Full Exercise of $40 Million Over-Allotment Option,https://www.nasdaq.com/press-release/kadmon-announces-closing-of-%24240-million-convertible-senior-notes-offering-including
KDNY,"FEB 2, 2021",Chinook Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for CHK-336 for Treatment of Primary Hyperoxaluria,https://www.nasdaq.com/press-release/chinook-receives-rare-pediatric-disease-designation-from-u.s.-food-and-drug
KIDS,5 DAYS AGO,"OrthoPediatrics Corp. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/orthopediatrics-corp.-to-participate-in-the-btig-virtual-medtech-digital-health-life
KIN,5 HOURS AGO,Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit,https://www.nasdaq.com/press-release/kindred-biosciences-to-present-at-the-bofa-securities-animal-health-virtual-summit
KLDO,5 DAYS AGO,Kaleido Biosciences Announces the Exercise of the Underwriters’ Option to Purchase Additional Shares of Common Stock,https://www.nasdaq.com/press-release/kaleido-biosciences-announces-the-exercise-of-the-underwriters-option-to-purchase
KMDA,6 DAYS AGO,"Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities",https://www.nasdaq.com/press-release/kamada-reports-fourth-quarter-and-fiscal-year-2020-financial-results-recent
KMPH,"JAN 27, 2021",KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program for the Treatment of Stimulant Use Disorder,https://www.nasdaq.com/press-release/kempharm-receives-fda-clearance-to-initiate-kp879-clinical-program-for-the-treatment
KNSA,"JAN 11, 2021",Kiniksa Highlights Corporate Priorities and Expected 2021 Milestones,https://www.nasdaq.com/press-release/kiniksa-highlights-corporate-priorities-and-expected-2021-milestones-2021-01-11
KNTE,,,
KOD,"FEB 2, 2021","Kodiak Sciences Announces Upcoming Presentation of KSI-301 Phase 1b Clinical Study Data at Angiogenesis, Exudation, and Degeneration 2021 - Virtual Edition",https://www.nasdaq.com/press-release/kodiak-sciences-announces-upcoming-presentation-of-ksi-301-phase-1b-clinical-study
KPTI,5 DAYS AGO,Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress,https://www.nasdaq.com/press-release/karyopharm-reports-fourth-quarter-and-full-year-2020-financial-results-and-highlights
KRBP,"JAN 26, 2021",Kiromic Announces License Agreement With Longwood University for chPD1,https://www.nasdaq.com/press-release/kiromic-announces-license-agreement-with-longwood-university-for-chpd1-2021-01-26
KRMD,"JAN 25, 2021",KORU Medical Systems Reports Preliminary Full Year 2020 Results; Announces CEO Transition,https://www.nasdaq.com/press-release/koru-medical-systems-reports-preliminary-full-year-2020-results-announces-ceo
KRON,"JAN 26, 2021","Kronos Bio Appoints Marianne De Backer, Ph.D., to Board of Directors",https://www.nasdaq.com/press-release/kronos-bio-appoints-marianne-de-backer-ph.d.-to-board-of-directors-2021-01-26
KROS,"DEC 21, 2020",Keros Therapeutics Announces Addition to NASDAQ Biotechnology Index,https://www.nasdaq.com/press-release/keros-therapeutics-announces-addition-to-nasdaq-biotechnology-index-2020-12-21
KRTX,6 DAYS AGO,PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares,https://www.nasdaq.com/press-release/puretech-receives-approximately-%24118-million-from-sale-of-portion-of-founded-entity
KRYS,"FEB 2, 2021",Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/krystal-biotech-announces-pricing-of-upsized-%24125-million-public-offering-of-common
KTRA,4 DAYS AGO,Kintara Therapeutics Announces Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/kintara-therapeutics-announces-fiscal-second-quarter-2021-financial-results-and
KURA,"JAN 7, 2021",Kura Oncology to Participate in H.C. Wainwright BioConnect 2021 Conference,https://www.nasdaq.com/press-release/kura-oncology-to-participate-in-h.c.-wainwright-bioconnect-2021-conference-2021-01-07
KYMR,"FEB 4, 2021",Kymera Therapeutics to Present at Upcoming February Investor Conferences,https://www.nasdaq.com/press-release/kymera-therapeutics-to-present-at-upcoming-february-investor-conferences-2021-02-04
KZIA,"JAN 6, 2021","Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazia’s Paxalisib and Kintara’s VAL-083 in GBM AGILE Trial",https://www.nasdaq.com/press-release/global-coalition-for-adaptive-research-kazia-and-kintara-announce-commencement-of
KZR,6 DAYS AGO,Kezar Life Sciences to Present at BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/kezar-life-sciences-to-present-at-bio-ceo-investor-digital-conference-2021-02-10
LABP,"FEB 3, 2021",Landos Biopharma Announces Pricing of Initial Public Offering,https://www.nasdaq.com/press-release/landos-biopharma-announces-pricing-of-initial-public-offering-2021-02-03
LAKE,"JAN 5, 2021",Lakeland Industries Bolsters Executive Management Team with Creation of New Position for EVP Global Sales and Marketing,https://www.nasdaq.com/press-release/lakeland-industries-bolsters-executive-management-team-with-creation-of-new-position
LCI,"FEB 9, 2021",Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin,https://www.nasdaq.com/press-release/lannett-expands-strategic-relationship-to-include-biosimilar-fast-acting-insulin-2021
LCTX,13 HOURS AGO,"Lineage to Host Virtual OPC1 Investor & Analyst Day on February 22, 2021",https://www.nasdaq.com/press-release/lineage-to-host-virtual-opc1-investor-analyst-day-on-february-22-2021-2021-02-16
LEGN,"FEB 1, 2021",Legend Biotech Announces BCMA CAR-T Therapy Cilta-cel Accepted for Accelerated Assessment in Europe for the Treatment of Relapsed and/or Refractory Multiple Myeloma,https://www.nasdaq.com/press-release/legend-biotech-announces-bcma-car-t-therapy-cilta-cel-accepted-for-accelerated
LEXX,15 HOURS AGO,Lexaria Bioscience (LEXX.NASDAQ) (LEXX.CSE) $11 million financing supports R&D program targeting high blood pressure and SARS-CoV-2 infection,https://www.nasdaq.com/press-release/lexaria-bioscience-lexx.nasdaq-lexx.cse-%2411-million-financing-supports-rd-program
LEXXW,,,
LFVN,"FEB 2, 2021",LifeVantage Announces Appointment of Chief Executive Officer,https://www.nasdaq.com/press-release/lifevantage-announces-appointment-of-chief-executive-officer-2021-02-02
LGND,"FEB 3, 2021",Ligand Reports Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/ligand-reports-fourth-quarter-and-full-year-2020-financial-results-2021-02-03
LGVW,15 HOURS AGO,"Butterfly Network, a Global Leader in Democratizing Medical Imaging, Closes Business Combination and Will Begin Trading on the New York Stock Exchange",https://www.nasdaq.com/press-release/butterfly-network-a-global-leader-in-democratizing-medical-imaging-closes-business
LH,8 HOURS AGO,"Amy Summy, Chief Marketing Officer of Labcorp, Named to Forbes’ CMO Next",https://www.nasdaq.com/press-release/amy-summy-chief-marketing-officer-of-labcorp-named-to-forbes-cmo-next-2021-02-16
LHCG,5 DAYS AGO,LHC Group announces fourth quarter and year end 2020 earnings release and conference call dates,https://www.nasdaq.com/press-release/lhc-group-announces-fourth-quarter-and-year-end-2020-earnings-release-and-conference
LHDX,5 DAYS AGO,"U.S. Physicians Can Now Order Lucira Health Self-Administered, Lab Quality, COVID-19 Molecular Test for Home or Office",https://www.nasdaq.com/press-release/u.s.-physicians-can-now-order-lucira-health-self-administered-lab-quality-covid-19
LIFE,5 DAYS AGO,aTyr Pharma Announces New tRNA Synthetase Discovery Programs,https://www.nasdaq.com/press-release/atyr-pharma-announces-new-trna-synthetase-discovery-programs-2021-02-11
LIVN,"JAN 20, 2021",LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results,https://www.nasdaq.com/press-release/livanova-to-host-conference-call-for-fourth-quarter-and-full-year-2020-results-2021
LIXT,"JAN 19, 2021",Lixte Biotechnology and City of Hope to Initiate Phase 1b Clinical Trial of Lixte’s Lead Compound LB-100 to Treat Small Cell Lung Cancer,https://www.nasdaq.com/press-release/lixte-biotechnology-and-city-of-hope-to-initiate-phase-1b-clinical-trial-of-lixtes
LIXTW,,,
LJPC,"JAN 12, 2021",La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe,https://www.nasdaq.com/press-release/la-jolla-pharmaceutical-company-announces-exclusive-licensing-agreement-for
LLY,5 DAYS AGO,Lilly To Participate in SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/lilly-to-participate-in-svb-leerink-global-healthcare-conference-2021-02-11
LMAT,5 HOURS AGO,LeMaitre Vascular to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/lemaitre-vascular-to-present-at-upcoming-investor-conferences-2021-02-16
LMNL,"JAN 27, 2021",Liminal BioSciences Provides Update on Business Strategy and Focus on Small Molecule Therapeutics,https://www.nasdaq.com/press-release/liminal-biosciences-provides-update-on-business-strategy-and-focus-on-small-molecule
LMNX,"FEB 8, 2021",Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results,https://www.nasdaq.com/press-release/luminex-corporation-reports-fourth-quarter-and-full-year-2020-results-2021-02-08
LNSR,"FEB 8, 2021",LENSAR to Present at Two Upcoming Investor Conferences,https://www.nasdaq.com/press-release/lensar-to-present-at-two-upcoming-investor-conferences-2021-02-08
LNTH,4 DAYS AGO,Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/lantheus-holdings-to-present-at-the-10th-annual-svb-leerink-global-healthcare
LOGC,"JAN 7, 2021",LogicBio Announces Extension Of Collaboration With Children's Medical Research Institute,https://www.nasdaq.com/press-release/logicbio-announces-extension-of-collaboration-with-childrens-medical-research
LPCN,"JAN 28, 2021",Lipocine Closes Underwritten Public Offering Of Common Stock,https://www.nasdaq.com/press-release/lipocine-closes-underwritten-public-offering-of-common-stock-2021-01-28
LPTX,"JAN 6, 2021",Leap Therapeutics to Present at H.C. Wainwright BioConnect 2021 Conference,https://www.nasdaq.com/press-release/leap-therapeutics-to-present-at-h.c.-wainwright-bioconnect-2021-conference-2021-01-06
LQDA,"DEC 14, 2020",Liquidia Corporation Announces Chief Executive Officer Transition,https://www.nasdaq.com/press-release/liquidia-corporation-announces-chief-executive-officer-transition-2020-12-14
LRMR,"DEC 15, 2020",Larimar Therapeutics Added to NASDAQ Biotechnology Index,https://www.nasdaq.com/press-release/larimar-therapeutics-added-to-nasdaq-biotechnology-index-2020-12-15
LTRN,"JAN 20, 2021",Lantern Pharma Announces Closing of Public Offering of $69 Million USD and Full Exercise of Underwriter's Over-Allotment Option,https://www.nasdaq.com/press-release/lantern-pharma-announces-closing-of-public-offering-of-%2469-million-usd-and-full
LUMO,5 HOURS AGO,Lumos Pharma Announces Changes to its Board of Directors,https://www.nasdaq.com/press-release/lumos-pharma-announces-changes-to-its-board-of-directors-2021-02-16
LUNA,"JAN 11, 2021",Luna Innovations to Present at Needham Virtual Investor Growth Conference,https://www.nasdaq.com/press-release/luna-innovations-to-present-at-needham-virtual-investor-growth-conference-2021-01-11
LUNG,5 HOURS AGO,"Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021",https://www.nasdaq.com/press-release/pulmonx-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-2-2021
LXRX,"JAN 14, 2021",Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure,https://www.nasdaq.com/press-release/lexicon-pharmaceuticals-provides-regulatory-update-on-sotagliflozin-in-heart-failure
LYRA,"JAN 22, 2021",Lyra Therapeutics Provides Corporate Update and Anticipated Milestones for 2021,https://www.nasdaq.com/press-release/lyra-therapeutics-provides-corporate-update-and-anticipated-milestones-for-2021-2021
MACK,"NOV 5, 2020",Merrimack Reports Third Quarter 2020 Financial Results,https://www.nasdaq.com/press-release/merrimack-reports-third-quarter-2020-financial-results-2020-11-05
MASI,12 HOURS AGO,"Masimo to Report Fourth Quarter and Full Year 2020 Financial Results after Market Close on Tuesday, February 23",https://www.nasdaq.com/press-release/masimo-to-report-fourth-quarter-and-full-year-2020-financial-results-after-market
MBIO,"FEB 2, 2021",Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”),https://www.nasdaq.com/press-release/mustang-bio-provides-updates-on-its-lentiviral-gene-therapies-for-the-treatment-of-x
MBOT,"FEB 4, 2021",Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ‘One & Done’ Technology,https://www.nasdaq.com/press-release/microbot-medical-granted-patent-allowance-in-japan-global-jurisdictions-recognizing
MBRX,6 DAYS AGO,Moleculin Announces Full Exercise of Over-Allotment Option,https://www.nasdaq.com/press-release/moleculin-announces-full-exercise-of-over-allotment-option-2021-02-10
MCK,"FEB 2, 2021",McKesson Reports Fiscal 2021 Third-Quarter Results,https://www.nasdaq.com/press-release/mckesson-reports-fiscal-2021-third-quarter-results-2021-02-02
MCRB,"JAN 19, 2021",Seres Therapeutics to Present SER-109 Phase 3 Mechanistic Data at Keystone Symposium,https://www.nasdaq.com/press-release/seres-therapeutics-to-present-ser-109-phase-3-mechanistic-data-at-keystone-symposium
MD,"FEB 5, 2021","Mednax 2020 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 18, 2021",https://www.nasdaq.com/press-release/mednax-2020-fourth-quarter-conference-call-webcast-scheduled-for-thursday-february-18
MDGL,"NOV 5, 2020",Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and Highlights,https://www.nasdaq.com/press-release/madrigal-pharmaceuticals-announces-completion-of-enrollment-in-phase-3-maestro-nafld
MDGS,11 HOURS AGO,Medigus: Leading Life Science and Pharmaceutical Entrepreneur Mori Arkin to Join ScoutCam’s Board of Directors,https://www.nasdaq.com/press-release/medigus%3A-leading-life-science-and-pharmaceutical-entrepreneur-mori-arkin-to-join
MDGSW,,,
MDNA,4 DAYS AGO,Medicenna Reports Third Quarter Fiscal 2021 Financial Results and Operational Highlights,https://www.nasdaq.com/press-release/medicenna-reports-third-quarter-fiscal-2021-financial-results-and-operational
MDT,10 HOURS AGO,Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021,https://www.nasdaq.com/press-release/medtronic-to-announce-financial-results-for-its-third-quarter-of-fiscal-year-2021
MDVL,"FEB 9, 2021",MedAvail’s SpotRx Pharmacy and Cigna Medical Group Partner to Help Improve Medication Access in Phoenix,https://www.nasdaq.com/press-release/medavails-spotrx-pharmacy-and-cigna-medical-group-partner-to-help-improve-medication
MDXG,6 DAYS AGO,"MiMedx to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/mimedx-to-participate-at-the-btig-virtual-medtech-digital-health-life-science
MEDP,1 DAY AGO,"Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Results",https://www.nasdaq.com/press-release/medpace-holdings-inc.-reports-fourth-quarter-and-full-year-2020-results-2021-02-15
MEDS,"FEB 9, 2021","MedCheks LLC, a Trxade Group Company, to Launch Health Passport App Led by Industry Thought Leader James Ram",https://www.nasdaq.com/press-release/medcheks-llc-a-trxade-group-company-to-launch-health-passport-app-led-by-industry
MEIP,"FEB 4, 2021",MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights,https://www.nasdaq.com/press-release/mei-pharma-reports-second-quarter-fiscal-year-2021-results-and-operational-highlights
MESO,6 DAYS AGO,Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease,https://www.nasdaq.com/press-release/mesoblast-phase-3-trial-shows-that-a-single-injection-of-rexlemestrocel-l-hyaluronic
MGLN,15 HOURS AGO,Magellan Rx Management and Health Partners Plans Achieve 5 Stars for the Medicare Star Ratings Measure: Statin Use in Persons with Diabetes,https://www.nasdaq.com/press-release/magellan-rx-management-and-health-partners-plans-achieve-5-stars-for-the-medicare
MGNX,5 DAYS AGO,MacroGenics Names Federica O’Brien to its Board of Directors,https://www.nasdaq.com/press-release/macrogenics-names-federica-obrien-to-its-board-of-directors-2021-02-11
MGTA,"FEB 8, 2021",Magenta Therapeutics to Present Additional Data from Phase 1 MGTA-145 Stem Cell Mobilization Program and Preclinical Updates on Targeting Conditioning Program at Transplantation and Cellular Therapy (TCT) 2021 Annual Meeting,https://www.nasdaq.com/press-release/magenta-therapeutics-to-present-additional-data-from-phase-1-mgta-145-stem-cell
MGTX,"JAN 26, 2021",MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia,https://www.nasdaq.com/press-release/meiragtx-announces-aav-cnga3-granted-fast-track-designation-by-u.s.-fda-for-treatment
MIRM,6 DAYS AGO,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/mirum-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7
MIST,"NOV 23, 2020",Milestone Pharmaceuticals to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-2020-11-23
MITO,6 DAYS AGO,Stealth BioTherapeutics Announces Pricing Of $4.7 Million Registered Direct Offering Of American Depositary Shares,https://www.nasdaq.com/press-release/stealth-biotherapeutics-announces-pricing-of-%244.7-million-registered-direct-offering
MLND,"JAN 5, 2021",Millendo Therapeutics Provides Pipeline and Business Update,https://www.nasdaq.com/press-release/millendo-therapeutics-provides-pipeline-and-business-update-2021-01-05
MLSS,7 HOURS AGO,Milestone Scientific Adds Three Additional Premier Distributors Providing Robust U.S. Coverage and a New Distributor in Canada for the Company’s Dental Instrument,https://www.nasdaq.com/press-release/milestone-scientific-adds-three-additional-premier-distributors-providing-robust-u.s.
MMM,14 HOURS AGO,"3M to Invest $1 Billion to Achieve Carbon Neutrality, Reduce Water Use, and Improve Water Quality",https://www.nasdaq.com/press-release/3m-to-invest-%241-billion-to-achieve-carbon-neutrality-reduce-water-use-and-improve
MMSI,4 DAYS AGO,"Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021",https://www.nasdaq.com/press-release/merit-medical-systems-to-announce-fourth-quarter-and-year-end-2020-results-on
MNKD,"JAN 4, 2021",MannKind Corporation to Participate in H.C. Wainwright Bioconnect 2021 Conference,https://www.nasdaq.com/press-release/mannkind-corporation-to-participate-in-h.c.-wainwright-bioconnect-2021-conference
MNOV,"JAN 31, 2021",MediciNova Announces Closing of US$20 Million Private Placement Transaction,https://www.nasdaq.com/press-release/medicinova-announces-closing-of-us%2420-million-private-placement-transaction-2021-01
MNPR,14 HOURS AGO,Monopar Announces First Patient Dosed in its Phase 2b/3 VOICE Trial Evaluating Validive® for the Prevention of Chemoradiotherapy-Induced Severe Oral Mucositis (SOM) in Oropharyngeal Cancer (OPC),https://www.nasdaq.com/press-release/monopar-announces-first-patient-dosed-in-its-phase-2b-3-voice-trial-evaluating
MOH,6 DAYS AGO,Molina Healthcare Reports Fourth Quarter and Year-End 2020 Financial Results,https://www.nasdaq.com/press-release/molina-healthcare-reports-fourth-quarter-and-year-end-2020-financial-results-2021-02
MOR,"JAN 25, 2021",MorphoSys and I-Mab Announce First Patient Dosed in U.S. Phase 1 Study of MOR210/TJ210 in Patients with Advanced Cancer,https://www.nasdaq.com/press-release/morphosys-and-i-mab-announce-first-patient-dosed-in-u.s.-phase-1-study-of-mor210
MORF,5 HOURS AGO,Morphic Therapeutic to Participate in GI/Microbiome Panel Discussion at the 41st Annual Cowen Health Care Conference,https://www.nasdaq.com/press-release/morphic-therapeutic-to-participate-in-gi-microbiome-panel-discussion-at-the-41st
MOTS,"JAN 27, 2021",Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million,https://www.nasdaq.com/press-release/motus-gi-announces-warrant-exercise-agreement-resulting-in-expected-gross-proceeds-to
MREO,4 DAYS AGO,Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares,https://www.nasdaq.com/press-release/mereo-biopharma-group-plc-announces-closing-of-public-offering-of-american-depositary
MRK,3 DAYS AGO,KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma,https://www.nasdaq.com/press-release/keytrudar-pembrolizumab-plus-lenvimar-lenvatinib-demonstrated-superior-progression
MRKR,"JAN 13, 2021",Marker Therapeutics Announces Completion of New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates,https://www.nasdaq.com/press-release/marker-therapeutics-announces-completion-of-new-manufacturing-facility-to-support
MRNA,12 HOURS AGO,Moderna Provides U.S. COVID-19 Vaccine Supply Update,https://www.nasdaq.com/press-release/moderna-provides-u.s.-covid-19-vaccine-supply-update-2021-02-16
MRNS,4 DAYS AGO,Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/marinus-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-11
MRSN,"JAN 22, 2021",Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/mersana-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-2021
MRTX,6 DAYS AGO,MD Anderson And Mirati Therapeutics Announce KRAS Strategic Research And Development Collaboration In Solid Tumors,https://www.nasdaq.com/press-release/md-anderson-and-mirati-therapeutics-announce-kras-strategic-research-and-development
MRUS,"FEB 1, 2021",Merus to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/merus-to-participate-in-upcoming-investor-conferences-2021-02-01
MRVI,6 DAYS AGO,Maravai LifeSciences Expands Its Intellectual Property Portfolio,https://www.nasdaq.com/press-release/maravai-lifesciences-expands-its-intellectual-property-portfolio-2021-02-10
MSA,"FEB 9, 2021",MSA Schedules Fourth Quarter Earnings Webcast,https://www.nasdaq.com/press-release/msa-schedules-fourth-quarter-earnings-webcast-2021-02-09
MTCR,15 HOURS AGO,Metacrine Announces Publication of MET409 NASH Proof-of-Concept Study Results in the Journal of Hepatology,https://www.nasdaq.com/press-release/metacrine-announces-publication-of-met409-nash-proof-of-concept-study-results-in-the
MTEM,5 DAYS AGO,Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer,https://www.nasdaq.com/press-release/molecular-templates-establishes-multi-target-collaboration-with-bristol-myers-squibb
MTNB,"FEB 1, 2021",Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa®,https://www.nasdaq.com/press-release/matinas-biopharma-announces-topline-results-from-enhance-it-study-of-lypdisotm
MTP,"JAN 26, 2021",Midatech Pharma PLC Announces Business Update,https://www.nasdaq.com/press-release/midatech-pharma-plc-announces-business-update-2021-01-26
MYGN,5 HOURS AGO,"Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021",https://www.nasdaq.com/press-release/myriad-genetics-to-announce-december-2020-quarterly-financial-results-on-february-23
MYO,13 HOURS AGO,Germany's Largest Statutory Health Insurance Company Approves MyoPro,https://www.nasdaq.com/press-release/germanys-largest-statutory-health-insurance-company-approves-myopro-2021-02-16
MYOV,13 HOURS AGO,HealthyWomen and Myovant Sciences Launch “Voices of Periods” to Fight Menstrual Stigma,https://www.nasdaq.com/press-release/healthywomen-and-myovant-sciences-launch-voices-of-periods-to-fight-menstrual-stigma
NAOV,6 DAYS AGO,NanoVibronix Reports Schedule Published by NICE for Review of UroShield® Device,https://www.nasdaq.com/press-release/nanovibronix-reports-schedule-published-by-nice-for-review-of-uroshieldr-device-2021
NARI,"FEB 3, 2021",Inari Medical to Present in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/inari-medical-to-present-in-upcoming-investor-conferences-2021-02-03
NATR,"NOV 9, 2020",Nature's Sunshine Reports Third Quarter 2020 Results,https://www.nasdaq.com/press-release/natures-sunshine-reports-third-quarter-2020-results-2020-11-09
NAVB,"FEB 8, 2021",Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA and Launch of NAV3-32 Phase 2B Trial in Rheumatoid Arthritis,https://www.nasdaq.com/press-release/navidea-biopharmaceuticals-announces-submission-of-formal-type-b-meeting-request-with
NBIX,"FEB 4, 2021",Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results,https://www.nasdaq.com/press-release/neurocrine-biosciences-reports-fourth-quarter-and-full-year-2020-financial-results
NBRV,"FEB 1, 2021",Nabriva Therapeutics Announces Retirement of its Chief Financial Officer,https://www.nasdaq.com/press-release/nabriva-therapeutics-announces-retirement-of-its-chief-financial-officer-2021-02-01
NBSE,5 DAYS AGO,NeuBase Therapeutics Reports Financial Results for the First Quarter of Fiscal Year 2021,https://www.nasdaq.com/press-release/neubase-therapeutics-reports-financial-results-for-the-first-quarter-of-fiscal-year
NBTX,"JAN 28, 2021",NANOBIOTIX Announces First Patient Injected With NBTXR3 in Esophageal Cancer,https://www.nasdaq.com/press-release/nanobiotix-announces-first-patient-injected-with-nbtxr3-in-esophageal-cancer-2021-01
NBY,"FEB 8, 2021",NovaBay CEO Issues Letter to Stockholders,https://www.nasdaq.com/press-release/novabay-ceo-issues-letter-to-stockholders-2021-02-08
NCNA,"JAN 15, 2021",NuCana Presents Encouraging Data at ASCO GI for NUC-3373 in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer,https://www.nasdaq.com/press-release/nucana-presents-encouraging-data-at-asco-gi-for-nuc-3373-in-heavily-pre-treated
NDRA,"JAN 26, 2021",ENDRA Life Sciences Further Strengthens TAEUS(R) System Intellectual Property Protection with Issuance of 14th U.S. Patent,https://www.nasdaq.com/press-release/endra-life-sciences-further-strengthens-taeusr-system-intellectual-property
NDRAW,,,
NEO,15 HOURS AGO,"NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/neogenomics-to-participate-in-the-btig-virtual-medtech-digital-health-life-science
NEOG,1 DAY AGO,Neogen launches wastewater detection screening for COVID-19,https://www.nasdaq.com/press-release/neogen-launches-wastewater-detection-screening-for-covid-19-2021-02-15
NEOS,6 DAYS AGO,"Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021",https://www.nasdaq.com/press-release/aytu-bioscience-and-neos-therapeutics-announce-special-meetings-of-stockholders
NEPH,"JAN 12, 2021",Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020,https://www.nasdaq.com/press-release/nephros-announces-preliminary-financial-results-for-fourth-quarter-and-fiscal-year-0
NEPT,1 DAY AGO,Neptune Reports Third Quarter Fiscal 2021 Results,https://www.nasdaq.com/press-release/neptune-reports-third-quarter-fiscal-2021-results-2021-02-15
NERV,"JAN 19, 2021",Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences,https://www.nasdaq.com/press-release/royalty-pharma-acquires-royalty-interest-in-seltorexant-from-minerva-neurosciences
NFH,6 DAYS AGO,New Frontier Health Corporation Announces Receipt of Clarification to Preliminary Non-Binding “Going Private” Proposal,https://www.nasdaq.com/press-release/new-frontier-health-corporation-announces-receipt-of-clarification-to-preliminary-non
NGM,"FEB 9, 2021","NGM Bio Announces Upcoming Oral Presentation of Phase 1 Study of NGM621 in Patients with Geographic Atrophy at Angiogenesis, Exudation, and Degeneration 2021 - Virtual Edition",https://www.nasdaq.com/press-release/ngm-bio-announces-upcoming-oral-presentation-of-phase-1-study-of-ngm621-in-patients
NHC,4 DAYS AGO,NHC Announces Common Dividend,https://www.nasdaq.com/press-release/nhc-announces-common-dividend-2021-02-12
NK,13 HOURS AGO,ImmunityBio Announces ASCO Genitourinary Cancer Symposium Presentation of Phase 2/3 Trial for BCG Unresponsive Non-Muscle Invasive Bladder Cancer CIS with 71% Complete Response Rate,https://www.nasdaq.com/press-release/immunitybio-announces-asco-genitourinary-cancer-symposium-presentation-of-phase-2-3
NKTR,"JAN 6, 2021","Nektar Therapeutics' President and CEO, Howard Robin, to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference",https://www.nasdaq.com/press-release/nektar-therapeutics-president-and-ceo-howard-robin-to-present-at-the-39th-annual-j.p.
NKTX,"NOV 12, 2020",Nkarta Reports Third Quarter 2020 Financial Results,https://www.nasdaq.com/press-release/nkarta-reports-third-quarter-2020-financial-results-2020-11-12
NLSP,"FEB 2, 2021",NLS Pharmaceutics Ltd. Announces Closing of $20.0 Million Initial Public Offering,https://www.nasdaq.com/press-release/nls-pharmaceutics-ltd.-announces-closing-of-%2420.0-million-initial-public-offering
NLSPW,,,
NLTX,"FEB 5, 2021",Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days,https://www.nasdaq.com/press-release/neoleukin-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021-oncology
NMRD,13 HOURS AGO,Nemaura Medical Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update,https://www.nasdaq.com/press-release/nemaura-medical-reports-financial-results-for-third-quarter-of-fiscal-year-2021-and
NMTR,6 DAYS AGO,"9 Meters Biopharma, Inc. to Present at the 23rd Annual BIO CEO & Investor Conference",https://www.nasdaq.com/press-release/9-meters-biopharma-inc.-to-present-at-the-23rd-annual-bio-ceo-investor-conference
NNOX,"FEB 8, 2021",Nanox Announces Secondary Offering of Ordinary Shares,https://www.nasdaq.com/press-release/nanox-announces-secondary-offering-of-ordinary-shares-2021-02-08
NNVC,"FEB 8, 2021",NanoViricides’s Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies,https://www.nasdaq.com/press-release/nanoviricidess-broad-spectrum-antiviral-drug-candidate-for-the-treatment-of-covid-19
NOVN,"FEB 1, 2021",Novan Completes Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum,https://www.nasdaq.com/press-release/novan-completes-enrollment-in-b-simple4-pivotal-phase-3-study-of-sb206-for-treatment
NRBO,"JAN 21, 2021",NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement,https://www.nasdaq.com/press-release/neurobo-pharmaceuticals-closes-%2410.0-million-private-placement-2021-01-21
NRC,"FEB 9, 2021",National Research Corporation Announces Fourth Quarter and Year-to-Date 2020 Results,https://www.nasdaq.com/press-release/national-research-corporation-announces-fourth-quarter-and-year-to-date-2020-results
NRIX,5 HOURS AGO,Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update,https://www.nasdaq.com/press-release/nurix-therapeutics-reports-fourth-quarter-and-fiscal-year-2020-financial-results-and
NSPR,"FEB 9, 2021","InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States",https://www.nasdaq.com/press-release/inspiremd-appoints-leading-interventional-cardiologist-chris-metzger-m.d.-as
NSTG,5 DAYS AGO,"NanoString to Release Fourth Quarter and Fiscal Year 2020 Operating Results and Host Conference Call on Monday, March 1, 2021",https://www.nasdaq.com/press-release/nanostring-to-release-fourth-quarter-and-fiscal-year-2020-operating-results-and-host
NTEC,"DEC 9, 2020",Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma,https://www.nasdaq.com/press-release/intec-pharma-announces-cannabinoid-research-collaboration-with-gw-pharma-2020-12-09
NTLA,"JAN 7, 2021",Intellia Therapeutics Highlights Strategic Priorities and Anticipated Development Milestones for 2021,https://www.nasdaq.com/press-release/intellia-therapeutics-highlights-strategic-priorities-and-anticipated-development
NTN,"FEB 3, 2021",NTN Buzztime Announces Date of Special Meeting of Stockholders to Vote on Proposed Merger and Asset Sale,https://www.nasdaq.com/press-release/ntn-buzztime-announces-date-of-special-meeting-of-stockholders-to-vote-on-proposed
NTRA,5 DAYS AGO,Natera to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/natera-to-participate-in-upcoming-investor-conferences-2021-02-11
NTUS,"JAN 8, 2021",Natus Updates Fourth Quarter 2020 Revenue Guidance and Announces Investor Conference Attendance,https://www.nasdaq.com/press-release/natus-updates-fourth-quarter-2020-revenue-guidance-and-announces-investor-conference
NURO,"JAN 28, 2021",NeuroMetrix Reports Q4 and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/neurometrix-reports-q4-and-full-year-2020-financial-results-2021-01-28
NUS,6 DAYS AGO,Nu Skin Enterprises Reports Fourth-Quarter Revenue Growth Of 28 Percent And EPS Growth Of 94 Percent,https://www.nasdaq.com/press-release/nu-skin-enterprises-reports-fourth-quarter-revenue-growth-of-28-percent-and-eps
NUVA,5 DAYS AGO,NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Results,https://www.nasdaq.com/press-release/nuvasive-announces-conference-call-and-webcast-of-fourth-quarter-and-full-year-2020
NVAX,14 HOURS AGO,"Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021",https://www.nasdaq.com/press-release/novavax-to-host-conference-call-to-discuss-fourth-quarter-financial-results-and
NVCN,4 DAYS AGO,Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market,https://www.nasdaq.com/press-release/neovasc-announces-closing-of-us%2472-million-registered-direct-offering-of-common-0
NVCR,"FEB 8, 2021",Novocure Announces Addition to Its Board of Directors,https://www.nasdaq.com/press-release/novocure-announces-addition-to-its-board-of-directors-2021-02-08
NVIV,14 HOURS AGO,InVivo Therapeutics Announces Publication in Peer-Reviewed Journal of Neurosurgery: Spine,https://www.nasdaq.com/press-release/invivo-therapeutics-announces-publication-in-peer-reviewed-journal-of-neurosurgery%3A
NVO,10 HOURS AGO,"Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021",https://www.nasdaq.com/press-release/trading-in-novo-nordisk-shares-by-board-members-executives-and-associated-persons-6
NVRO,"FEB 1, 2021",Nevro to Present at 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/nevro-to-present-at-10th-annual-svb-leerink-global-healthcare-conference-2021-02-01
NVS,8 HOURS AGO,Novartis Entresto® granted expanded indication in chronic heart failure by FDA,https://www.nasdaq.com/press-release/novartis-entrestor-granted-expanded-indication-in-chronic-heart-failure-by-fda-2021-0
NVST,15 HOURS AGO,Envista Extends Partnership With Heartland Dental To Continue Providing Innovative Dental Solutions To Its Vast Network Of Supported Doctors.,https://www.nasdaq.com/press-release/envista-extends-partnership-with-heartland-dental-to-continue-providing-innovative
NVTA,6 DAYS AGO,Invitae to Present at the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/invitae-to-present-at-the-10th-annual-svb-leerink-global-healthcare-conference-2021
NXTC,"JAN 14, 2021",Dr. Han Myint Appointed as NextCure’s Chief Medical Officer,https://www.nasdaq.com/press-release/dr.-han-myint-appointed-as-nextcures-chief-medical-officer-2021-01-14
NYMX,"NOV 16, 2020",Nymox Provides Update on Regulatory Filing Activities,https://www.nasdaq.com/press-release/nymox-provides-update-on-regulatory-filing-activities-2020-11-16
OBLN,"NOV 6, 2020",Obalon Announces Third Quarter 2020 Financial Results,https://www.nasdaq.com/press-release/obalon-announces-third-quarter-2020-financial-results-2020-11-06
OBSV,5 DAYS AGO,ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares,https://www.nasdaq.com/press-release/obseva-to-increase-issued-share-capital-by-creating-additional-treasury-shares-2021-1
OCDX,"FEB 9, 2021",Ortho Clinical Diagnostics Amends Credit Agreement to Extend Maturity and Increase Borrowing Capacity Under its Revolving Credit Facility,https://www.nasdaq.com/press-release/ortho-clinical-diagnostics-amends-credit-agreement-to-extend-maturity-and-increase
OCGN,6 DAYS AGO,"Ocugen, Inc. Announces Closing of $23 Million Registered Direct Offering of Common Stock",https://www.nasdaq.com/press-release/ocugen-inc.-announces-closing-of-%2423-million-registered-direct-offering-of-common
OCUL,4 DAYS AGO,"Ocular Therapeutix™ Announces Upcoming Presentation of Interim OTX-TKI Phase 1 Clinical Trial Data at Angiogenesis, Exudation, and Degeneration 2021 – Virtual Edition",https://www.nasdaq.com/press-release/ocular-therapeutixtm-announces-upcoming-presentation-of-interim-otx-tki-phase-1
OCUP,5 DAYS AGO,Ocuphire to Participate in the 2021 BIO CEO & Investor Conference and Cantor Fitzgerald’s Panel on Eyeing Key Events in the Ophthalmology Space in 2021,https://www.nasdaq.com/press-release/ocuphire-to-participate-in-the-2021-bio-ceo-investor-conference-and-cantor
OCX,6 HOURS AGO,"Oncocyte to Participate in Fireside Chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/oncocyte-to-participate-in-fireside-chat-at-the-btig-medtech-digital-health-life
ODT,"DEC 11, 2020","Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)",https://www.nasdaq.com/press-release/positive-results-of-contessa-a-phase-3-study-of-tesetaxel-in-patients-with-metastatic
OFIX,5 DAYS AGO,"Orthofix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference on February 19",https://www.nasdaq.com/press-release/orthofix-to-present-at-the-btig-medtech-digital-health-life-science-diagnostic-tools
OGEN,4 DAYS AGO,Oragenics Announces Recent Capital Raise and Warrant Exercises Totaling $21.9 Million and the Redemption of Its Series C Preferred Stock,https://www.nasdaq.com/press-release/oragenics-announces-recent-capital-raise-and-warrant-exercises-totaling-%2421.9-million
OGI,"FEB 2, 2021",Organigram Announces Executive Changes,https://www.nasdaq.com/press-release/organigram-announces-executive-changes-2021-02-02
OLMA,"DEC 17, 2020",Olema Oncology to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference,https://www.nasdaq.com/press-release/olema-oncology-to-present-at-39th-annual-j.p.-morgan-virtual-healthcare-conference
OM,"JAN 12, 2021",Outset Medical Appoints Karen Drexler to Board of Directors,https://www.nasdaq.com/press-release/outset-medical-appoints-karen-drexler-to-board-of-directors-2021-01-12
OMER,"JAN 26, 2021",Omeros Hires Nadia Dac as Chief Commercial Officer,https://www.nasdaq.com/press-release/omeros-hires-nadia-dac-as-chief-commercial-officer-2021-01-26
OMI,6 HOURS AGO,"Owens & Minor will Report Fourth Quarter & Full Year Financial Results on Wednesday, February 24, 2021",https://www.nasdaq.com/press-release/owens-minor-will-report-fourth-quarter-full-year-financial-results-on-wednesday
ONCR,4 DAYS AGO,Oncorus Announces Pricing of Public Offering of Common Stock,https://www.nasdaq.com/press-release/oncorus-announces-pricing-of-public-offering-of-common-stock-2021-02-11
ONCS,"FEB 2, 2021",OncoSec Strengthens Management Team With Two New Appointments,https://www.nasdaq.com/press-release/oncosec-strengthens-management-team-with-two-new-appointments-2021-02-02
ONCT,"JAN 28, 2021",Oncternal Therapeutics Announces the Appointment of Dr. Rosemary Mazanet to the Board of Directors,https://www.nasdaq.com/press-release/oncternal-therapeutics-announces-the-appointment-of-dr.-rosemary-mazanet-to-the-board
ONCY,"DEC 9, 2020",Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium,https://www.nasdaq.com/press-release/oncolytics-and-solti-report-clinical-synergy-of-pelareorep-with-checkpoint-inhibitors
ONEM,,,
ONTX,5 HOURS AGO,"Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option",https://www.nasdaq.com/press-release/onconova-therapeutics-inc.-announces-closing-of-%2428.75-million-public-offering-of
ONTXW,,,
ONVO,"SEP 3, 2020",Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement,https://www.nasdaq.com/press-release/organovo-regains-compliance-with-nasdaq-minimum-bid-price-requirement-2020-09-03
OPCH,"FEB 8, 2021","Option Care Health Announces Upsizing and Pricing of Secondary Offering of 15,000,000 Shares of Common Stock",https://www.nasdaq.com/press-release/option-care-health-announces-upsizing-and-pricing-of-secondary-offering-of-15000000
OPGN,14 HOURS AGO,OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing,https://www.nasdaq.com/press-release/opgen-subsidiary-ares-genetics-announces-publication-of-study-introducing-best
OPK,"FEB 3, 2021","OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021",https://www.nasdaq.com/press-release/opko-health-to-report-fourth-quarter-2020-financial-results-on-february-18-2021-2021
OPNT,"FEB 8, 2021","Opiant Pharmaceuticals Announces First Patient Dosed in Confirmatory Pharmacokinetic Study Assessing OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose",https://www.nasdaq.com/press-release/opiant-pharmaceuticals-announces-first-patient-dosed-in-confirmatory-pharmacokinetic
OPTN,"JAN 25, 2021",Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/optinose-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-01-25
ORGO,15 HOURS AGO,Organogenesis Appoints David C. Francisco as Chief Financial Officer,https://www.nasdaq.com/press-release/organogenesis-appoints-david-c.-francisco-as-chief-financial-officer-2021-02-16
ORGS,15 HOURS AGO,Orgenesis to Present Today at the Winter Wonderland Conference-Best Ideas from the Buy-Side,https://www.nasdaq.com/press-release/orgenesis-to-present-today-at-the-winter-wonderland-conference-best-ideas-from-the
ORIC,"FEB 3, 2021",ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences-2021-02-03
ORMP,"JAN 27, 2021",Oramed Issues Letter to Shareholders,https://www.nasdaq.com/press-release/oramed-issues-letter-to-shareholders-2021-01-27
ORPH,5 DAYS AGO,CytRx is Added to the LD Micro Index,https://www.nasdaq.com/press-release/cytrx-is-added-to-the-ld-micro-index-2021-02-11
ORTX,"FEB 9, 2021",Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH),https://www.nasdaq.com/press-release/orchard-therapeutics-announces-interim-data-for-otl-203-showing-positive-clinical
OSH,5 DAYS AGO,Oak Street Health Announces the Upsize and Pricing of Secondary Offering,https://www.nasdaq.com/press-release/oak-street-health-announces-the-upsize-and-pricing-of-secondary-offering-2021-02-11
OSMT,"FEB 1, 2021","DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013",https://www.nasdaq.com/press-release/disclosure-under-rule-8.1a-and-bi-of-the-irish-takeover-panel-act-1997-takeover-0
OSUR,"JAN 29, 2021",OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test,https://www.nasdaq.com/press-release/orasure-subsidiary-dna-genoteks-omnigener%3Aoral-included-in-eua-granted-to-ambry
OTIC,5 DAYS AGO,Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/otonomy-reports-fourth-quarter-and-full-year-2020-financial-results-and-provides
OTLK,13 HOURS AGO,Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update,https://www.nasdaq.com/press-release/outlook-therapeutics-reports-financial-results-for-first-quarter-fiscal-year-2021-and
OTLKW,,,
OTRK,"FEB 5, 2021",Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock,https://www.nasdaq.com/press-release/ontrak-declares-quarterly-dividend-on-9.50-non-convertible-series-a-preferred-stock
OTRKP,"FEB 5, 2021",Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock,https://www.nasdaq.com/press-release/ontrak-declares-quarterly-dividend-on-9.50-non-convertible-series-a-preferred-stock
OVID,"DEC 16, 2020",Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index,https://www.nasdaq.com/press-release/ovid-therapeutics-announces-addition-to-the-nasdaq-biotechnology-index-2020-12-16
OXFD,"FEB 4, 2021",Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses,https://www.nasdaq.com/press-release/oxford-immunotec-updates-their-t-spotr-discovery-sars-cov-2-kit-and-include-a-new
OYST,4 DAYS AGO,"Oyster Point Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 18, 2021",https://www.nasdaq.com/press-release/oyster-point-pharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on
PAHC,"FEB 8, 2021",Phibro Animal Health Corporation to Participate in the Barclays Virtual Global Healthcare Conference,https://www.nasdaq.com/press-release/phibro-animal-health-corporation-to-participate-in-the-barclays-virtual-global
PANA,6 DAYS AGO,"Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company",https://www.nasdaq.com/press-release/nuvation-bio-closes-transaction-with-panacea-debuts-as-publicly-traded-oncology
PAND,"JAN 4, 2021",Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells,https://www.nasdaq.com/press-release/pandion-therapeutics-announces-positive-top-line-phase-1a-clinical-data-showing-pt101
PASG,"FEB 8, 2021","FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment Options",https://www.nasdaq.com/press-release/fda-clears-ind-application-for-passage-bios-gene-therapy-candidate-pbkr03-for
PAVM,12 HOURS AGO,First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device,https://www.nasdaq.com/press-release/first-u.s.-patient-undergoes-successful-minimally-invasive-carpal-tunnel-release
PAVMW,,,
PAVMZ,,,
PBH,6 DAYS AGO,Prestige Consumer Healthcare Inc. Announces Upsize and Pricing of $600 Million Senior Notes,https://www.nasdaq.com/press-release/prestige-consumer-healthcare-inc.-announces-upsize-and-pricing-of-%24600-million-senior
PBLA,6 DAYS AGO,Panbela Announces Research Agreement with Johns Hopkins University School of Medicine,https://www.nasdaq.com/press-release/panbela-announces-research-agreement-with-johns-hopkins-university-school-of-medicine
PBYI,5 DAYS AGO,Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/puma-biotechnology-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-0
PCRX,6 DAYS AGO,Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021,https://www.nasdaq.com/press-release/pacira-biosciences-reports-preliminary-net-product-sales-of-%2436.0-million-for-january
PCSA,"JAN 11, 2021",Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference,https://www.nasdaq.com/press-release/processa-pharmaceuticals-to-present-at-the-h.c.-wainwright-bioconnect-2021-virtual
PCVX,"JAN 6, 2021","Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections",https://www.nasdaq.com/press-release/vaxcyte-announces-publication-of-preclinical-proof-of-concept-data-supporting
PDCO,"JAN 4, 2021",Patterson Companies to Present at the 2021 J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/patterson-companies-to-present-at-the-2021-j.p.-morgan-healthcare-conference-2021-01
PDEX,5 DAYS AGO,"Pro-Dex, Inc. Discusses 2021 Second Quarter Results with The Stock Day Podcast",https://www.nasdaq.com/press-release/pro-dex-inc.-discusses-2021-second-quarter-results-with-the-stock-day-podcast-2021-02
PDSB,"FEB 3, 2021",PDS Biotech Announces Preliminary Efficacy Achievement in Phase 2 Combination Trial of PDS0101 Led by the National Cancer Institute,https://www.nasdaq.com/press-release/pds-biotech-announces-preliminary-efficacy-achievement-in-phase-2-combination-trial
PEN,6 DAYS AGO,"Penumbra, Inc. to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference",https://www.nasdaq.com/press-release/penumbra-inc.-to-present-at-citis-2021-healthcare-services-medtech-tools-hcit-virtual
PETQ,5 DAYS AGO,"PetIQ, Inc. to Report Fourth Quarter and Full Year 2020 Results on Thursday, February 25, 2021",https://www.nasdaq.com/press-release/petiq-inc.-to-report-fourth-quarter-and-full-year-2020-results-on-thursday-february
PETS,"JAN 19, 2021",PetMed Express d/b/a 1-800-PetMeds Announces Its Third Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.28 Per Share,https://www.nasdaq.com/press-release/petmed-express-d-b-a-1-800-petmeds-announces-its-third-fiscal-quarter-financial-0
PFE,4 DAYS AGO,U.S. FDA Approves PANZYGA® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),https://www.nasdaq.com/press-release/u.s.-fda-approves-panzygar-for-the-treatment-of-adults-with-chronic-inflammatory
PGEN,"FEB 4, 2021",Precigen to Participate in Guggenheim Healthcare Talks Oncology Day,https://www.nasdaq.com/press-release/precigen-to-participate-in-guggenheim-healthcare-talks-oncology-day-2021-02-04
PGNY,6 DAYS AGO,"Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year Results Report",https://www.nasdaq.com/press-release/progyny-inc.-announces-details-for-its-fourth-quarter-and-full-year-results-report-0
PHAR,,,
PHAS,"JAN 28, 2021",PhaseBio Announces Dosing of First Patient in European Union as Part of REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor,https://www.nasdaq.com/press-release/phasebio-announces-dosing-of-first-patient-in-european-union-as-part-of-reverse-it
PHAT,"JAN 19, 2021",Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial,https://www.nasdaq.com/press-release/phathom-pharmaceuticals-announces-completion-of-patient-enrollment-in-pivotal-phase-0
PHG,5 DAYS AGO,Philips wins ‘Best in KLAS’ award for its Vendor-Agnostic Image Viewer Vue Motion,https://www.nasdaq.com/press-release/philips-wins-best-in-klas-award-for-its-vendor-agnostic-image-viewer-vue-motion-2021
PHGE,"FEB 2, 2021",BiomX Announces Positive Results of a Phase 1a Pharmacokinetic Study for Inflammatory Bowel Disease/Primary Sclerosing Cholangitis (IBD/PSC) Evaluating Delivery of Oral BX002 Phage Therapy,https://www.nasdaq.com/press-release/biomx-announces-positive-results-of-a-phase-1a-pharmacokinetic-study-for-inflammatory
PHIO,4 DAYS AGO,Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market,https://www.nasdaq.com/press-release/phio-pharmaceuticals-announces-%247.7-million-registered-direct-offering-of-common
PHIOW,,,
PHVS,"FEB 9, 2021",Pharvaris Announces Closing of Initial Public Offering,https://www.nasdaq.com/press-release/pharvaris-announces-closing-of-initial-public-offering-2021-02-09
PIRS,"JAN 19, 2021",FDA Lifts Partial Clinical Hold on PRS-343 Phase 1 Studies,https://www.nasdaq.com/press-release/fda-lifts-partial-clinical-hold-on-prs-343-phase-1-studies-2021-01-19
PLRX,"JAN 12, 2021",Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors,https://www.nasdaq.com/press-release/pliant-therapeutics-announces-appointment-of-david-pyott-to-board-of-directors-2021
PLSE,14 HOURS AGO,Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®,https://www.nasdaq.com/press-release/pulse-biosciences-announces-start-of-controlled-launch-of-the-cellfx-systemr-2021-02
PLX,5 DAYS AGO,Protalix BioTherapeutics Announces Pricing of its Upsized Public Offering of Common Stock,https://www.nasdaq.com/press-release/protalix-biotherapeutics-announces-pricing-of-its-upsized-public-offering-of-common
PLXP,"NOV 16, 2020",PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update,https://www.nasdaq.com/press-release/plx-pharma-inc.-reports-third-quarter-2020-results-and-provides-business-update-2020
PMD,"JAN 26, 2021","Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller",https://www.nasdaq.com/press-release/andrew-limbek-joins-psychemedics-corporation-as-vice-president-controller-2021-01-26
PMVP,14 HOURS AGO,PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board,https://www.nasdaq.com/press-release/pmv-pharma-appoints-p53-pioneer-dr.-guillermina-lozano-to-scientific-advisory-board
PNTG,"JAN 19, 2021",The Pennant Group Acquires Arizona Home Health Provider,https://www.nasdaq.com/press-release/the-pennant-group-acquires-arizona-home-health-provider-2021-01-19
POAI,5 HOURS AGO,Predictive Oncology Announces Closing of $7.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules,https://www.nasdaq.com/press-release/predictive-oncology-announces-closing-of-%247.4-million-registered-direct-offering
PODD,"FEB 8, 2021",Insulet to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/insulet-to-present-at-upcoming-investor-conferences-2021-02-08
PPBT,"JAN 4, 2021",Purple Biotech to Ring the Nasdaq Stock Market Opening Bell,https://www.nasdaq.com/press-release/purple-biotech-to-ring-the-nasdaq-stock-market-opening-bell-2021-01-04
PPD,,,
PRAH,"FEB 4, 2021",PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings,https://www.nasdaq.com/press-release/pra-health-sciences-to-report-fourth-quarter-and-full-year-2020-earnings-2021-02-04
PRAX,13 HOURS AGO,Praxis Precision Medicines Partners With Ciitizen to Improve Patient-Guided Drug Development,https://www.nasdaq.com/press-release/praxis-precision-medicines-partners-with-ciitizen-to-improve-patient-guided-drug
PRFX,"JAN 7, 2021",PainReform to Present at the H.C. Wainwright BioConnect 2021 Conference,https://www.nasdaq.com/press-release/painreform-to-present-at-the-h.c.-wainwright-bioconnect-2021-conference-2021-01-07
PRGO,12 HOURS AGO,"Perrigo To Release Fourth Quarter And Calendar Year 2020 Financial Results On March 1, 2021",https://www.nasdaq.com/press-release/perrigo-to-release-fourth-quarter-and-calendar-year-2020-financial-results-on-march-1
PRLD,"JAN 11, 2021",Prelude Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/prelude-therapeutics-announces-closing-of-upsized-public-offering-and-full-exercise
PROF,5 DAYS AGO,"Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference",https://www.nasdaq.com/press-release/profound-medical-to-participate-in-the-btig-virtual-medtech-digital-health-life
PROG,4 DAYS AGO,SMFM Conference and Publications Highlight the Challenges and Complexities of Diagnosing and Managing Preeclampsia,https://www.nasdaq.com/press-release/smfm-conference-and-publications-highlight-the-challenges-and-complexities-of
PRPH,"FEB 9, 2021","ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations",https://www.nasdaq.com/press-release/prophase-labs-begins-advanced-saliva-based-viral-pcr-multiplex-testing-for-covid-19
PRQR,5 HOURS AGO,ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome,https://www.nasdaq.com/press-release/proqr-announces-expert-perspectives-call-on-disease-education-and-endpoints-in-usher
PRTA,5 DAYS AGO,"Prothena Reports Fourth Quarter and Full Year 2020 Financial Results, and Provides Financial Guidance and R&D Update",https://www.nasdaq.com/press-release/prothena-reports-fourth-quarter-and-full-year-2020-financial-results-and-provides
PRTC,6 DAYS AGO,PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares,https://www.nasdaq.com/press-release/puretech-receives-approximately-%24118-million-from-sale-of-portion-of-founded-entity
PRTK,"FEB 8, 2021",Paratek Announces Expansion of NUZYRA® Launch into the Community Setting,https://www.nasdaq.com/press-release/paratek-announces-expansion-of-nuzyrar-launch-into-the-community-setting-2021-02-08
PRVB,"JAN 28, 2021",Provention Bio Announces Key Findings from Pre-clinical Proof-of-concept Study for PRV-3279 for the Prevention of Immunogenicity of Gene Therapy,https://www.nasdaq.com/press-release/provention-bio-announces-key-findings-from-pre-clinical-proof-of-concept-study-for
PSNL,6 HOURS AGO,Personalis to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/personalis-to-present-at-upcoming-investor-conferences-2021-02-16
PSTI,"FEB 2, 2021",Pluristem Therapeutics Inc. Announces $30 Million Registered Direct Offering,https://www.nasdaq.com/press-release/pluristem-therapeutics-inc.-announces-%2430-million-registered-direct-offering-2021-02
PSTV,5 DAYS AGO,"Plus Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 22, 2021",https://www.nasdaq.com/press-release/plus-therapeutics-to-announce-fourth-quarter-and-full-year-2020-financial-results-and
PSTX,6 DAYS AGO,"Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021",https://www.nasdaq.com/press-release/poseida-therapeutics-to-host-virtual-rd-day-on-february-24-2021-2021-02-10
PTCT,13 HOURS AGO,PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences,https://www.nasdaq.com/press-release/ptc-therapeutics-to-participate-at-upcoming-virtual-investor-conferences-2021-02-16
PTE,6 DAYS AGO,PolarityTE Provides Corporate Update,https://www.nasdaq.com/press-release/polarityte-provides-corporate-update-2021-02-10
PTGX,14 HOURS AGO,Protagonist Therapeutics to Participate in the SVB Leerink Virtual 10th Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/protagonist-therapeutics-to-participate-in-the-svb-leerink-virtual-10th-annual-global
PTN,4 DAYS AGO,"Palatin Technologies, Inc. to Report Second Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on February 17, 2021",https://www.nasdaq.com/press-release/palatin-technologies-inc.-to-report-second-quarter-fiscal-year-2021-results
PTPI,"FEB 4, 2021",Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil),https://www.nasdaq.com/press-release/petros-pharmaceuticals-establishes-steering-committee-to-expand-into-non-rx-status
PULM,8 HOURS AGO,Pulmatrix Announces Closing of $40 Million Registered Direct Offering,https://www.nasdaq.com/press-release/pulmatrix-announces-closing-of-%2440-million-registered-direct-offering-2021-02-16
PYPD,14 HOURS AGO,PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections,https://www.nasdaq.com/press-release/polypid-announces-100th-patient-enrolled-in-shield-i-phase-3-clinical-trial-of-d
QDEL,"FEB 3, 2021",Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19,https://www.nasdaq.com/press-release/quidel-opens-new-manufacturing-facility-to-mass-produce-quickvuer-rapid-antigen-tests
QGEN,"FEB 9, 2021","QIAGEN Beats Outlook for Fourth Quarter and Full-Year 2020, Reaffirms Expectations for Further Growth in 2021",https://www.nasdaq.com/press-release/qiagen-beats-outlook-for-fourth-quarter-and-full-year-2020-reaffirms-expectations-for
QLGN,"JAN 26, 2021",Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China,https://www.nasdaq.com/press-release/qualigen-therapeutics-announces-completion-of-milestone-related-to-the-license-and
QLI,5 DAYS AGO,Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results,https://www.nasdaq.com/press-release/qilian-international-holding-group-limited-reports-fiscal-year-2020-financial-results
QTNT,4 DAYS AGO,"Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/quotient-limited-participate-in-the-btig-virtual-medtech-digital-health-life-science
QURE,"FEB 8, 2021",uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease,https://www.nasdaq.com/press-release/uniqure-announces-positive-recommendation-from-data-safety-monitoring-board-of-phase
RAD,5 DAYS AGO,Rite Aid Statement on Federal Retail Pharmacy Program Involvement,https://www.nasdaq.com/press-release/rite-aid-statement-on-federal-retail-pharmacy-program-involvement-2021-02-11
RAPT,"JAN 5, 2021",RAPT Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/rapt-therapeutics-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference
RARE,5 DAYS AGO,Ultragenyx Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Update,https://www.nasdaq.com/press-release/ultragenyx-reports-fourth-quarter-and-full-year-2020-financial-results-and-corporate
RCEL,5 DAYS AGO,AVITA Medical Reports Full Second Quarter 2021 Financial Results,https://www.nasdaq.com/press-release/avita-medical-reports-full-second-quarter-2021-financial-results-2021-02-11
RCKT,"JAN 11, 2021",Rocket Pharmaceuticals Announces Buildout of R&D and Manufacturing Facility to Support Development of Innovative Gene Therapy Pipeline,https://www.nasdaq.com/press-release/rocket-pharmaceuticals-announces-buildout-of-rd-and-manufacturing-facility-to-support
RCUS,5 DAYS AGO,Arcus Biosciences to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/arcus-biosciences-to-participate-in-upcoming-investor-conferences-2021-02-11
RDHL,"FEB 9, 2021",RedHill Biopharma to Present at SVB Leerink Global Healthcare and BIO CEO & Investor Conferences,https://www.nasdaq.com/press-release/redhill-biopharma-to-present-at-svb-leerink-global-healthcare-and-bio-ceo-investor
RDNT,6 DAYS AGO,RadNet Leases Significant New Space in Phoenix at Park Central,https://www.nasdaq.com/press-release/radnet-leases-significant-new-space-in-phoenix-at-park-central-2021-02-10
RDUS,13 HOURS AGO,"Radius Health to Announce Fourth Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, February 25, 2021",https://www.nasdaq.com/press-release/radius-health-to-announce-fourth-quarter-2020-financial-results-host-conference-call
RDY,"FEB 2, 2021","Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market",https://www.nasdaq.com/press-release/dr.-reddys-laboratories-announces-the-launch-of-vigabatrin-tablets-usp-in-the-u.s.
REGN,4 DAYS AGO,Regeneron Announces Investor Conference Presentations,https://www.nasdaq.com/press-release/regeneron-announces-investor-conference-presentations-2021-02-12
REPH,5 DAYS AGO,Recro Strengthens Leadership Team With Key Executive and Board Appointments,https://www.nasdaq.com/press-release/recro-strengthens-leadership-team-with-key-executive-and-board-appointments-2021-02
REPL,"FEB 4, 2021",Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update,https://www.nasdaq.com/press-release/replimune-reports-third-fiscal-quarter-financial-results-and-provides-corporate-0
RETA,"DEC 4, 2020","Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Offering",https://www.nasdaq.com/press-release/reata-pharmaceuticals-inc.-announces-closing-of-class-a-common-stock-offering-2020-12
RGEN,5 DAYS AGO,Repligen to Report Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/repligen-to-report-fourth-quarter-and-full-year-2020-financial-results-2021-02-11
RGLS,6 DAYS AGO,Regulus Therapeutics Announces Completion of Enrollment in First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD),https://www.nasdaq.com/press-release/regulus-therapeutics-announces-completion-of-enrollment-in-first-cohort-of-phase-1b
RGNX,15 HOURS AGO,REGENXBIO Announces Additional Positive Interim Phase I/IIa and Long-Term Follow-Up Data of RGX-314 for the Treatment of Wet AMD,https://www.nasdaq.com/press-release/regenxbio-announces-additional-positive-interim-phase-i-iia-and-long-term-follow-up
RIGL,"JAN 29, 2021",Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients,https://www.nasdaq.com/press-release/rigel-awarded-%2416.5-million-from-u.s.-department-of-defense-for-phase-3-clinical
RLAY,,,
RLMD,"DEC 7, 2020",Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder,https://www.nasdaq.com/press-release/relmada-therapeutics-announces-initiation-of-phase-3-program-for-rel-1017-as
RMD,"FEB 2, 2021",MatrixCare Home Health EHR Solution Wins Best in KLAS – Again,https://www.nasdaq.com/press-release/matrixcare-home-health-ehr-solution-wins-best-in-klas-again-2021-02-02
RMED,"FEB 4, 2021",Ra Medical Systems Appoints Susanne L. Meline to its Board of Directors,https://www.nasdaq.com/press-release/ra-medical-systems-appoints-susanne-l.-meline-to-its-board-of-directors-2021-02-04
RMTI,"FEB 9, 2021",Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis,https://www.nasdaq.com/press-release/rockwell-medical-announces-u.s.-availability-of-trifericr-avnu-for-replacement-of
RNA,"JAN 21, 2021","Avidity Biosciences Appoints W. Michael Flanagan, Ph.D. as Chief Technical Officer",https://www.nasdaq.com/press-release/avidity-biosciences-appoints-w.-michael-flanagan-ph.d.-as-chief-technical-officer
RNLX,,,
RPRX,"JAN 22, 2021","Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021",https://www.nasdaq.com/press-release/royalty-pharma-to-announce-fourth-quarter-2020-financial-results-on-february-17-2021
RPTX,"JAN 4, 2021",Repare Therapeutics to Present at Virtual Investor Conferences in January,https://www.nasdaq.com/press-release/repare-therapeutics-to-present-at-virtual-investor-conferences-in-january-2021-01-04
RUBY,"FEB 9, 2021",Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/rubius-therapeutics-to-announce-fourth-quarter-and-full-year-2020-financial-results
RVMD,"FEB 8, 2021",Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/revolution-medicines-announces-closing-of-upsized-public-offering-of-common-stock-0
RVNC,4 DAYS AGO,"Revance to Release Fourth Quarter and Full Year 2020 Financial Results on Monday, February 22, 2021",https://www.nasdaq.com/press-release/revance-to-release-fourth-quarter-and-full-year-2020-financial-results-on-monday
RVP,"JAN 8, 2021","Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders",https://www.nasdaq.com/press-release/retractable-technologies-inc.-declares-dividends-to-series-i-and-ii-class-b-3
RVPH,"DEC 14, 2020","Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.",https://www.nasdaq.com/press-release/reviva-pharmaceuticals-inc.-and-tenzing-acquisition-corp.-complete-their-business
RVPHW,,,
RWLK,1 DAY AGO,"ReWalk Robotics to Report Fourth Quarter 2020 Financial Results on February 18, 2021",https://www.nasdaq.com/press-release/rewalk-robotics-to-report-fourth-quarter-2020-financial-results-on-february-18-2021
RYTM,6 DAYS AGO,"Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares",https://www.nasdaq.com/press-release/rhythm-pharmaceuticals-inc.-announces-closing-of-%24172.5-million-public-offering
RZLT,6 DAYS AGO,Rezolute Reports Second Quarter Fiscal 2021 Financial Results,https://www.nasdaq.com/press-release/rezolute-reports-second-quarter-fiscal-2021-financial-results-2021-02-10
SAGE,5 DAYS AGO,Sage Therapeutics to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/sage-therapeutics-to-present-at-upcoming-investor-conferences-2021-02-11
SANA,"FEB 8, 2021",Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,https://www.nasdaq.com/press-release/sana-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters
SAVA,4 DAYS AGO,Cassava Sciences Announces Closing of $200 Million Registered Direct Offering,https://www.nasdaq.com/press-release/cassava-sciences-announces-closing-of-%24200-million-registered-direct-offering-2021-02
SBBP,14 HOURS AGO,Strongbridge Biopharma plc Announces Promotion of Richard S. Kollender to President and Chief Financial Officer,https://www.nasdaq.com/press-release/strongbridge-biopharma-plc-announces-promotion-of-richard-s.-kollender-to-president
SBTX,,,
SCPH,5 DAYS AGO,scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/scpharmaceuticals-to-present-at-the-10th-annual-svb-leerink-global-healthcare
SCPS,6 DAYS AGO,Scopus BioPharma Announces Closing of Underwriters' Over-Allotment Option in Full,https://www.nasdaq.com/press-release/scopus-biopharma-announces-closing-of-underwriters-over-allotment-option-in-full-2021
SCYX,"DEC 22, 2020","SCYNEXIS Announces Closing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants",https://www.nasdaq.com/press-release/scynexis-announces-closing-of-%2485-million-public-offering-of-common-stock-pre-funded
SDC,4 DAYS AGO,"Smile Direct Club to Report Fourth Quarter and Year End 2020 Results on March 4, 2021",https://www.nasdaq.com/press-release/smile-direct-club-to-report-fourth-quarter-and-year-end-2020-results-on-march-4-2021
SDGR,,,
SEEL,"FEB 1, 2021",Seelos Therapeutics to Participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference February 3-4,https://www.nasdaq.com/press-release/seelos-therapeutics-to-participate-in-canaccord-genuitys-new-paradigms-and-treatment
SELB,13 HOURS AGO,Selecta Biosciences to Present at the SVB Leerink 10th Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/selecta-biosciences-to-present-at-the-svb-leerink-10th-annual-global-healthcare
SEM,"JAN 21, 2021","Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2020 Results on Thursday, February 25",https://www.nasdaq.com/press-release/select-medical-holdings-corporation-to-announce-fourth-quarter-and-full-year-2020
SESN,15 HOURS AGO,Sesen Bio Announces FDA Acceptance and Priority Review of its Biologics License Application for Vicineum™,https://www.nasdaq.com/press-release/sesen-bio-announces-fda-acceptance-and-priority-review-of-its-biologics-license
SGEN,4 DAYS AGO,Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer,https://www.nasdaq.com/press-release/seagen-and-astellas-announce-phase-3-trial-results-demonstrating-survival-advantage
SGMO,"FEB 1, 2021","Sangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as Head of Development; Elevates Jason Fontenot, PhD to Chief Scientific Officer",https://www.nasdaq.com/press-release/sangamo-therapeutics-appoints-rob-schott-md-mph-facc-as-head-of-development-elevates
SGRY,"JAN 28, 2021","Surgery Partners, Inc. Announces Pricing of $226.9 Million Public Offering of Common Stock",https://www.nasdaq.com/press-release/surgery-partners-inc.-announces-pricing-of-%24226.9-million-public-offering-of-common
SGTX,"FEB 8, 2021",Sigilon Therapeutics Announces Preclinical Data in Multiple Lysosomal Diseases at the 17th Annual WORLDSymposium™,https://www.nasdaq.com/press-release/sigilon-therapeutics-announces-preclinical-data-in-multiple-lysosomal-diseases-at-the
SHC,14 HOURS AGO,Sotera Health to Present at Upcoming Healthcare Conferences,https://www.nasdaq.com/press-release/sotera-health-to-present-at-upcoming-healthcare-conferences-2021-02-16
SIBN,"FEB 9, 2021","SI-BONE To Report Fourth Quarter and Full Year 2020 Financial Results on March 8, 2021",https://www.nasdaq.com/press-release/si-bone-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-8-2021
SIEN,5 DAYS AGO,Sientra to Present at the SVB Leerink 10th Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/sientra-to-present-at-the-svb-leerink-10th-annual-global-healthcare-conference-2021
SIGA,"JAN 13, 2021",SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®,https://www.nasdaq.com/press-release/siga-announces-public-health-agency-of-canada-contract-award-to-purchase-up-to
SILK,6 HOURS AGO,"Silk Road Medical to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021",https://www.nasdaq.com/press-release/silk-road-medical-to-report-fourth-quarter-and-full-year-2020-financial-results-on
SINT,"NOV 16, 2020",SINTX Technologies Shares Q3 Business Update and Identifies Growth Opportunities for 2021,https://www.nasdaq.com/press-release/sintx-technologies-shares-q3-business-update-and-identifies-growth-opportunities-for
SIOX,15 HOURS AGO,Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/sio-gene-therapies-to-present-at-the-10th-annual-svb-leerink-global-healthcare
SLDB,"JAN 6, 2021",Solid Biosciences to Present at 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/solid-biosciences-to-present-at-39th-annual-j.p.-morgan-healthcare-conference-2021-01
SLGL,"JAN 11, 2021",Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference,https://www.nasdaq.com/press-release/sol-gel-technologies-to-present-at-upcoming-2021-solebury-trout-virtual-investor
SLN,"FEB 5, 2021",Silence Therapeutics plc Announces $45 Million Private Placement,https://www.nasdaq.com/press-release/silence-therapeutics-plc-announces-%2445-million-private-placement-2021-02-05
SLNO,"FEB 5, 2021",Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome,https://www.nasdaq.com/press-release/soleno-therapeutics-provides-recap-of-key-opinion-leader-webinar-on-dccr-for
SLRX,14 HOURS AGO,Salarius Pharmaceuticals to Present at BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/salarius-pharmaceuticals-to-present-at-bio-ceo-investor-digital-conference-2021-02-16
SLS,"JAN 14, 2021",SELLAS Life Sciences Highlights 2020 Business and Clinical Progress and 2021 Milestones,https://www.nasdaq.com/press-release/sellas-life-sciences-highlights-2020-business-and-clinical-progress-and-2021
SMMT,"NOV 23, 2020",Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer,https://www.nasdaq.com/press-release/summit-therapeutics-appoints-dr.-mahkam-maky-zanganeh-as-chief-operating-officer-2020
SMTI,4 DAYS AGO,Sanara MedTech Inc. Announces Pricing of Public Offering,https://www.nasdaq.com/press-release/sanara-medtech-inc.-announces-pricing-of-public-offering-2021-02-12
SNCA,"JAN 25, 2021",Seneca Biopharma Regains Compliance with NASDAQ Listing Requirements,https://www.nasdaq.com/press-release/seneca-biopharma-regains-compliance-with-nasdaq-listing-requirements-2021-01-25
SNDX,"DEC 18, 2020",Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index,https://www.nasdaq.com/press-release/syndax-pharmaceuticals-to-be-added-to-the-nasdaq-biotechnology-index-2020-12-18
SNGX,5 DAYS AGO,Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/soligenix-to-present-at-the-2021-bio-ceo-investor-digital-conference-2021-02-11
SNGXW,,,
SNN,"JAN 27, 2021",Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications,https://www.nasdaq.com/press-release/smithnephews-picotm-single-use-negative-pressure-wound-therapy-system-again-shown-to
SNOA,4 HOURS AGO,Sonoma Pharmaceuticals Reports Third Quarter FY 2021 Financial Results,https://www.nasdaq.com/press-release/sonoma-pharmaceuticals-reports-third-quarter-fy-2021-financial-results-2021-02-16
SNSE,6 DAYS AGO,Sensei Biotherapeutics Announces Closing of Initial Public Offering,https://www.nasdaq.com/press-release/sensei-biotherapeutics-announces-closing-of-initial-public-offering-2021-02-10
SNSS,14 HOURS AGO,Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma,https://www.nasdaq.com/press-release/viracta-therapeutics-announces-notice-of-allowance-for-u.s.-patent-application
SNY,4 DAYS AGO,The Lancet publishes Libtayo® (cemiplimab) data showing extended overall survival in patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ³50%,https://www.nasdaq.com/press-release/the-lancet-publishes-libtayor-cemiplimab-data-showing-extended-overall-survival-in-0
SOLY,6 DAYS AGO,Soliton President & CEO Brad Hauser Named as Aesthetic Industry Association Advisory Board Member,https://www.nasdaq.com/press-release/soliton-president-ceo-brad-hauser-named-as-aesthetic-industry-association-advisory
SONN,14 HOURS AGO,Sonnet BioTherapeutics Provides Fiscal Year 2021 First Quarter Business and Earnings Update,https://www.nasdaq.com/press-release/sonnet-biotherapeutics-provides-fiscal-year-2021-first-quarter-business-and-earnings
SPNE,"FEB 5, 2021",SeaSpine Reports Granting of Inducement Awards,https://www.nasdaq.com/press-release/seaspine-reports-granting-of-inducement-awards-2021-02-05
SPPI,"FEB 4, 2021",Spectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology Day,https://www.nasdaq.com/press-release/spectrum-pharmaceuticals-to-participate-in-guggenheim-healthcare-talks-2021-oncology
SPRB,"JAN 6, 2021",Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021,https://www.nasdaq.com/press-release/spruce-biosciences-provides-corporate-update-and-outlines-milestones-for-2021-2021-01
SPRO,"FEB 5, 2021",Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial,https://www.nasdaq.com/press-release/spero-therapeutics-provides-update-on-spr720-phase-2a-clinical-trial-2021-02-05
SQZ,,,
SRDX,"FEB 9, 2021",Surmodics Reports First Quarter Fiscal 2021 Results,https://www.nasdaq.com/press-release/surmodics-reports-first-quarter-fiscal-2021-results-2021-02-09
SRGA,4 DAYS AGO,"Surgalign Holdings, Inc. Announces Record Date and Annual Meeting Date",https://www.nasdaq.com/press-release/surgalign-holdings-inc.-announces-record-date-and-annual-meeting-date-2021-02-12
SRNE,"FEB 9, 2021","Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical Cancer",https://www.nasdaq.com/press-release/lees-pharmaceutical-announces-its-anti-pd-l1-antibody-socazolimab-licensed-from
SRPT,"FEB 4, 2021",Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition,https://www.nasdaq.com/press-release/sarepta-therapeutics-announces-winners-of-the-rare-lessons-lesson-planning
SRRA,4 DAYS AGO,Sierra Oncology Announces Presentation at LifeSci Partners Precision Oncology Day,https://www.nasdaq.com/press-release/sierra-oncology-announces-presentation-at-lifesci-partners-precision-oncology-day
SRRK,"FEB 4, 2021",Scholar Rock Announces Senior Management Promotions,https://www.nasdaq.com/press-release/scholar-rock-announces-senior-management-promotions-2021-02-04
SRTS,"JAN 6, 2021","Holy Name Medical Center in Teaneck, New Jersey Acquires Sensus Healthcare’s Low-dose Radiation Therapy System to Treat Pneumonia in COVID-19 Patients",https://www.nasdaq.com/press-release/holy-name-medical-center-in-teaneck-new-jersey-acquires-sensus-healthcares-low-dose
SSKN,"JAN 12, 2021",STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics,https://www.nasdaq.com/press-release/strata-skin-sciences-announces-preliminary-fourth-quarter-2020-financial-results-and
SSY,13 HOURS AGO,"SunLink Health Systems, Inc. Announces Fiscal 2021 Second Quarter Results, Recognition of a Portion of Provider Relief Funds Received, and COVID-19 Update",https://www.nasdaq.com/press-release/sunlink-health-systems-inc.-announces-fiscal-2021-second-quarter-results-recognition
STAA,6 DAYS AGO,"STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021",https://www.nasdaq.com/press-release/staar-surgical-to-report-fourth-quarter-and-fiscal-year-results-on-february-24-2021
STE,"FEB 3, 2021",STERIS Announces Leadership Succession Plan,https://www.nasdaq.com/press-release/steris-announces-leadership-succession-plan-2021-02-03
STIM,15 HOURS AGO,Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call,https://www.nasdaq.com/press-release/neuronetics-to-report-fourth-quarter-and-fiscal-year-2020-financial-and-operating
STOK,"JAN 4, 2021",Stoke Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.nasdaq.com/press-release/stoke-therapeutics-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference
STRO,"JAN 21, 2021",Sutro Biopharma Announces First Patient Dosed in the Dose-Expansion Study of STRO-002 in Patients with Ovarian Cancer,https://www.nasdaq.com/press-release/sutro-biopharma-announces-first-patient-dosed-in-the-dose-expansion-study-of-stro-002
STRR,"DEC 28, 2020","Digirad Corporation Changes Corporate Name to Star Equity Holdings, Inc.",https://www.nasdaq.com/press-release/digirad-corporation-changes-corporate-name-to-star-equity-holdings-inc.-2020-12-28
STRRP,"DEC 28, 2020","Digirad Corporation Changes Corporate Name to Star Equity Holdings, Inc.",https://www.nasdaq.com/press-release/digirad-corporation-changes-corporate-name-to-star-equity-holdings-inc.-2020-12-28
STSA,"NOV 24, 2020",Satsuma Pharmaceuticals to Participate in the Evercore ISI 3rd Annual HealthCONx Conference ,https://www.nasdaq.com/press-release/satsuma-pharmaceuticals-to-participate-in-the-evercore-isi-3rd-annual-healthconx
STTK,4 DAYS AGO,Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day,https://www.nasdaq.com/press-release/shattuck-labs-announces-participation-in-citis-2021-virtual-immuno-oncology-day-2021
STXS,5 DAYS AGO,Stereotaxis to Present at Upcoming Investor Conferences,https://www.nasdaq.com/press-release/stereotaxis-to-present-at-upcoming-investor-conferences-2021-02-11
SUPN,"FEB 8, 2021",Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients  ,https://www.nasdaq.com/press-release/supernus-resubmits-new-drug-application-for-spn-812-for-the-treatment-of-adhd-in
SURF,5 DAYS AGO,"Surface Oncology to Appoint Robert Ross, M.D., as President and Chief Executive Officer",https://www.nasdaq.com/press-release/surface-oncology-to-appoint-robert-ross-m.d.-as-president-and-chief-executive-officer
SVRA,"DEC 10, 2020",Savara Provides Pipeline and Business Update,https://www.nasdaq.com/press-release/savara-provides-pipeline-and-business-update-2020-12-10
SWAV,15 HOURS AGO,Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease,https://www.nasdaq.com/press-release/shockwave-intravascular-lithotripsy-fda-approved-to-treat-advanced-heart-disease-2021
SWTX,"FEB 4, 2021",SpringWorks Therapeutics to Present at the Guggenheim Healthcare Talks 2021 Oncology Day,https://www.nasdaq.com/press-release/springworks-therapeutics-to-present-at-the-guggenheim-healthcare-talks-2021-oncology
SXTC,5 DAYS AGO,"China SXT Pharmaceuticals, Inc. Enters into Non-Binding LOI to Acquire Jiangsu Renji Pharmaceutical Chain Co., Ltd.",https://www.nasdaq.com/press-release/china-sxt-pharmaceuticals-inc.-enters-into-non-binding-loi-to-acquire-jiangsu-renji
SYBX,1 DAY AGO,Synlogic to Present at Upcoming Virtual Banking and Industry Conferences,https://www.nasdaq.com/press-release/synlogic-to-present-at-upcoming-virtual-banking-and-industry-conferences-2021-02-15
SYK,"FEB 2, 2021",Stryker declares a $0.63 per share quarterly dividend,https://www.nasdaq.com/press-release/stryker-declares-a-%240.63-per-share-quarterly-dividend-2021-02-02
SYN,"DEC 22, 2020",Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) Phase 1b/2a Clinical Protocol,https://www.nasdaq.com/press-release/synthetic-biologics-announces-washington-university-school-of-medicine-in-st.-louis
SYNH,5 DAYS AGO,Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare,https://www.nasdaq.com/press-release/syneos-health-identifies-important-drivers-of-change-expected-to-disrupt-healthcare
SYRS,"JAN 19, 2021",Syros Announces Pricing of $75.6 Million Public Offering of Common Stock,https://www.nasdaq.com/press-release/syros-announces-pricing-of-%2475.6-million-public-offering-of-common-stock-2021-01-19
TAK,4 DAYS AGO,"Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease",https://www.nasdaq.com/press-release/takedas-maribavir-phase-3-clinical-trial-met-primary-endpoint-of-superiority-to
TARA,"FEB 4, 2021",Protara Therapeutics to Present at Upcoming Virtual Investor Conferences,https://www.nasdaq.com/press-release/protara-therapeutics-to-present-at-upcoming-virtual-investor-conferences-2021-02-04
TARO,"JAN 27, 2021","Taro Provides Results for December 31, 2020",https://www.nasdaq.com/press-release/taro-provides-results-for-december-31-2020-2021-01-27
TARS,"JAN 19, 2021","Tarsus Pharmaceuticals, Inc. Appoints Bryan Wahl, MD, JD as General Counsel",https://www.nasdaq.com/press-release/tarsus-pharmaceuticals-inc.-appoints-bryan-wahl-md-jd-as-general-counsel-2021-01-19
TBIO,"FEB 3, 2021",Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4),https://www.nasdaq.com/press-release/translate-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-02-03
TBPH,6 DAYS AGO,Theravance Biopharma to Participate in Upcoming Investor Conferences,https://www.nasdaq.com/press-release/theravance-biopharma-to-participate-in-upcoming-investor-conferences-2021-02-10
TCDA,"JAN 27, 2021","Notice of Lead Plaintiff Deadline for Shareholders in the Tricida, Inc. Class Action Lawsuit",https://www.nasdaq.com/press-release/notice-of-lead-plaintiff-deadline-for-shareholders-in-the-tricida-inc.-class-action
TCMD,"FEB 9, 2021",Tactile Medical to Participate in Upcoming Investor Conferences in February and March,https://www.nasdaq.com/press-release/tactile-medical-to-participate-in-upcoming-investor-conferences-in-february-and-march
TCON,"JAN 19, 2021",TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China for Priority Review,https://www.nasdaq.com/press-release/tracon-pharmaceuticals-announces-acceptance-of-the-envafolimab-kn035-nda-by-the-0
TCRR,"FEB 4, 2021",TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors,https://www.nasdaq.com/press-release/tcr2-therapeutics-announces-commercial-cell-therapy-leader-shawn-tomasello-joins-its
TDOC,6 DAYS AGO,Teladoc Health to Announce Fourth-Quarter and Full-Year 2020 Financial Results,https://www.nasdaq.com/press-release/teladoc-health-to-announce-fourth-quarter-and-full-year-2020-financial-results-2021
TECH,14 HOURS AGO,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",https://www.nasdaq.com/press-release/bio-techne-to-present-at-citis-2021-healthcare-services-medtech-tools-hcit-virtual
TELA,"FEB 4, 2021","TELA Bio to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/tela-bio-to-participate-in-upcoming-btig-virtual-medtech-digital-health-life-science
TENX,"JAN 20, 2021",Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med,https://www.nasdaq.com/press-release/tenax-therapeutics-schedules-conference-call-to-discuss-its-transformative
TERN,6 DAYS AGO,"Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares",https://www.nasdaq.com/press-release/terns-pharmaceuticals-inc.-announces-closing-of-initial-public-offering-and-exercise
TEVA,6 DAYS AGO,Teva Reports Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/teva-reports-fourth-quarter-and-full-year-2020-financial-results-2021-02-10
TFFP,4 DAYS AGO,TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/tff-pharmaceuticals-to-present-at-the-bio-ceo-investor-digital-conference-2021-02-12
TFX,15 HOURS AGO,Teleflex Named One of America’s Best Employers 2021 by Forbes,https://www.nasdaq.com/press-release/teleflex-named-one-of-americas-best-employers-2021-by-forbes-2021-02-16
TGTX,"FEB 8, 2021","Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL",https://www.nasdaq.com/press-release/rhizen-pharmaceuticals-ag-announces-that-its-partnered-asset-umbralisib-ukoniqtm-has
THC,6 DAYS AGO,Tenet Healthcare 15% Shareholder Glenview Capital Issues Letter of Support for Spin-Off of Conifer by Mid 2022,https://www.nasdaq.com/press-release/tenet-healthcare-15-shareholder-glenview-capital-issues-letter-of-support-for-spin
THTX,5 DAYS AGO,Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2020,https://www.nasdaq.com/press-release/theratechnologies-to-announce-financial-results-for-fourth-quarter-and-fiscal-year-0
TLC,"FEB 5, 2021",TLC Reports Fiscal Year End 2020 Financial Results and Provides Business Update,https://www.nasdaq.com/press-release/tlc-reports-fiscal-year-end-2020-financial-results-and-provides-business-update-2021
TLGT,14 HOURS AGO,"Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors",https://www.nasdaq.com/press-release/teligent-inc.-announces-appointment-of-william-s.-marth-to-board-of-directors-2021-02
TLMD,"JAN 26, 2021",SOC Telemed Launches New telePulmonology Service Line,https://www.nasdaq.com/press-release/soc-telemed-launches-new-telepulmonology-service-line-2021-01-26
TLMDW,,,
TLSA,12 HOURS AGO,Tiziana Life Sciences to Present at the BIO CEO & Investor Digital Conference,https://www.nasdaq.com/press-release/tiziana-life-sciences-to-present-at-the-bio-ceo-investor-digital-conference-2021-02-0
TMBR,"JAN 25, 2021","Timber Pharmaceuticals Appoints Alan Mendelsohn, M.D., as Chief Medical Officer",https://www.nasdaq.com/press-release/timber-pharmaceuticals-appoints-alan-mendelsohn-m.d.-as-chief-medical-officer-2021-01
TMDI,14 HOURS AGO,Titan Medical Launches “Titan Living Labs” Showcasing a Behind-the-Scenes Look at Product Development,https://www.nasdaq.com/press-release/titan-medical-launches-titan-living-labs-showcasing-a-behind-the-scenes-look-at
TMDX,6 HOURS AGO,TransMedics to Present at the Cowen 41st Annual Healthcare Conference,https://www.nasdaq.com/press-release/transmedics-to-present-at-the-cowen-41st-annual-healthcare-conference-2021-02-16
TNDM,6 HOURS AGO,Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations,https://www.nasdaq.com/press-release/tandem-diabetes-care-announces-upcoming-virtual-conference-presentations-2021-02-16
TNXP,5 DAYS AGO,"Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)",https://www.nasdaq.com/press-release/tonix-pharmaceuticals-licenses-technology-for-treating-prader-willi-syndrome-a-rare
TPTX,"FEB 4, 2021",Turning Point Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days,https://www.nasdaq.com/press-release/turning-point-therapeutics-to-participate-in-guggenheim-healthcare-talks-2021
TRIB,"JAN 5, 2021",Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test,https://www.nasdaq.com/press-release/trinity-biotech-announces-ce-mark-of-its-covid-19-igg-elisa-antibody-test-2021-01-05
TRIL,13 HOURS AGO,Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development,https://www.nasdaq.com/press-release/entheon-biomedical-hires-chief-business-officer-senior-pharma-executive-dr.-brian
TRUP,5 DAYS AGO,Training for Success: Trupanion Reveals Jedi Mind Tricks for New Pet Parents,https://www.nasdaq.com/press-release/training-for-success%3A-trupanion-reveals-jedi-mind-tricks-for-new-pet-parents-2021-02
TRVI,"FEB 1, 2021","Trevi Therapeutics Appoints William Forbes, Pharm.D. as Chief Development Officer",https://www.nasdaq.com/press-release/trevi-therapeutics-appoints-william-forbes-pharm.d.-as-chief-development-officer-2021
TRVN,"JAN 28, 2021","Trevena, Inc. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy",https://www.nasdaq.com/press-release/trevena-inc.-announces-publication-highlighting-olinvyktm-respiratory-safety-data-in
TRXC,6 DAYS AGO,"TransEnterix to Host Virtual Investor Day on February 23, 2021",https://www.nasdaq.com/press-release/transenterix-to-host-virtual-investor-day-on-february-23-2021-2021-02-10
TSHA,15 HOURS AGO,Taysha Gene Therapies Announces Formation of Independent Scientific Advisory Board,https://www.nasdaq.com/press-release/taysha-gene-therapies-announces-formation-of-independent-scientific-advisory-board
TTNP,"FEB 1, 2021",Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program,https://www.nasdaq.com/press-release/positive-early-study-results-help-pave-wave-for-titan-pharmaceuticals-to-move-forward
TTOO,"FEB 8, 2021","T2 Biosystems to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools Conference",https://www.nasdaq.com/press-release/t2-biosystems-to-participate-in-the-btig-virtual-medtech-digital-health-life-science
TVTX,5 HOURS AGO,Travere Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/travere-therapeutics-to-report-fourth-quarter-and-full-year-2020-financial-results
TVTY,"FEB 9, 2021",Tivity Health to Issue Fourth Quarter and Full Year 2020 Financial Results After Market Close on February 24,https://www.nasdaq.com/press-release/tivity-health-to-issue-fourth-quarter-and-full-year-2020-financial-results-after
TWST,"FEB 4, 2021",Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results,https://www.nasdaq.com/press-release/twist-bioscience-reports-first-quarter-fiscal-2021-financial-results-2021-02-04
TXMD,6 HOURS AGO,TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock,https://www.nasdaq.com/press-release/therapeuticsmd-announces-closing-of-its-underwritten-public-offering-of-common-1
TYME,"FEB 8, 2021",TYME Announces Closing of $100 Million Registered Direct Offering of Common Stock,https://www.nasdaq.com/press-release/tyme-announces-closing-of-%24100-million-registered-direct-offering-of-common-stock
UBX,"FEB 8, 2021",Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease,https://www.nasdaq.com/press-release/study-published-in-cell-metabolism-reveals-new-therapeutic-approach-aimed-at
UFPT,"NOV 17, 2020","UFP Technologies, Inc. to Present Virtually and Host 1x1 Investor Meetings at the 12th Annual Southwest IDEAS Investor Conference on November 18, 2020",https://www.nasdaq.com/press-release/ufp-technologies-inc.-to-present-virtually-and-host-1x1-investor-meetings-at-the-12th
UHS,"FEB 8, 2021","Universal Health Services, Inc. Announces Date For 2020 Fourth Quarter And Full Year Earnings Release And Conference Call",https://www.nasdaq.com/press-release/universal-health-services-inc.-announces-date-for-2020-fourth-quarter-and-full-year
UNH,"FEB 4, 2021",UnitedHealth Group Announces Executive Leadership Actions,https://www.nasdaq.com/press-release/unitedhealth-group-announces-executive-leadership-actions-2021-02-04
URGN,"JAN 13, 2021",UroGen Pharma and MD Anderson Announce Strategic Research Collaboration to Advance Investigational Treatment for High-Grade Bladder Cancer,https://www.nasdaq.com/press-release/urogen-pharma-and-md-anderson-announce-strategic-research-collaboration-to-advance
UROV,4 DAYS AGO,Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results,https://www.nasdaq.com/press-release/urovant-sciences-provides-merger-update-and-reports-third-quarter-fiscal-year-2020
USPH,"JAN 21, 2021","U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended 2020 Release and Conference Call for Thursday, February 25, 2021",https://www.nasdaq.com/press-release/u.s.-physical-therapy-inc.-schedules-fourth-quarter-and-year-ended-2020-release-and
UTHR,6 DAYS AGO,United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin®,https://www.nasdaq.com/press-release/united-therapeutics-announces-commercial-launch-of-the-remunityr-pump-for-remodulinr
UTMD,"FEB 9, 2021","Utah Medical Products, Inc. Announces Quarterly Dividend",https://www.nasdaq.com/press-release/utah-medical-products-inc.-announces-quarterly-dividend-2021-02-09
VAPO,4 DAYS AGO,"Vapotherm to Participate in Fireside Chat at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference",https://www.nasdaq.com/press-release/vapotherm-to-participate-in-fireside-chat-at-the-btig-virtual-medtech-digital-health
VAR,"FEB 4, 2021",Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health,https://www.nasdaq.com/press-release/varian-installs-worlds-first-probeamr-360deg-proton-therapy-system-at-penn-medicine
VBIV,"FEB 2, 2021",VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine,https://www.nasdaq.com/press-release/vbi-vaccines-announces-u.s.-fda-acceptance-of-bla-filing-for-vbis-3-antigen
VBLT,"JAN 27, 2021",VBL Therapeutics Treats First Patient in Phase 2 Randomized Controlled Study of VB-201 in COVID-19 Patients,https://www.nasdaq.com/press-release/vbl-therapeutics-treats-first-patient-in-phase-2-randomized-controlled-study-of-vb
VCEL,13 HOURS AGO,"Vericel to Participate in the BTIG Virtual MedTech Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021",https://www.nasdaq.com/press-release/vericel-to-participate-in-the-btig-virtual-medtech-digital-health-life-science
VCNX,"JAN 5, 2021",Vaccinex to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event,https://www.nasdaq.com/press-release/vaccinex-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate
VCYT,5 DAYS AGO,"Veracyte to Present at BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/veracyte-to-present-at-btig-virtual-medtech-digital-health-life-science-diagnostic
VERO,"FEB 9, 2021","Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th",https://www.nasdaq.com/press-release/venus-concept-inc.-to-participate-in-the-btig-virtual-medtech-digital-health-life
VERU,6 DAYS AGO,Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 First Quarter,https://www.nasdaq.com/press-release/veru-sets-another-quarterly-record-in-both-net-revenues-and-in-gross-profit-for
VIE,"FEB 1, 2021","Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio",https://www.nasdaq.com/press-release/horizon-therapeutics-plc-to-acquire-viela-bio-inc.-to-significantly-expand
VINC,"JAN 7, 2021",Vincera Pharma Announces Name Change to Vincerx,https://www.nasdaq.com/press-release/vincera-pharma-announces-name-change-to-vincerx-2021-01-07
VINCU,"JAN 7, 2021",Vincera Pharma Announces Name Change to Vincerx,https://www.nasdaq.com/press-release/vincera-pharma-announces-name-change-to-vincerx-2021-01-07
VINCW,,,
VIR,5 DAYS AGO,"Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021",https://www.nasdaq.com/press-release/vir-biotechnology-to-provide-corporate-update-and-report-fourth-quarter-and-full-year
VIRI,"FEB 1, 2021","Virios Therapeutics, Inc. Announces Research Collaboration to Explore Role of HSV-1 in Irritable Bowel Syndrome",https://www.nasdaq.com/press-release/virios-therapeutics-inc.-announces-research-collaboration-to-explore-role-of-hsv-1-in
VIVE,"FEB 9, 2021",Viveve Recognized for Leadership in Appointing Women to Board of Directors,https://www.nasdaq.com/press-release/viveve-recognized-for-leadership-in-appointing-women-to-board-of-directors-2021-02-09
VIVO,13 HOURS AGO,Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission,https://www.nasdaq.com/press-release/meridian-bioscience-provides-an-update-on-the-revogener-sars-cov-2-eua-submission
VKTX,6 DAYS AGO,"Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17, 2021",https://www.nasdaq.com/press-release/viking-therapeutics-to-report-financial-results-for-fourth-quarter-and-year-end-2020
VKTXW,,,
VMD,5 DAYS AGO,Commonwealth Primary Care ACO and VieMed Healthcare announce an innovative chronic respiratory care and sleep management alliance,https://www.nasdaq.com/press-release/commonwealth-primary-care-aco-and-viemed-healthcare-announce-an-innovative-chronic
VNDA,6 DAYS AGO,Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results,https://www.nasdaq.com/press-release/vanda-pharmaceuticals-reports-fourth-quarter-and-full-year-2020-financial-results
VNRX,4 DAYS AGO,VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock,https://www.nasdaq.com/press-release/volitionrx-limited-announces-closing-of-%2420-million-underwritten-public-offering-of
VOR,6 DAYS AGO,PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering,https://www.nasdaq.com/press-release/puretech-founded-entity-vor-biopharma-closes-over-%24200m-initial-public-offering-2021
VRAY,5 DAYS AGO,ViewRay Announces Appointment of Phil Spencer to its Board of Directors,https://www.nasdaq.com/press-release/viewray-announces-appointment-of-phil-spencer-to-its-board-of-directors-2021-02-11
VRCA,"JAN 19, 2021",Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference,https://www.nasdaq.com/press-release/verrica-pharmaceuticals-presents-positive-data-from-clinical-studies-evaluating-the
VRDN,"JAN 19, 2021","miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team",https://www.nasdaq.com/press-release/miragen-therapeutics-announces-company-name-change-to-viridian-therapeutics-and-new
VRNA,"FEB 2, 2021",CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD,https://www.nasdaq.com/press-release/correcting-and-replacing-verona-pharma-reports-positive-phase-2-results-with-pmdi
VRTX,"FEB 1, 2021",Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results,https://www.nasdaq.com/press-release/vertex-reports-full-year-and-fourth-quarter-2020-financial-results-2021-02-01
VSTM,"JAN 20, 2021","Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology",https://www.nasdaq.com/press-release/frank-neumann-m.d.-ph.d.-to-depart-verastem-oncology-2021-01-20
VTGN,5 DAYS AGO,VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021,https://www.nasdaq.com/press-release/vistagen-therapeutics-reports-fiscal-2021-third-quarter-financial-results-and
VTRS,"FEB 9, 2021","Viatris Inc. to Hold Conference Call on Monday, Feb. 22, 2021, to Discuss 2021 Financial Guidance",https://www.nasdaq.com/press-release/viatris-inc.-to-hold-conference-call-on-monday-feb.-22-2021-to-discuss-2021-financial
VTVT,"JAN 6, 2021",vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually,https://www.nasdaq.com/press-release/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare
VVOS,14 HOURS AGO,Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults,https://www.nasdaq.com/press-release/vivos-therapeutics-launches-vivoscore-diagnostic-technology-for-home-sleep-apnea
VXRT,"FEB 3, 2021",Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate,https://www.nasdaq.com/press-release/vaxart-announces-positive-preliminary-data-from-phase-1-clinical-trial-evaluating-its
VYGR,"FEB 2, 2021",Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program,https://www.nasdaq.com/press-release/voyager-therapeutics-provides-update-on-nbib-1817-vy-aadc-gene-therapy-program-2021
VYNE,5 DAYS AGO,VYNE Therapeutics Announces Reverse Stock Split,https://www.nasdaq.com/press-release/vyne-therapeutics-announces-reverse-stock-split-2021-02-11
WBA,14 HOURS AGO,Walgreens Expressions Creative Art Contest Expands to High School Students Across the Country,https://www.nasdaq.com/press-release/walgreens-expressions-creative-art-contest-expands-to-high-school-students-across-the
WINT,15 HOURS AGO,Windtree Announces Issuance of New U.S. Patent Covering Technology on Its Redesigned AEROSURF® Device,https://www.nasdaq.com/press-release/windtree-announces-issuance-of-new-u.s.-patent-covering-technology-on-its-redesigned
WVE,5 HOURS AGO,Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference  ,https://www.nasdaq.com/press-release/wave-life-sciences-to-present-at-the-10th-annual-svb-leerink-global-healthcare
XAIR,14 HOURS AGO,Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease,https://www.nasdaq.com/press-release/beyond-airr-receives-grant-for-up-to-%242.17-million-from-the-cystic-fibrosis
XBIO,14 HOURS AGO,"Xenetic Biosciences, Inc. Announces Partner's Filing of Registration Dossier in Russia for Epolong Product Candidate That Utilizes Xenetic's PolyXen(R) Platform Technology",https://www.nasdaq.com/press-release/xenetic-biosciences-inc.-announces-partners-filing-of-registration-dossier-in-russia
XBIOW,,,
XBIT,"JAN 21, 2021",XBiotech Candidate True Human™ COVID-19 Therapy Found to Target Highly Infectious Emerging Strain,https://www.nasdaq.com/press-release/xbiotech-candidate-true-humantm-covid-19-therapy-found-to-target-highly-infectious
XCUR,"FEB 9, 2021",Exicure Announces Participation in 10th Annual SVB Leerink Global Healthcare Conference,https://www.nasdaq.com/press-release/exicure-announces-participation-in-10th-annual-svb-leerink-global-healthcare
XENE,"JAN 14, 2021",Xenon Pharmaceuticals Outlines Key Milestone Opportunities and Planned Leadership Transition in 2021,https://www.nasdaq.com/press-release/xenon-pharmaceuticals-outlines-key-milestone-opportunities-and-planned-leadership
XENT,5 DAYS AGO,Intersect ENT Announces Launch of the New Straight Delivery System Packaged with the PROPEL® Mini Sinus Implant,https://www.nasdaq.com/press-release/intersect-ent-announces-launch-of-the-new-straight-delivery-system-packaged-with-the
XERS,4 DAYS AGO,"Xeris Pharmaceuticals Receives European Commission Approval of Ogluo™ (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus",https://www.nasdaq.com/press-release/xeris-pharmaceuticals-receives-european-commission-approval-of-ogluotm-glucagon
XFOR,5 DAYS AGO,"X4 Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call and Webcast on March 4, 2021",https://www.nasdaq.com/press-release/x4-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2020-financial-results
XGN,"FEB 3, 2021","Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference",https://www.nasdaq.com/press-release/exagen-inc.-to-participate-in-btig-medtech-digital-health-life-science-diagnostic
XLRN,14 HOURS AGO,"Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living With Myelodysplastic Syndromes",https://www.nasdaq.com/press-release/health-canada-approves-reblozylr-luspatercept-new-class-of-treatment-for-adult-0
XNCR,6 HOURS AGO,"Xencor to Host Fourth Quarter and Full Year 2020 Financial Results Webcast and Conference Call on February 23, 2021",https://www.nasdaq.com/press-release/xencor-to-host-fourth-quarter-and-full-year-2020-financial-results-webcast-and
XOMA,"JAN 4, 2021",XOMA to Present at H.C. Wainwright Virtual BioConnect 2021 and Biotech Showcase Digital Conferences,https://www.nasdaq.com/press-release/xoma-to-present-at-h.c.-wainwright-virtual-bioconnect-2021-and-biotech-showcase
XOMAP,,,
XRAY,"FEB 4, 2021",Dentsply Sirona to Host Fourth Quarter and Full Year 2020 Conference Call on March 1st,https://www.nasdaq.com/press-release/dentsply-sirona-to-host-fourth-quarter-and-full-year-2020-conference-call-on-march
XTLB,,,
XTNT,"DEC 7, 2020",Xtant Medical Announces Expiration of Rights Offering,https://www.nasdaq.com/press-release/xtant-medical-announces-expiration-of-rights-offering-2020-12-07
YI,"FEB 5, 2021","111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services",https://www.nasdaq.com/press-release/111-inc.-signs-strategic-cooperation-agreement-with-jilin-baiyi-doctor-group-to
YMAB,6 HOURS AGO,Y-mAbs Announces Proposed Public Offering of Common Stock,https://www.nasdaq.com/press-release/y-mabs-announces-proposed-public-offering-of-common-stock-2021-02-16
YMTX,6 DAYS AGO,"Yumanity Therapeutics Provides Update on Its Lead Parkinson’s Disease Clinical Program, YTX-7739",https://www.nasdaq.com/press-release/yumanity-therapeutics-provides-update-on-its-lead-parkinsons-disease-clinical-program
ZBH,15 HOURS AGO,"Vafa Jamali Appointed as CEO of ""NewCo"", New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet",https://www.nasdaq.com/press-release/vafa-jamali-appointed-as-ceo-of-newco-new-publicly-traded-spine-and-dental-company-to
ZEAL,"FEB 9, 2021",Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference,https://www.nasdaq.com/press-release/zealand-pharma-to-participate-in-svb-leerink-9th-annual-global-healthcare-conference
ZGNX,5 DAYS AGO,Zogenix to Release Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25,https://www.nasdaq.com/press-release/zogenix-to-release-fourth-quarter-and-full-year-2020-financial-results-and-host
ZIOP,6 HOURS AGO,"Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021",https://www.nasdaq.com/press-release/ziopharm-oncology-to-report-fourth-quarter-and-full-year-2020-financial-results-and
ZLAB,"JAN 28, 2021",Zai Lab Announces Upcoming Presentations in February Investor Conferences,https://www.nasdaq.com/press-release/zai-lab-announces-upcoming-presentations-in-february-investor-conferences-2021-01-28
ZNTL,6 DAYS AGO,Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors,https://www.nasdaq.com/press-release/zentalis-pharmaceuticals-announces-the-appointment-of-dr.-enoch-kariuki-to-its-board
ZOM,10 HOURS AGO,Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter,https://www.nasdaq.com/press-release/zomedica-corp.-announces-full-exercise-of-over-allotment-option-by-underwriter-2021
ZSAN,"FEB 1, 2021",Zosano Pharma Presents Early-Onset of Action Data for Qtrypta™ in Acute Treatment of Migraines,https://www.nasdaq.com/press-release/zosano-pharma-presents-early-onset-of-action-data-for-qtryptatm-in-acute-treatment-of
ZTS,15 HOURS AGO,Zoetis Reports Fourth Quarter and Full Year 2020 Results,https://www.nasdaq.com/press-release/zoetis-reports-fourth-quarter-and-full-year-2020-results-2021-02-16
ZYME,6 DAYS AGO,Zymeworks to Participate in Upcoming Investor Conferences and Events,https://www.nasdaq.com/press-release/zymeworks-to-participate-in-upcoming-investor-conferences-and-events-2021-02-10
ZYNE,"JAN 4, 2021",Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences,https://www.nasdaq.com/press-release/zynerba-pharmaceuticals-to-present-at-two-january-virtual-investor-conferences-2021
ZYXI,"JAN 28, 2021",Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical,https://www.nasdaq.com/press-release/zynex-appoints-anna-lucsok-as-chief-operating-officer-of-zynex-medical-2021-01-28
